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Unlike most other host-specific mycoplasmas, Mycoplasma gallinarum exists as a
commensal with a host range including most poultry as well as some mammals. This property of
M. gallinarum may reflect unique mechanisms for its colonization and persistence in hosts.
Whereas M. gallinarum shows leucine and arginine aminopeptidase activity, the genes encoding
the enzymes had not been cloned and characterized. We identified an aminopeptidase gene (APN)
by oligonucleotide hybridization to a genomic library of M. gallinarum in lambda ZAPII
bacteriophage. Nucleotide sequence analysis of overlapping phage clones identified a 1,362 bp
open reading frame (ORF) encoding a putative leucine aminopeptidase gene. Database searches
indicate that this ORF has 68% nucleotide identity and 51% amino acid identity with the M. 
salivarium leucine aminopeptidase gene. The active sites of the leucine aminopeptidases in other
eukaryotes and prokaryotes were conserved in the cloned aminopeptidase gene. Northern-blot
hybridization analysis showed that this ORF is expressed as a 1.5 kb transcript. Southern-blot
hybridization analysis demonstrated this gene was present as a single copy in M. gallinarum. 






    
 
      
(EC 3.4.11.1) and is located in the cytoplasm with a weak interaction with the cell membrane.
The subcellular location was further confirmed by immunoblotting with polyclonal anti-
recombinant APN serum and M. gallinarum Triton-114 partitions. Immunoblotting results with
sera from three chickens experimentally infected with M. gallinarum showed that there were very
few proteins in M. gallinarum exposed to the host immune responses and that leucine
aminopeptidase was not able to stimulate production of specific humoral antibody. Our results
suggest that this leucine aminopeptidase play a role in nutrition supply for the host adaptation of
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Mycoplasmas belong to gram-positive bacteria but they differ from other gram-positive 
bacteria in lacking a cell wall (Fox et al. 1980; Woese et al. 1980). Genus I Mycoplasma and 
Genus II Ureaplasma constitute the family Mycoplasmataceae, which belongs to the Order I
Mycoplasmatales in the class Mollicutes. According to the standards of International Committee
on Systematic Bacteriology, Subcommittee on the Taxonomy of Mollicutes (1979), Mollicutes
(molis, soft; cutis, skin, Lat.) is a class of organisms “lack of cell wall, typical colonial
appearance, filterability through a membrane filter with a pore size 450 nm in diameter.” The
Mollicutes include also Order II Entomoplasmatales, Order III Acholeplasmatales, Order IV
Anaeroplasmatales, and some undefined taxonomic phytoplasma (Razin et al. 1998). More than
178 species of Mollicutes have been identified from humans, animals, insects, and plants since
the first animal mycoplasma, Mycoplasma mycoides, was reported by Nocard and Roux in 1898
(Maniloff et al. 1992; Razin et al. 1998; Garnier et al. 2001). The first human mycoplama was 
isolated from female genital organs in the 1930s (Dienes and Edsall 1937; Dienes 1940). 
Physical properties 
Mycoplasma cells vary in diameter from 0.2 to 0.5 µm. Their shape can be coccoid, 
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form a small, smooth, circular colony on culture plates. Some mycoplasmas may be motile on the
surface of eukaryotic cells and show chemotactic behavior. For example, M. pneumoniae shows
gliding motility, but the associated genes have yet to be identified (Razin et al. 1998).
Mycoplasmas grow very slowly, and inhabitants of mammals and birds have an optimal growth
temperature of 37 °C to 38 °C. Growth usually takes more than 3 days to form a visible colony. 
The lack of a cell wall provides mycoplasmas the ability to resist beta-lactam antibiotics,
such as penicillin and ampicillin, which prevent the formation of peptidoglycan, an essential
element in the cell wall. Beta-lactam antibiotics, however, can be added in the media to eliminate 
other bacteria during preparation of mycoplasma cultures. However, the presence of inhibitory
antibiotics in the cultures may affect the antigenicity of some mycoplasmas (Clark et al. 1985). 
Mycoplasmas are sensitive to antibiotics that inhibit protein synthesis, such as tetracyclines and
erythromycins. 
Genomic features 
Mycoplasmas have a small genome, 580 to 1350 kb, and a low Mol%G+C, 23-40% 
(Razin et al. 1998; Woese et al. 1980). It has been proposed that mycoplasmas arose as a branch
with a reduced genome and had a closely phylogentical relation with gram positive bacteria
Bacillus spp. and Clostridium spp. (Maniloff et al. 1992). The low Mol%G+C might result from
mutation of GC to AT pairs by an AT-biased directional mutation pressure (AT pressure).
Different GC content in different mycoplasmas may reflect the footprints of their evolution
(Maniloff et al. 1992). In contrast to other bacteria, mycoplamas utilize the UGA codon in
addition to UGG to encode tryptophan in mRNA (Yamao et al. 1985). UGA serves as a stop
codon in most other bacteria, such as E. coli. This may represent an example of AT pressure





















The genome sequence of M. genitalium, a cause of non-gonococcal urethritis in humans, 
was elucidated in 1995 (Fraser et al. 1995). Since then, the genome sequences of three other
source-originated mycoplasmas, M. pneumonia, M. pulmonis, and U. ureaplasma, have been
completed (Himmelreich et al. 1996; Glass et al. 2000; Chambaud et al. 2001). The number of
genes coding proteins varies from 484 in M. genitalium to 782 in M. pulmonis. These numbers
are much smaller than corresponding gene numbers in other bacteria. For example, Escherichia
coli K-12 has 4,289 protein-coding genes (Blattner et al. 1997). There are also fewer genes
encoding tRNA in mycoplasma genomes. Mycoplasma pulmonis only has 30 structural RNA 
genes, whereas E. coli K-12 has 115 structural RNA genes. The reduced gene number reflects one
feature of mycoplasmas: they lack the genes to synthesize a cell wall and many of the genes of
major biosynthetic pathways for amino acid, fatty acid, and nucleic acid precursors (Himmelreich
et al. 1997). On the other hand, there are some repetitive genomic sequences in mycoplasma
genomes that can be classified as structural gene fragments, integrated viral sequences, and
insertion-like (IS) elements. For instance, M. pneumoniae has multiple P1 operons; the S. citri
genome contains the SpV1 virus sequence; and IS elements and transposons were reported to be
distributed in different mycoplasma genomes, such as M. homonis and M. hyopenumoniae. The
ongoing Mollicutes genome sequencing projects include M. mycoides sbsp. Mycoides SC, M.
hyopneumoniae, M. gallisepticum, M. penetrans, S. citri, and S. kunkelii. The genomic data
obtained by comparative genome analysis will provide a more comprehensive understanding of




















Mycoplasmas have been known as a widespread “ideal parasite” (Razin et al. 1998),
generally causing little disease. However, they have been associated with diseases after the host is
herded or crowded, like other infectious pathogens. 
In humans, more than 16 mycoplamas have been associated with various diseases (Tully
1993). Among them, M. salivarium, M. orale, M. buccale, M. faucium, M. lipophilum, M. 
pneumoniae, and A. laidlawii may colonize the oropharynx of humans. Mycoplamsa primatum, M.
spermatophilum, M. penetrans, and U. Urealyticum primarily colonize in the genitourinary tract
of humans. Mycoplasma hominis, M. genitalium, and M. fermentans may colonize in both the
oropharynx and genitourinary tract. 
More than 20 species of mycoplamas have been isolated from avian species (Stipkovits 
and Kempf 1996; Yoder 1991). The mycoplasma species from chickens and turkeys include M.
gallisepticum, M. synoviae, M. meleagridis, M. iowae, M. gallopavonis, M. cloacale, M.
gallinarum, M. gallinaeceum, M. pullorum, M. iners, A. equifetale, M. imitans, and Ureplasma 
gallorale, and Ureaplasma spp. The species from ducks and geese include M. anseris, M. anatis,
A. axanthum and M. imitans. Mycoplasma glycophilum, M. lipofacies, and A. laidlwii have been
reported from both birds and waterfowl. The pigeon source mycoplasmas include M. columbinum,
M. columbinasale, and M. columborale. Among these mycoplamas, M. gallisepticum, M.
synoviae, M. meleagridis and M. iowae have been most significant to the poultry industry.
Mycoplamsa gallisepticum can cause chronic respiratory disease (CRD) in chickens and 
infectious sinusitis in turkeys. Mycoplasma synoviae generally causes a subclinical respiratory 
infection and occasionally results in an infectious synovitis. Mycoplamsa meleagridis infection
























iowae is a problem in the hatchery because it reduces hatchability and increases embryonic
mortality (Yoder 1991). 
Mycoplasmas may also spread widely to other animals, insects, and plants. Mycoplasma
pulmonis is an important pathogen in the respiratory and genital tracts of mice and rats, and M.
capri and M. mycoidesis may cause pleuropneumonia in goats and the bovine. Mycoplasma
suipneumoniae may be the etiological agent of enzootic pneumonia of pigs (Taylor-Robinson
1975), M. equirhinis causes disease in horses (Allam and Lemcke 1975), and M. hyosynoviae and
M. hyorhinis may cause arthritis in pigs (Nielsen et al. 2001; Furlong and Turner 1975).
Mycoplasma hyopneumoniae is a frequent cause in pneumonia in piglets, and M. mobile, M. 
phocarhinis, and M. phocacerebrale were isolated from aquatic animals (Furlong and Turner
1975; Wilson 1976). However, rabbits are unusual in their lack of mycoplasma infection. This
characteristic makes them partiticularly valuable for generating antisera for mycoplasmas
(Maniloff et al. 1992). The wide prevalence of mycoplasmas also includes insects and plants
(Bove 1981; Maniloff et al. 1992; Garnier et al. 2001).
Nutrition and host specificity 
Because mycoplasmas do not encode many of the major genes for synthesis of
macromolecule precursors, amino acids, lipids, and nucleotides, the survival of mycoplasmas 
depends on a nutrient rich environment. The growth environment is critical. A change of the
environment may kill mycoplasmas or change their physical properties (Maniloff et al. 1992).
Excessively rich media may inhibit growth (Razin et al. 1998). 
Nutritional requirements and optimal growth media have not been defined for most
mycoplasmas. Mycoplasma media development is done experimentally. Generally, a large





       
   













vary for each mycoplama, even for different strains of the same species of mycoplasma. Two 
strains of A. laidlawii show different amino acid requirements. Spiroplasma melliferum only
needs asparagine, cysteine, and glutamine, and this species may represent the Mollicute with the 
fewest required amino acids (Moniloff et al. 1992). In the host, amino acids may be provided by
proteolytic degradation of proteins (Clark et al. 1985). 
The inorganic requirements are also difficult to define. A high concentration of ions may 
inhibit mycoplasma growth. Zn2+, Mn2+, Co2+, and Fe2+ have been reported to prevent the growth
of M. mycoides if the ionic concentration is higher than 1mM (Moniff et al. 1992). The inhibitory
effect may vary for different media. Watanabe (1994) demonstrated that M. orale was more
sensitive to MnCl2 than was M. salivarium, and MnCl2 had a higher inhibitory effect in media 
with 10% (vol/vol) horse serum than in media with 20% (vol/vol) horse serum.
Mycoplasmas are grouped as fermentative and non-fermentative, based on utilization of
glucose. Mycoplasma gallisepticum is a typical fermentative mycoplasma, which employs 
glucose as a principle energy source. Different metabolic products may be derived from glucose,
based on specific growth conditions. Lactate is produced under anaerobic conditions and acetate
is produced under aerobic conditions. With M. fermentans, lactate will be produced in both 
anaerobic and aerobic conditions (Maniloff et al. 1992; Miles et al. 1991). 
Non-fermentative mycoplasmas do not ferment sugar to produce acid. They may 
hydrolyze arginine or oxidize lactate, pyruvate, α-ketobutyrate, or ethanol as an energy source.
Mycoplasma hominis and M. gallinarum are arginine-utilizing and non-fermentative
mycoplasmas. Arginine hydrolyzation is accomplished through the arginine dihydrolase pathway.
Most arginine-utilizing mycoplasmas utilize arginine as the only energy source (Maniloff et al.





















ethanol, L-lactate, pyruvate, or 2-oxobutyrate as alternative energy sources. The organic acid
catabolism does not interfere with arginine hydrolysis in M. gallinarum (Taylor et al. 1994). 
The diverse habitats of various mycoplasmas reflect different nutrient requirements. This
difference may underly the host or tissue-specific properties of most mycoplasmas. However, 
some mycoplasmas are exceptions. Mycoplasma iowae, an important mycoplasma for the poultry
industry, has been isolated from apple seeds (Maniloff et al. 1992). Moreover, M. gallinarum and
another Mollicute, A. laidlawii, have been reported in both mammalian and avian hosts
(Stipkovits and Kempf 1996; Yoder 1991; Tully 1993; Maniloff 1992; Taylor-Robinson and
Cherry 1972; Taylor-Robinson, Williams, and Haig 1968; Singh and Uppal 1987). Acholeplasma
laidlawii was even reported in both plants and insects (Maniloff et al. 1992). Mycoplasma
fermentans has been isolated not only from urogenital tracts, respiratory tracts, and joint fluids,
but also in cell culture. Ozcan and Miles (1999) found that different strains of M. fermentans had 
different utilization patterns for nutrient components such as glucose, fructose, and N-
acetylglucosamine, and that the patterns were associated with the colonization sites of the strains.
They suggest the different nutrition utilization was due to insertion sequence-like elements in the
M. fermentans genome. The underling mechanisms need to be evaluated. 
Membrane structures 
Like many other bacteria, the cell membrane of mycoplasmas possesses important
functions besides providing a physical barrier. Because mycoplasmas must import a large number
of nutrients from their extracellular environments, the membrane plays a very active role in
metabolism. Mycoplasma membranes mainly are composed of phospholipid bilayer and various
proteins, which consistute up to 2/3 of the membrane mass (Razin, Yogev and Naot 1998). 
 
   
 
 



















There are more than 28 different U. urealyticum transporters, which represent 9
transporter families: “(1) an F-type ATPase; (2) two Amt ammonium transporters; (3) CopA, a
copper-importing P-type ATPase, and PacL, a cation transport P-type ATPase; (4) a K+ channel 
from the voltage-gated ion channel (VIC) superfamily; (5) a Mg2+ MgtE transporter; (6) XasA a
glutamate: GABA antiporter from the amino-acid-polyamine-organocation (APC) transporter
superfamily; (7) two multidrug antimicrobial extrusion family transporters (MATE); (8) a ptsH
element of a phosphoenolpyruvate-dependent sugar phosphotransferase transport system (PTS),
which probably has a regulatory instead of transport function as the genome lacks the PTS EI
component needed for sugar transport; and (9) a broad array of ABC transporters” (Glass et al.
2000). However, the transporters for bases, nucleotides, nickel, and urea have not been identified
in U. urealyticum, and possibly they are in the hypothetical proteins whose functions have not
been defined (Glass et al. 2000). 
The gene numbers of lipoprotein in the complete genomes vary from 29 in M. genitalium
to 54 in M. pneumonize, 60 in M. pulmonis, and 19 in U. urealyticum (Himmelreich et al. 1996;
Himmelreich et al. 1997; Chambaud et al. 2001; Glass et al. 2000). Some of these annotated
proteins are putative lipoproteins. The prokaryotic signal peptides were present in mycoplasmal 
membrane-bound proteins to direct the protein into the target location site after synthesis and
processing (Yogev et al. 1991; Mader et al. 1991; Markham et al. 1993; Cleavinger et al. 1994;
Cleavinger et al. 1995; Theiss et al. 1996; Voelker and Dybvig 1999; Flitman-Tene et al. 2000;
Nishiguchi et al. 2001). Edman et al. (1999) compared the signal peptides from mycoplasmal
membrane protein with those from gram-positive bacteria and E. coli. They found mycoplasmal
signal peptides are different from the other two categories in many aspects: mycoplasmal signal
peptides have longer sequences than do any other bacterial signal peptides; mycoplasmal signal
peptides have their own unique periodicities of side chain hydrophobicity and volume and a 
 
 










     
 







differing N terminal charge. Some differences with other bacteria signal peptidases were also
found. The membrane proteins in M. pneumoniae were detected based on a signal peptide
preceding a cysteine residue. However, details about processing and targeting of the membrane 
proteins are unknown. Currently, three categories of signal peptidases have been reported in 
prokaryotes, and they are lipoprotein diacylglycerol transferase, prolipoprotein signal peptidase,
and phospholipids N-acyltransferase. The lipoprotein diacylglycerol transferase has been found in
M. genitalium, M. pneumoniae, and M. pulmonis. The prolipoprotein signal peptidase was
identified only in M. pulmonis. The phospholipids N-acyltransferase has not been identified in
any of these three genome sequences (Himmelreich et al. 1997; Chambaud et al. 2001). Jan et al.
(1995) showed that M. gallisepticum has an acylation mechanism similar to that in gram-negative 
bacteria, but different mycoplasmas probably have different mechanisms (Razin et al. 1998). 
The fatty acids of membrane lipids, including phospholipids, glycolipids, and neutral
lipids, are the primary sources of the hydrophobic core in mycoplasmal membranes. Like most
other macromolecular synthesis procursors, mycoplasmas have a fastidious requirement for lipids.
Different from other bacteria, mycoplasmas have a unique need for cholesterol. These membrane 
lipids have been associated with fusogenic properties of mycoplasmas. Because of the lack of a
cell wall, mycoplasmal cell membranes contact directly with eukaryotic cell membranes. The
membrane fusion leads to exchange of DNA and other biological materials between mycoplasmas
and the eukaryotic cells, such as the importation of the nutrient requirements from the host cells
and the exportation of DNA into the host cells (Rottem and Naot 1998; Razin et al. 1998).
Dimitrov et al. (1993) reported that cell fusion of M. fermentans with T lymphocytes may require
a proton gradient across the cell membrane. The membrane fusion may facilitate gene transfer
between mycoplasmal cells and the host cells. 
 
     
  
 








    
  
   
 








The bacterial oriC replication origin has been found in many Mollicutes genomes. It was
reported that oriC origin was identified in S. citri, M. homonis, and M. capricolum and in the four
completely sequenced mycoplasmas genomes, M. genitaium, M. pneumonia, M. pulmonis, and U.
urealyticum (Chambaud et al 2001; Renaudin et al. 1995; Himmelreich et al. 1997; Glass et al.
2000; Sano and Miyata 1994; Hilbert et al. 1996). However, there exists a divergence between the
replication origins in Mollicutes and those from bacteria. Not all of the components in bacterial
oriC have been found in mycoplama oriC, although generally rnpA-rmpH-dnaA-dnaN-recF-gyrB
is highly conserved in mycoplasmas (Razin et al. 1998). The gyrA and gyrB genes were located 
elsewhere in the M. pulmonis genome and were not found in M. hominis and M. capricolum. In M. 
genitalium, AT and GC content skews symmetrically around the origin and terminus of
replication (McLean et al. 1998). 
Some mycoplasmas, such as M. orale, M. hyorhinis, and U. urealyticum, have only a
single DNA polymerase, whereas there are three DNA polymerases present in S. siproplasma and
A. laidlawaii. The DNA polymerases of M. orale, M. hyorhinis, M. genitalium, M. pneumonis,
and M. pulmonis lack 3’→5’ proofreading function and impart a high rate mutation in these
mycoplasmas (Barnes 1994; Razin et al. 1998).  
The mycoplasmal RNA polymerases are similar to other bacteria polymerases in that they
are encoded by conserved genes rpoA (α subunit), rpoB (β subunit), and rpoC(β’ subunit).
However, unlike other bacterial RNA polymerases, mycoplasmal RNA polymerases are not
sensitive to rifamycin and streptolydigin. There is a single sigma factor in mycoplasmas, but at
least 6 in E. coli and 18 in B. subtilis (Razin et al. 1998). 
It was reported that E. coli transcription factors can recognize mycoplasma promoters
that are similar to those in E. coli (Dhandayuthapani et al. 1998). The Shine-Dalgarno sequences
 

















(AGGAGG) may be present in some mycoplasmal genes, whereas some mycoplasmal genes do 
not have this leader translation signal (Razin et al. 1998). The genome analysis using positional
weight matrices (Boyle and Boyle, submitted) showed the annotated open reading frames in M. 
pneumoniae and M. genitalium do not have apparent Shine-Dalgarno sequences (Figure 1.1 A
and B). However, in U. ureaplasma and M. pulmonis, the Shine-Dalgarno sequences are very
apparent (Figure 1.1 C and D). Loechel et al. (1991) found another signal sequence
(UUAACAACAU) was applied as a ribosome binding site in the tuf gene of M. genitalium. This
sequence also worked well for E. coli LacZ gene. The rho-independent termination is usually 
employed to terminate the transcription in mycoplasmas. This termination class utilizes the step
loop structure at the 3’ of the gene sequence followed by a series of U residues and does not
depend on the rho termination factor (Calcutt et al. 1999; Taschke and Herrmann 1986; Bove
1993). The elongation factors, NusA gene and NusG gene, have been identified in M. genitalium
and M. pneumoniae. NusA decreases termination efficiency, and NusG increases termination
efficiency in E. coli (Burns et al. 1998; Mah et al. 1999). Their roles in mycoplasmas are
unknown. 
Like other bacterial pathogens with small genomes, mycoplasmas have evolved to
maintain genetic polymorphism so that they can evade the host immune response (Palmer 2002).
As a result, a large portion of their genomes encoded lipoproteins, which play an important role in














Figure 1.1 The positional weight matrices of mycoplasmal genomes. A. M. genitalilum; B. M. 
pneumonia genomes; C. U. urealyticum; and D. M. pulmonis. The genomes of M. genitalium and 
M. pneumonia genomes do not have G rich regions at the SD region, whereas those of M. 
pulmonis and U. urealyticum do. These results suggest there might be different translation























Pathogenesis and persistence in the hosts 
The relations between mycoplasmas and associated hosts can be symbiosis or parasitism. 
Mycoplasmas generally exist as “ideal parasites” in chronic infections rather than as lethal
pathogens in acute infections. However, parasitic and symbiotic existences are difficult to define
confidently (Mims et al. 2001). Because of the knowledge gained about their pathogenesis, 
mycoplasmas have been implicated in various important human diseases, such as AIDS, the gulf
war syndrome, chronic fatigue syndrome, Crohn’s disease, and various arthritides (Razin et al.
1998). Mycoplasma fermentans, M. pirum, U. Urealyticum, and M. homonis have been reported
to be associated with HIV infections (Pollack et al. 1993; Cordova and Cunha 2000). As stated in
the introductory section, mycoplasmas can also have different pathogenecities in different
animals.  
Factors involved in pathogenesis 
Like many other bacterial pathogens, mycoplasmas enter hosts through epithelial cells of
the body surfaces, especially the mucosal tissues of the respiratory or urinogenital tracts. 
Mycoplasmas can be transmitted among hosts both vertically or horizonally. Both pathways have
been demonstrated for Mycoplasma gallisepticum infection (Yoder 1991). Kleven (1981) found
leghorn chickens have a greater transmission potential during rather than after the first 4 weeks of
infection. Lin and Kelven (1982a) found that egg transmission of M. gallisepticum occurred at a
high rate the first 4 weeks postinfection. Grattard et al. (1995) demonstrated vertical transmission
of U. urealyticum and M. hominis by isolating both mycoplasmas from women at delivery and
from their neonates. 
The pathogenesis of mycoplasmas may be affected by different factors. Different species
of hosts, even different individuals, may show differing resistance to mycoplasma infection.
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Turkeys are more susceptible to M. gallisepticum infection than are chickens. Mycoplasma
gallisepticum may cause serious airsacculitis in turkey poults (Lin and Kelven 1982b), and
different infection routes may result in differing pathogenecity. For M. gallisepticum, the
intrasinus or intra-air sac inoculation may generate more serious lesions than the introaocular,
intranasal, or intratracheal routes (Yoder 1991). Also, different strains of mycoplasmas may show
differing virulence within a species. Power and Jordan (1976) showed that M gallisepticum S6 
caused high mortality in chicks, turkey poults, and embryos, whereas two other strains of M.
gallisepticum had much less virulence. In addition, co-infections with other viruses, bacteria, or
parasites usually increased pathogenecity of M. gallisepticum infection. The clinical signs in
chickens with M. gallisepticum are often serious when the chickens are co-infected with
infectious bronchitis virus or avian influenza virus. Moreover, the pathogenicity may also be
complicated by environmental conditions. Stress promotes infection by mycoplasmas, and this is
a probable explanation for the observation that M. gallisepticum infection is more severe during
cold winter. Mycoplasma infection rate depends also on how long it survives in the environment.
Nagatomo et al. (2001) demonstrated that survival of M. bovigenitalium, M. gallisepticum, M.
bovirhinis, and M. gateae depended on medium components and environmental temperature.
The pathogenesis of mycoplasma infections has been investigated extensively. As with
other microorganisms, mycoplasmas are challenged by diverse environments. To survive in a
potentially adverse environment, the bacteria must have mechanisms to compensate for 
challenges. Only those bacteria that can “enter, adhere to, and replicate” within the hosts would
be maintained in the population (Razin et al. 1998). One challenge for the mycoplasmas in vivo is 
to avoid the host immune responses. As a result of selection pressures, mycoplasmas have
developed a special tip structure organelle for adhesion and a series of strategies to avoid

























associated with mycoplamsa infection results from innate and adaptive immune responses
generated against the bacteria. 
Studies show that mycoplasmas do not produce toxins, although metabolism by-products,
such as hydrogen peroxide, superoxide radicals, and ammonia, may damage host cells (Megid et
al. 2001; Avron and Gallily 1995; Stalheim and Gallagher 1977; Kannan and Baseman 2000b).
Recently, the bacteriophage MAV1 was found to increase the virulence of M. arthritidis to host
cells after infecting this species of mycoplasma. Voelker and Dybvig (1999) identified a potential
virulence factor in this virus.
Adhesion to host cells 
Adhesion of mycoplasmas to host cells is a prerequisite for successful infection and
colonization. Various adhesion-related lipoproteins and associated factors have been identified
and characterized in different mycoplasmas. Loss or mutation of the corresponding genes
encoding these cytadhesins will remove or weaken the adhesion ability of these pathogens and
thus their virulence. In addition to the cytadhesins, adhesion of mycoplasmas requires the
presence of corresponding receptors in host epithelial cells, such as sialoglycoconjugates and
sulfated glycolipids (Razin et al. 1981; Kahane et al. 1982; Kahane 1983 &1984; Zhang et al.
1994; Krivan et al. 1989). Receptors vary due to different adhesion circumstances. Even the same
strain of mycoplasma may have different attachment mechanisms due to different host receptors
(Gabridge et al. 1977). As a result, the presence of a flexible adhesion complex in mycoplasmas
provides more opportunity to survive in hosts. The data relating to a large number of cytadhesins
and their accessory proteins identified so far have given strong evidence of this flexibility. The















   
 
 









Mycoplasma pneumoniae. Mycoplasma pneumoniae is one of the mycoplasmas whose
adherence mechanisms have been best characterized. This mycoplasma has specificity for various
sialoligosaccharides of glycoproteins, which are found on host cells and erythrocytes (Gabridge
and Taylor-Robinson 1979; Loomes et al. 1984; Roberts et al. 1989). This mycoplasma can also
bind specifically to sulfated glycolipid, which can be inhibited by dextran sulfate (Krivan et al.
1989). Ultra-structural studies with tracheal tissue infected with M. pneumoniae showed that a
specialized extension of the mycoplasma cell membrane, the attachment organelle, is found in
close association with tracheal cells (Herrmann and Reiner, 1998). These organelle proteins are 
located in the M. pneumoniae Triton X-100-insoluble fraction or triton shell. Expressed on the
surface of the M. pneumoniae attachment organelle are the products of two adhesin genes, P1 and
P30 (Krause et al. 1982; Dallo et al. 1990; Krause 1996; Razin and Jacobs 1992). The P1 and P30
gene products are integral membrane proteins and are critical for adherence to respiratory
epithelium cells. Avirulent mutant isolates of M. pneumoniae lacking the expression of P1 or P30
or both genes failed to adhere to host cells in vitro (Hedreyda and Krause 1995). Studies
demonstrated that the P1 protein product functions as a bonafide adhesin by recognizing host cell
glycoproteins (Dallo et al. 1988), and the P30 gene product was found to serve an accessory role
required for the adherence properties of the P1 protein (Romero-Arroyo et al. 1999). Interestingly,
both P1 and P30 genes show homology to eukaryotic cytoskeletal proteins, keratin, fibrinogen,
myosin, and actin (Su et al. 1987; Dallo et al. 1996). These proteins have proline rich repeats (X-
Pro-Pro-X) in the C terminus that might be involved in forming the spatial organization of tip
structure of the organelle. 
The Mycoplasma pneumoniae attachment organelle is a network of lipoproteins. Besides
P1 and P30 mentioned above, HMW1, HMW2, HMW3, HMW4, P65, P40, P90, and proteins A,
B, and C are also reported as components of the attachment organelle (Krause 1998; Baseman et
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al. 1987; Franzoso et al. 1993). These proteins have been localized subcellularly by
immunoelectron microscopy (Seto et al. 2001). Mutant characterization demonstrated these
proteins were involved directly or indirectly in enhancing the adhesion of M. pneumoniae to all 
hosts. For instance, HMW1, located in filamentous extensions of the mycoplasma cells, is
involved in P1 trafficking to the attachment organelle and in locating other components of the
organelle (Hahn et al. 1998; Seto et al. 2001). HMW3 dominates the tip structure of the organelle
as a polymer and enhances the attachment by increasing surface area. HMW3 forms an electron-
dense core anchored to the terminal button with the functions of other proteins such as P30, P90,
and P40 (Stevens and Krause 1992; Krause 1998). P65 is another cytoskeleton protein found in
the organelle. However, the level of P65 was reportedly be related to the level of other organelle
components, such as HMW1, HMW2, P1, P30, A, B, and C (Jordan et al. 2001). Recently, Layh-
Schmitt et al. (2000) demonstrated that pyruvate dehydrogenase might also be a component of the
attachment organelle. DnaK, one subunit of pyruvate dehydrogenase, might enhance the
translocation of protein from the cytoplasm to the membrane. 
Based on the M. pneumoniae organelle assembly model established by Seto et al. (2001),
all of the components would be translocated in a specific order. HMW1 would be translocated
first, followed by a group of proteins, and HMW3, P1, P30, P90, and P40. P65 would be
translocated later. 
Mycoplasma genitalium. The attachment mechanisms of M. genitalium and M. 
pneumoniae have also been investigated, because both are significant to human health.
Mycoplasma genitalium infects and colonizes the urigenital tract, whereas M. pneumoniae
localizes in the respiratory tract. The MgPa cytadhesin of M. genitalium showed large homology
with P1 in M. pneumoniae (Hu et al. 1987; Inamine et al. 1989; Mader et al. 1991; Opitz and























conserved. Proline-rich organization indicates an inflexible structure, and cysteine-rich
organization indicates a flexible structure. A proline-rich region is usually involved in the
interaction of multiple proteins (William 1994). This suggests that this region has important
functions during the interaction between cytadhesins and their receptors. Interestingly, the other 
two cytadhesins in M. genitalium, P32 and P69, not only were homologous with P30 and HMW3
in M. pneumoniae, but also conserved the operon-like organization of the latter. Moreover, the
accessory proteins in M. pneumoniae, HMW1, HMW2, and HMW4, were also identified in M.
genitalium. 
Despite the similarity between MgPa and P1, epitope mapping experiments with different
anti-MgPa monoclonal antibodies demonstrated different adherence sites. The functional domain 
of MgPa is apparently located in a region of the sequence that is not homologous with P1 in M.
pneumoniae (Opitz and Jacobs 1992). These results suggest that mycoplasmas have adapted to
different epithelial cells during evolution. The different A+T content in MgPa and P1 suggests
these two genes might have evolved independently (Dallo et al. 1989). The associated similarity
might result from a gene transfer during evolution (Reddy et al. 1995). 
Mycoplasma gallisepticum. The adhesion of M. gallisepticum to glycoprotein on ciliated
tracheal epithelial cells is necessary for the initiation of chronic respiratory disease in poultry
(Glasgow and Hill 1980; Whithear 1996). Experiments to evaluate the adhesion of M. 
gallisepticum to glass suggested that an ionic bond rather than salt bridges functions in the
attachment process (Kahane et al. 1979).  
Similar to other mycoplasmas, a number of lipoproteins have been associated with this
adhesion of M. gallisepticum to host cells. The cytadhesin mgc1 cloned from a virulent field 







   
   
  
 













to P1 in M. pneumoniae (28.7%) (Dohms et al. 1993; Keeler et al. 1996). The mgc1 gene was
identified as the second gene of a three gene operon. Subsequent studies identified the first gene
of the same operon as a P30 homolog termed mgc2. This 0.9 kb open reading frame showed
about 40.9% predicted amino acid homology with the P30 of M. pneumoniae and 31.4% with P32
of M. genitalium (Hnatow et al. 1998). An additional P30-like cytadhesin, pvpA, was identified in
M. gallisepticum with 54% and 52% homology to P30 of M. pneumoniae and P32 of M. 
genitalium, respectively. pvpA also shared 50% homology with P30 of mgc2 and 49% to HMW3
of M. pneumoniae. Similar to some organelle components in M. pneumonae, pvpA protein has a
proline-rich carboxy-terminal region. Interestingly, the pvpA gene showed length variation in
different strains of M. gallisepticum (Boguslavsky et al. 2000). GapA, another P1-like cytadhesin
in M. gallisepticum, is a trypsin-sensitive, surface-exposed protein, and the encoding gene exists
as a single copy in M. gallisepticum (Goh et al. 1998). Papazisi et al. (2000) found that two
proteins, p116 and p45, may also play an important role in the adherence process.
Additionally, pMGA cytadhesins were found to function in the adhesion of M. 
gallisepticum (Markham et al. 1992). Studies suggested that there are between 33 and 79 copies
of this gene in the virulent M. gallisepticum S6 and R strains, respectively (Baseggio et al. 1996).
The currently ongoing M. gallisepticum genome sequencing project will unveil the structural
organization of this cytadhesin family. 
Other mycoplasmas. A number of adherence associated proteins were also identified
and characterized in other mycoplasmas. Some of them are homologous to the proteins described 
above. However, some are novel and do not show any homology with the currently identified
cytadhesins, such as P50 in M. hominis and P97 in M. hypopneumoniae (Feldmann et al. 1992;









      
 
 










in different mycoplasmas genomes, such as vlp family in M. hyorhinis, vsp family in M. bovis, 
and vsa family in M. pulmonis (Rosengarten and Wise 1991; Behrens et al. 1994; Bhugra et al.
1995). As stated above, different numbers of cytadhesins provide the opportunity for
mycoplasmas to infect different hosts. The motility of mycoplasmas carries them to the target
colonization sites, at which the attachment process begins. 
Antigenic variation 
Antigenic variation of surface antigens is one mechanism by which mycoplasmas evade
phagocytosis from the host immune system (Razin et al. 1998). This phenomenon is also called
phenotypic switching because this process will result in alteration of the microorganism’s
phenotype. Antigenic variation may result from random point mutations in associated genes. This
variation is irreversible and inherited by the next generation. This phenomenon is also referred to
as phase variation, and it may occur even without host immune responses and generate a large 
mutant pool. However, host phagocytes and shifting of the bacteria’s living environments may 
provide selection pressure for this process. As a result, only the population with “preferred”
mutations will survive. Another source of antigenic variation comes from regulated antigenic
changes that respond to the extracellular signals, which might regulate the expression of a gene
family in mycoplasmas and lead to alteration of the bacteria’s antigenic character. 
The changes in mycoplasma surface proteins are usually studied with monoclonal
antibody reagents and colony blots of colonial mycoplasma populations. In these experiments, a 
given strain would appear heterogeneous for the expression of a particular protein, as detected by
a monoclonal antibody reagent. Those colonies that lack expression of the protein will generally
initiate expression of the protein with replating (Rosengarten and Yogev 1996). This has led to
























immune response (Citti and Rosengarten 1997). As stated above, mycoplasmas could have a
different protein export system from other bacteria. So mycoplasmas might have an efficient and
unique signal transport pathway by utilizing the minimal associated genes in their genomes. 
However, the minimal genomes of mycoplasmas have a limited number or no genes associated
with this signal transport process (Razin et al. 1998). Thus, phase variation with random
mutations may be a more frequent mechanism utilized by mycoplasmas.  
Antigenic variation via regulation of gene family expression. Although they have a 
minimal genome size, many mycoplasmas have a number of gene repeats, such as pMGA gene 
family in M. gallisepticum, vlp family in M. hyorhinis, vsp family in M. bovis, and vsa family in
M. pulmonis. In M. gallisepticum, the pMGA gene family occupies up to 7.7% and 16% of the
total genome size in strains F and R, respectively (Razin et al. 1998). Presence of these various
gene copies allows the flexibility of turning on or off an individual gene copy during expression.
In addition, the selection of a gene from the family can cause alternation of its length to provide
further flexibility.
Although there are a large number of pMAG gene copies in M. gallisepticum, only a
single copy of this gene will be expressed for an individual strain. For example, M. gallisepticum
S6 strain expresses the pMGA1.1 gene, whereas the M. galliseptcum R strain expresses the 
pMGA1.2 gene. In RT-PCR experiments, a low level of mRNA for two additional pMGA genes 
(pMGA1.4 and pMGA1.8) was also found in the M. gallisepticum S6 strain population. However,
only the pMGA1.1 gene was expressed at the protein level (Glew et al. 1995). These observations
were confirmed further and extended by Milosevic et al. (2000). They examined pMGA gene 
expression in samples of virulent M. gallisepticum obtained from infected chickens throughout

















      
 
   





1.2 or pMGA 1.9 gene, but not both. It is intriguing that in the samples that expressed only the
pMGA1.2, analysis of the primary sequence revealed duplication or deletion of short sequences.
Moreover, other deletions of sequence within the pMGA1.2 gene of some samples resulted in the 
loss of epitopes recognized by monoclonal antibodies. These studies suggest a mechanism by
which M. gallisepticum strains can survive in the presence of host immunity, given the limited
number of pMGA genes expressed. However, it is unclear if the pMGA variant proteins possess
additional functions in the host adaptation of M. gallisepticum. 
One example of a gene family in which surface proteins differ in amino acid sequence is
the vsp gene family of M. bovis. At the gene level, the vsp genes show conservation in the 5’
region encompassing the lipoprotein signal peptide sequence. However, the C-terminal region of
the genes contain 1 to 4 regions or blocks of repeated sequences. The expansion or contraction of
these regions can result in surface vsp proteins with different antigenic properties (Rosengarten et
al 1994; Sachse et al. 2000).
The vlp family of M. hyorhinis shows variation both in size and expression. The vlp
lipoproteins are encoded by a family of 7 genes. In the promoter region of these genes is a
sequence of adenines that undergoes random length changes by the addition or deletion of a
single base pair. Only those vlp genes with a total of 17 adenines in this region are transcribed,
and silencing the gene correlates with the presence of an additional base pair. Similar to the vsp
genes of M. bovis, the C-terminus of the vlp genes has several regions of repeated sequence
(Yogev et al. 1991&1995). Examination of colony blots of M. hyorhinis isolates with vlp-specific
monoclonal antibodies demonstrated that more than one vlp gene can be expressed at a time 
(Rosengarten and Wise 1991). 
Similar to the pMGA family of M. gallisepticum, the number of vsa copies can vary for
different M. pulmonis strains. Seven vsa genes were found in the M. pulmonis UAB 6510 strain,
 
 
   
   



















and 11 of these genes were reported in strain KD735-15 (Bhugra et al. 1995; Shen et al. 2000).
Shen et al. (2000) compared the vsa genes in M. pulmonis KD735-15 with those in strain CT.
They found that vsaB and vsaD are absent in CT and vsaG and vsaH are absent in KD735-15.
Like M. gallisepticum, only a single vsa gene is expressed for a given strain of M. pulmonis
(Bhugra et al. 1995). The difference between active vsa genes and silent vsa genes is that the
latter do not have a lipoprotein signal peptides. However, both genes conserved the vsa mature
protein coding sequence and 3’-terminal repetitive elements (Simmons et al. 1996). 
In addition to the variable expression of genes for a large gene family, mycoplasmas also
have mechanisms to shield the products of single copy genes from the host immune response.
Zhang and Wise (2001) found the expression of P120 masked the expression P56 in M. hominis
and P120 was present only when the P56 protein was absent. These mechanisms would enhance
the antigenic diversity of mycoplasma surface protein presented to the immune system.  
Phase variation via random mutations. The mutations contributing to phase variation
could occur at the promoter regions, the sequence preceding the mature protein or the inner
sequence of the protein. The first case would down-regulate the expression, and the latter two
would lead to phenotypic shifting in translational level. In addition, phase variation can occur
through genomic rearrangement, which might result from gene conversion, DNA inversion, gene
duplication or homologous recombination, or movements of a transposon within the chromosome
(Razin et al. 1998; Lysnyansky et al. 1996). 
At 21 bases upstream of the -35 box of pMGA in M. gallisepticum, there are a series of
GAA tri-nucleotide repeats (Markham et al. 1993). Previous studies suggest that the exact
number (12) of GAA repeats is required for proper positioning of the RNA polymerase and
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less than this number blocks expression of the pMGA gene. In the vlp promoter of M. hyorhinis, 
there is a poly (A) track between the -10 box and -35 box. The alteration of this poly (A) site with
random insertion or deletion also led to an on and off switching of transcription (Yogev et al.
1991; Citti and Wise 1995).
There is a poly(A) site located between the signal peptide and mature vaa gene in M. 
homonis. Insertion or deletion of a single nucleotide at this site could lead to a translational
frameshift, which would result in a UAG stop codon right after the poly(A) tract and before the 
mature vaa (Zhang and Wise 1997). Thus mutation of this poly(A) would turn on or off the vaa
expression at the translational level. This phase variation mechanism is employed also in the P78
gene, a surface protein in M. fermentans. Mutation of poly(A) located before the mature protein
resulted in the selective expression of this gene (Theiss and Wise 1997). Phase variation can also
occur in “hot spots” within the structure genes. The insertion or deletion of a single adenine into a
normal stretch of 7 adenines within P1 of M. pneumoniae truncates P1 translation products (Su et
al. 1989).  
The phase variation of vspA can occur by genomic rearrangement. This process can
silence the vspA gene. Sequence analysis found an insertion of about 800 bp was located 70 bp
upstream of the initiation codon of vspA (Razin et al. 1998). A gene family adjacent to vspA has 
significant homology to bacterial IS elements, suggesting a possible involvement of regulatory
proteins with these elements in phase variation. Lysnyansky et al. (2001) identified gene
inversion as one possible mechanism of phase variation in the vsp genes of M. bovis. Their
studies showed that the two “cassettes” located upstream of the gene were active in phase
variation of vsp in M. bovis. The first cassette is located at a 71-bp region upstream of the ATG
initiation codon. This cassette has 98% homology among all vsp genes. The second cassette has a
size of 50 to 180 bp and is located upstream of the first cassette. When the second cassette was
 























juxtaposed to a silent vsp gene, this gene was found to be expressed. This result demonstrated the
active role of the second cassette in regulation of gene expression. 
Reiterated sequences in other bacterial species were shown to be associated with ligand
binding and generation of antigenic variation (Razin et al. 1998). These repetitive sequences are
present in mycoplasmas, such as P30 and P1 in M. pneumoniae, vlp in M. hyorhinis, and vsp in M.
bovis, and they may generate another mechanism of antigenic variation by size variation. 
As stated above, antigenic variation provides mycoplasmas a good shield to escape host
immune responses. However, mycoplasmas might employ mechanisms other than antigenic
variation to survive in a specific host. Jensen et al. (1998) investigated antigen variation among 
strains of M. hominis isolated from one patient and those from different patients. Their results
showed that there was almost no antigenic variation or genomic variation among isolates from the
same patient. However, isolates from different patients exhibited a high level of antigenic and
genomic variation. These results suggest mycoplasmas may utilize other mechanisms to avoid
host immune responses once it establishes infection in the hosts. Why did M. hominis not undergo
antigenic variation within the same patients? One possible reason may be the disadvantage of
antigen variation by random mutation, which may generate many dead cells. This phenomenon
was different from other reports of antigenic variation, which usually occurs in infected
individuals at the population level (Mims et al. 2001). 
Interactions with the host immune system
A successful mycoplasma infection has to overcome various challenges, including
adherence, colonization, and transmission in the host population. First, mucus secreted by goblet
cells will provide a physical barrier against the mycoplasmas infection. Both nonspecific and





   





   
 
 






mucus. Secretion IgA can bind mycoplasma cells and prohibit them from binding to mucosal
cells and thus from entering the host (Mims et al. 2001). Cell-surface lipoproteins of
mycoplasmas are the primary targets of humoral immunity (Chambaud et al. 1999). 
Infection by mycoplasmas stimulates both systemic and local immune responses.
However, some mycoplasmas may mimic molecules of the host and avoid recognition by
elements of the immune system. Furthermore, some mycoplasmas have evolved some special 
strategies to induce immunosuppression. 
The following sections review current findings with the interaction of mycoplasmas and 
their hosts: 1. how mycoplasmas activate the host immune responses; 2. how mycoplasmas result
in immunosuppression of the hosts; and 3. how mycoplasmas mimic host molecules to avoid
recognition by the host. 
Phagocytosis of mycoplasmas. The non-specific immune response that mycoplasmas
face includes phagocytosis from macrophages and polymorphonuclear leucocytes of the
respiratory and genitourinary mucosae (Marshall et al. 1995). These phagocytic cells set up the
first line of host defense. 
The first step for phagocytosis is the attachment of mycoplasmas to phagocytes. 
Cytadhesins, sialoglyco-conjugated proteins, or lipids will take part directly in the interaction
between mycoplasmas and phagocytes. The morphology of mycoplasmas affects the attachment.
Filamentous mycoplasmas are difficult to engulf, although this effect may be removed by
opsonisation. A highly hydrophobic membrane may facilitate the engulfment of mycoplasmas
(Marshall et al. 1995). However, this process may be inhibited by antiphagocytic proteins or
capsular material. The capsule of M. dispar was found to prohibit the activation of bovine





















weaken this inhibitory effect (Jones et al. 1972). Other inhibitory factors may come from physical
barriers, such as binding of the immunoglobulin Fc region to mycoplasma cells (Marshall et al.
1995). 
Following attachment, mycoplasmas cells will be engulfed by invagination of the
phagocyte membrane. This is followed by a respiratory burst and fusion of the engulfed cells with
lysosomes to create phagosomes, which destroys the mycoplasma (Marshall et al. 1995).
Mycoplasmas can avoid phagocytosis and killing by mycoplasmal proteases, lipases, and
phosphlipases. The oxygen radical generation affects the integration and metabolism of
phagocytes. Moreover, ammonia produced by mycoplasmas may damage the lysosome or 
phagosome. 
However, some mycoplasmas may survive after being engulfed by phagocytes. Thus, the
opsonization with both specific antibody and complement components results in efficient
phagocytosis and destruction of mycoplasmas. Mycoplasma fermentans cells were found in the
peripheral mononuclear cells of AIDS patients (Lo et al. 1989 a&b). Complement-mediated
phagocytosis provides more chance for mycoplasmas to survive than does antibody-mediated
phagocytosis (Webster et al. 1988; Marshall et al. 1995). However, the mechanism by which the
intracellular mycoplasmas escape the phagocyte bactericidal effect is not understood well. 
Different types of phagocytes use different mechanisms to kill mycoplasmas. 
Polymorphonuclear leucocytes and mononuclear phagocytes are employed efficiently via
antibody mediation, whereas phagocytes use direct mycoplasmacidal acitivity. As a result,
different strains of mycoplasmas may be eliminated by different mechanisms because of different
features of mycoplasmal cells (Davidson et al. 1988; Lai et al. 1987; Marshall et al. 1995). 
 






















Activation of host immune responses. Infection by mycoplasmas stimulates the release
of proinflammatory cytokines from phagocytes. These cytokines play an important role in
interactions of mycoplasmas with host immune systems. The immunological responses of hosts
vary based on the associated antigens of various mycoplasmas. The cytokines detected in
mycoplasma infection are IL-1, IL-2, IL4, IL8, TNF-α, IFN-α, IFN-γ, and granulocyte-monocyte
colonystimulating factor (GM-CSF) (Razin et al. 1998). These proinflammatory cytokines
activate B cells, T cells, NK cells, monocytes, and polymorphonuclear cells. They also upregulate
adhesion molecule expression on the surface of endothelial cells and neutrophils surface.
Inflammation results as chemokines attract leukocytes (Ross et al. 1992). 
NK cells may be activated directly by mycoplasmas or indirectly by different cytokines 
secreted by macrophages in response to the mycoplasma infection, such as TNF-α, IFN-α, IFN-γ, 
IL-1, and IL-2. Although there are many reports of NK activation in vivo by different
mycoplasma species, it is not clear whether they are activated directly by mycoplasma or
indirectly by proinflammatory cytokines in vivo (Razin et al. 1998). The expression of MHC class
I and class II on macrophages can be upregulated by proinflammatory cytokines or by
mycoplasma antigens. The M. arthritidis mitogen (MAM) was reported to directly activate NK
cells (D'Orazio et al 1996). Binding of the N-terminus of MAM can activate MHC class II,
whereas the C-terminus of MAM mediates its recognition by T cell receptors (Langlois et al.
2000). The activation of MHC by M. arginini depends on macrophage-derived TNF-α, but not
IFN-γ, IL-4, and GM-CSF (Stuart 1993). 
As occurs with other infectious pathogens, T and B cells are activated both by
mycoplasma mitogens and cytokines released by macrophages. After activation, B cells
proliferate, differentiate into antibody secreting plasma cells, and then generate specific
























antigen to the T-cell receptor in the context of MHC. Activated T lymphocytes secrete various
cytokines, including both upregulating and downregulating cytokines. Upregulating cytokines,
such as IL-4, IL-6, and TNF-α, may activate memory B cells to differentiate into plasma cells and
secrete specific antibody. Mycoplasma fermentans-infected macrophages can induce T-cell
apoptosis, which might be responsible for the persistent infection of this mycoplasma (Jendro et
al. 2000). 
Immunosuppression. Arginine metabolism through the arginine dihydrolase pathway is 
an energy yielding pathway for non-fermentative and some fermentative mycoplasmas (Miles
1992). Interestingly, arginine depletion was found to suppress the activation of lymphocytes in 
vitro, although this effect has not been verified in vivo (Razin et al. 1998). The temporary
suppression of lymphocytes caused by M. arthritidis, an arginine-utilizing mycoplasma, might 
reflect the effects of arginine depletion in vivo. 
Cole et al. (1993) demonstrated that the superantigen MAM may also be involved in
suppressing T-cell mediated immunity and activating B-cell immunity. Splenocytes from mice
injected with MAM showed decreased interleukin-2 (IL-2) production but a marked increase of
IL-4 and IL-6 production. This suggested that mycoplasmas may directly suppress T-cell
cytokine production. Mycoplasma pneumoniae, M. bovis, and M. pulmonis can also suppress host
lymphocytes directly. The former two mycoplasmas can affect the T-cell mediated immune 
responses, and M. pulmonis is able to decrease humoral immunity (Thomas et al. 1990; Jacobs et
al. 1988; Aguila et al. 1988; Razin et al. 1998). Mycoplasma  hyorhinis can also suppress both
cell mediated and humoral immunity and the production of IL-2 (Teh et al. 1988).
Mycoplasma fermentans and M. penetrans interfered with host immune responses by



















with T lymphocytes and induce apoptosis (Dimitrov et al. 1993), and M. penetrans can penetrate
human CD4+ lymphocytes and monocytes and kill these cells (Lo et al. 1993; Sasaki et al. 1995). 
Mycoplasmas also induce the production of downregulating cytokines, such as IL-10 and
IL-13, both of which can prevent inflammation. IL10 is secreted by the Th2 subset of CD4+ cells
and macrophages. IL-10 can inhibit IFNγ secretion and mononuclear cell inflammation. IL-13 is 
secreted by the Th2 subset of CD4+ cells, CD8+ T cells, neutrophils, and non-immune cells and
tissues. IL-13 can inhibit mononuclear phagocyte activation and the proliferation and
differentiation of B cells. Under normal situations, both cytokines have a role in regulating
immune responses. However, some pathogens can take advantage of this mechanism and employ 
the downregulation of cytokines in suppressing immune responses so that they can escape the
host immune responses (Mims et al. 2001). 
Several mycoplasmas, such as M. pneumoniae, M. arthritidis, M. fermentans, M.
hyorhinis, and M. hypopneumoniae, exhibit the capacity to upregulate IL-10 secretion (Kita et al.
1992; Pietsch et al. 1994; Mu et al. 2001; Thanawongnuwech et al. 2001; Jayagopala et al. 2000;
Matsumoto et al. 1998). IL-10 mRNA levels were increased in mice that were intranasally
inoculated with M. pneumoniae (Pietsch et al. 1994). Mu et al. (2001) showed that the levels of
IL-2, INFγ, IL-12, and TNFα were decreased, whereas those of IL-4, IL-6, and IL-10 were 
elevated in mice injected with M. arthritidis MAA superantigen. The M. fermentans complement-
activating protein M161Ag was shown to increase IL-10 along with IL-1β, TNFγ, IL-6, and IL-12 
in human peripheral blood monocytes (Matsumoto et al. 1998). In M. hyorhinis infected pigs,
there was also an increase of expression of IL-6, IL-10, and TNF-α (Jayagopala et al. 2000). IL-
10 is found also along with IL-2 and IL-6 in an adult infected with M. pneumoniae (Mizukane et
al. 2002). Zurita-Salinas et al. (1996) showed IL-13 was generated in cultured human fibroblasts
contaminated with mycoplasmas.  
 
   


















Different antigens show different abilities to induce anti-inflammatory cytokines. Rink et 
al. (1996) compared the induction of cytokines from M. arthritidis-derived superantigen (MAS)
and LPS. They found MAS showed a significantly decreased capacity to induce the anti-
inflammatory cytokine IL-10 and IL-1α, although both MAS and LPS have the same ability to
induce proinflammatory cytokines IL-1, IL-6, and IL-8 compared to LPS. Interestingly, M.
fermentans-derived lipid inhibited MHC II expression without mediation by IL-6, IL-10, TNF, 
transforming growth factor-beta, type I interferon, prostaglandins, or nitric oxide (Frisch et
al.1996). 
Evasion of host immune responses. Mycoplasma components may mimic the antigenic
character of host molecules. Activation of both T and B cells by such mycoplasmas components,
which exhibit similar antigenic character to the host, may cause autoimmune manifestations in the
host. For instance, the T cells can be stimulated as non-specific due to nonfunctional down-
regulating systems, such as down-regulating cytokines induction. Bar et al. (2000) suggested that
the pathogenesis of thrombotic thrombocytopenic purpura resulted from the cross-reaction
between mycoplasma proteases and host proteases.  
Aminopeptidases in prokaryotes 
Peptidases catalyze peptide degradation. Those peptidases that cleave within the peptides
are endopeptidases, whereas exopeptidases function on the N-terminus or C-terminus of peptides.
Endopeptidases can be dipeptidases or tri-peptidases according to their role in cleavage of di-
peptides or tri-peptides, respectively. Exopeptidases may be classified as aminopeptidases or
carboxypeptidases, respectively, based on their functions on the N-terminus or C-terminus





















Aminopeptidases are distributed widely among both prokaryotes and eukaryotes. They
have been investigated extensively, especially recently because of their multifunctional roles in
metabolism, pathogenicity, and control of cellular functions (Gonzales and Robert-Baudouy 1996;
Neidhardt 1996; Riemann et al. 1999). Aminopeptidases in eukaryotes are mainly extracellular,
but those in prokaryotes are not secreted into the extracellular environment. Gonzales and Robert-
Baudouy (1996) stated that only 16% of 102 selected prokaryotic aminopeptidases were
excellular, while the others are either cytoplasmic or membrane-bound. The following review will
refer to the aminopeptidases in prokaryotes, except for special comments. 
Properties of aminopeptidases
Aminopeptidases can be classified into metallo-aminopeptidases, cysteine
aminopeptidases, and serine aminopeptidases based on their inhibitors (Gonzales and Robert-
Baudouy 1996). Metallo-aminopeptidases may be inhibited by chelating agents such as EDTA
and 1,10-phenanthroline. Cysteine aminopeptidase are inhibited by “Hg2+, iodoacetamide, N-
ethylmaleimide, p-chloro-mercuribenzoate”, and serine aminopeptiases are sensitive to
“phenylmethylsulfonyl fluoride and siisopropyl fluorophosphate (Gonzales and Robert-Baudouy
1996).” Divalent metallic cations are required to enhance the functions of metallo-
aminopeptidases. Zn2+ is the most commonly associated cation. The number of Zn2+ ions needed
per molecule varies according to different aminopeptidases. Bovine lens leucine aminopeptidase
(blLAP; EC 3.4.11.1) requires two Zn2+ ions, although the second Zn2+ can be exchanged with
other divalent cations, such as Mg2+ (Kim and Lipscomb 1993). Other cations, such as Mn2+, can 
also be involved also in enhancing and restoring some aminopeptidase enzyme acitivities. Some
metallo-aminopeptidases can be activated with various divalent cations, and some can be












   
   
 
    
 
  







12, was activated by various divalent cations such as Ni2+, Mn2+, Co2+, and Cd2+(Suzuki et al.
2001). Direct ionic interaction with an active metal cation may lead to loss of function of an
aminopeptidase (Green et al. 2000). Cu2+, Hg2+, and Cd2+ inhibited peptidases within L. reuteri
CRL 1098. These required cations may help form and stabilize an optimal three dimensional 
structure for the activity of the associated enzyme. The functions of dipeptidases or tri-peptidases
can be restored by Co2+ or Zn2+ in 10 mM potassium phosphate buffer (pH 7.0), whereas the
function of aminopetidases can be restored by Mn2+ in 10 mM potassium phosphate buffer
(pH 6.0) (Rollan and Valdez 2001). 
There are several different models of inhibition and activation of metallo-
aminopeptidases with metal ions. The first model proposed that the metal ions bind directly with 
substrate at active sites (King et al. 1989; Mock and Liu 1995). King et al. (1989) demonstrated
there was a bidentate ligand between the Mn2+ and the substrate. They suggested this was the
reason why porcine kidney prolidase prefers Mn2+ rather than other metal ions. Mock and Liu
(1995) suggested the binding of two metal ions to the substrates within the active sites stabilized
the three dimensional structure of substrate-enzyme intermediate. In contrast, a second model
proposed that direct binding of metal ions to the substrate is not necessary (Wilce et al. 1998). In
this model, the functions of metal ions would increase the acidity of the water bond for a proline-
specific aminopeptidase in E. coli. Lowther et al. (1999a) proposed two mechanisms may be
present in the catalysis of methionine aminopeptidase in E. coli. They demonstrated that the
tetrahedral intermediate was stabilized by interaction of Glu204 with the metal center or by
chelation of the trigonal bipyramidal cobalt ion (Co1) and potential hydrogen binding with
His178. In the same year, Lowther et al (1999b) confirmed the second proposed interpretation
and included His79 into this interaction as the catalytic mechanism for methionine
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Metallo-aminopeptidases can be sub-classified into three families (Gonzales and Robert-
Baudouy 1996). One family has the conserved motif HExxH. Zn2+ is also associated with this
family. The members of this family include PepN aminopeptidases of E. coli and other lactic acid
bacteria. Membranes of the second family have very strong thermostability and can be inhibited
by bestatin. Bovine lens leucine aminopeptidase belongs to this family. The third family includes
those enzymes employing Co2+ as the cofactor, such as aminopeptidase-A of Lactococcus lactis
ssp. lactis. 
Both cysteine aminopeptidases and serine aminopeptidases do not utilize metallic ions as
cofactors. As the name states, they require an active cysteine or serine residue in the active site.
PepC in L. lactis ssp. cremoris AM2 is a cysteine aminopeptidase gene (Chapot-Char et al. 1993).
The catalytic mechanisms are similar for both cysteine and serine aminopeptidases. Both utilize
“nucleophilic attack” to specific sites of the substrate groups, such as the sulphur of the sulphydril
group for cysteine aminopeptidase and the oxygen of the hydroxyl group for serine
aminopeptidases (Gonzales and Robert-Baudouy 1996). 
Different aminopeptidases have different pH and temperature optimums. Usually, pH 
values vary from 6 to 9. The temperature for enzyme activity is similar to the living temperature
of the prokaryotic cell growth. The aminopeptidases from E. coli show maximum catalytic
activity at 37 °C. The optimal temperature is 75 °C for an intracellular aminopeptidase from the 
thermophilic Sulfolobus solfataricus (Hanner et al. 1990).  
Some aminopeptidases show very broad substrate specificity. They can digest various
kinds of amino acids from the N terminus of the peptides. However, some aminopeptides can
catalyze the cleavage of only one type of amino acid from the N terminus of the peptidases. An
aminopeptidase from Sphingomonas capsulate released glycine, alanine, leucine, proline, and























the highest efficiency (Byun et al.2001). In addition to the N-terminal amino acid, residues within
the substrate play a role in the substrate specificity of aminopeptidase (Ben-Bassat et al. 1987;
Yoshimota et al. 1994). Yoshimota et al. (1994) synthesized 150 peptides with different amino
acids at 4 specific subsites to test their relationship with enzyme activity of aminopeptidase P
from E. coli. Their results showed that the amino acid at the second subsite affected the digestion
of the N terminal amino acid. 
Some aminopeptidases are monomers, but others may consist of two or more peptides.
Gonzales and Robert-Baudouy (1996) recorded that 47% of their selected 102 aminopeptidases
were monomers, most of which were secreted enzymes. They also found that most of the other
53% were paired as 2, 4, or 6 peptides. The quaternary structures of these enzymes have the
hydrophobic regions inside and hydrophilic regions outside the molecule, giving the structure
more stablility. The leucine aminopeptidase from M. salivarium was suggested to consist of two 
molecules of 50 and 46 kDa (Shibata and Watanabe 1987). 
To date, a number of structures of aminopeptidases have been resolved. There are 19
aminopeptidases entries in the Protein Data Bank (http://www.pdb.org). These structures reflect
the underlying catalytic mechanisms for each specific enzyme. Wilce et al. (1998) solved the
structure of a proline-specific aminopeptidase in E. coli. This enzyme catalyzes the cleavage of
proline from the N-terminus of the substrate. Their results indicated that this enzyme was a
monomer that folds into two domains under physiological conditions. At the active site, the C-
terminal domain and a Mn2+ forms a center, with which a hydroxide ion acts on the Xaa-Pro with
a nucleophilic attack. Combining the results from three inhibitors, they proposed the second
model described above for the interaction between ions and substrates. Methionine
aminopeptidase in E. coli is another metallo-aminopeptidase that functions in the cleavage of N-


























reflects its catalytic mechanisms. Binding of substrate to the enzyme involves interaction with a
metal cofactor. This structure was stabilized by chelation of Co1 and potential hydrogen binding
with His178 and His79 (Lowther et al. 1999a&1999b). However, inhibition occured when the
Co1 was still bound to His178, which was similar in many aspects to the model proposed by
Wilce et al. (1998). 
As stated above, some aminopeptidases can be secreted into the extracellular
environment. They can also be membrane associated enzymes. The membrane associated proteins
can be classified into two categories: integral membrane proteins and weakly bound internal
membrane proteins. Similar to other membrane bound proteins, these enzymes usually have an
apparent hydrophobic spanning region within their sequences. Aminopeptidases can also be
soluble proteins present in the cytoplasm or in the periplasm of gram-negative bacteria.
Periplasmic aminopeptidases generally have a signal peptide at the N terminus of the sequence,
which plays a role in the protein targeting process (Gonzales and Robert-Baudouy 1996).
The leucine aminopeptidase of M. salivarium was shown to be a membrane-bound 
enzyme. The protein was reported with an apparent hydrophobic region in its C-terminus (Shibata
and Watanabe 1987; Shibata et al. 1995), although they indicated this enzyme was a putative
cytoplasmic protein when they submitted their sequence into GenBank (accession number
P47707). Jensch and Fricke (1997) applied different subcellular location methods and identified
the subcellular locations of alanyl aminopeptidase (AAP) and leucyl aminopeptidase (LAP) from
Pseudomonas aeruginosa. Their results demonstrated LAP was cytosolic but located near the
cytoplasmic membrane and that AAP was a periplasmic enzyme that had hydrophobic
interactions with the cytoplasmic membrane. There are numerous aminopeptidases with similar
features to LAP. They interact with the cytoplasmic membrane, especially the internal side. They























Because the interaction between aminopetidases and membranes is very weak, these
aminopeptidases can be separated easily from membranes even without detergents (Gonzales and
Robert-Baudouy 1996). Some typical examples are listed by Gonzales and Robert-Baudouy
(1996): E. coli N-aminopeptidase (Murgier et al. 1977); the aminopeptidase from A. 
calcoaceticus (Ludewig et al. 1987); and I-aminopeptidase from B. stearothermophilus
(Yoshimoto and Tsuru 1982). Generally, cytoplasmic aminopeptidases do not have a leader
sequence (Lazdunski 1989). The aminopeptidase N of L. lactis is a cytoplasmic aminopeptidase
(van Alen-Boerrigter et al. 1991). However, this enzyme may also be associated with the
membrane (Gonzales and Robert-Baudouy 1996). 
Functions of aminopeptidases 
The basic function of aminopeptidases in prokaryotes is to digest the amino acids from
extracellular peptides, which can then be used in biochemical metabolism of prokaryotes.
Lactococcus lactis is an important bacterium in the dairy fermentation processes. During this
process, lactose is fermented into lactic acid. Short peptides and free amino acids are released
from milk caseins by proteolytic activity. These free amino acids are utilized by L. lactis as
nutrients (Tan et al. 1993; Morales et al. 2001). The enzymes involved include various
aminopeptidases and other peptidases. McDonnell et al. (1999) found two different cytoplasmic
aminopeptidases were involved in releasing proline from Tyr-Pro-Phe-Pro-Gly. This result
suggested a mechanism utilizing a combination of different aminopeptidases in the breakdown of
proline-containing peptides. 
Aminopeptidases can be involved also in the degradation of intracellular peptides. The
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1974). Escherichia coli and S. typhimurium with aminopeptidase activity will be more stable than
those strains with fewer or no corresponding aminopeptidases during carbon starvation (Reeve et
al. 1984). Sequential digestion with different specific aminopeptidases may be involved in this
degradation process (Miller and Green 1983). This result suggests an important role of internal
peptides for survival of bacteria during starvation.
Aminopeptidases also function in protein maturation. During protein sythesis, the N-
formyl-methionine terminus is formed for nascent polypeptides. The maturation of the
polypeptides involves the initial removal of the N-formyl group. The removal of the methionine
residue requires methionine aminopeptidase. Solbiati et al. (1999) demonstrated that removal of
the N-formyl group must be completed before the further removal of the methionine residue.
Their results showed methionine aminopeptidase from S. typhimurium is inactive on an N-
formyl-methionyl peptide.
Aminopeptidases were also reported with other functions in prokaryotes (Gonzales and
Robert-Baudouy 1996). The aminopeptidase encoded by xerB in E. coli, which is homologous to
pepA in S. typhimurium, has been found to be involved in the stability of high copy number of
ColE1 plasmids (Stirling et al. 1989). D-aminopeptidase, which digests D-form amino acids, has
been demonstrated to take part in the synthesis and degradation of peptidoglycan (Asano et al.
1992). Aminopeptidase N from E. coli and two other aminopeptidases from S. typhimurium, 
aminopeptidase N and aminopeptidase A, were also reported as enzymes hydrolyzing and 
activating albomycin (Braun et al. 1983). 
The functions of aminopetidases from eukaryotes have been found to be much broader
than those from prokaryotes. In addition to peptide degradation and amino acid scavenging, they
can cleave peptide mediators, which will lead to activation or inactivation of function. In addition, 
 
 


















they can function in “adhesion or signal transduction” (Riemann et al. 1999). Moreover,
aminopeptidases located on the cell surface might be important in the “control growth and
differentiation of many cellular systems by modulating the activity of peptide factors, as well as
by regulating their access to adjacent cells” (Riemann et al. 1999; Shipp and Look 1993). CD13, 
aminopetidase N, is an example of these multifunctional aminopeptidases.  
Aminopeptidases in mycoplasmas 
Aminopeptidase activities of mycoplasmas have been studied widely since the 1970s.
Because arginine is used as an energy source, arginine aminopeptidase activity was investigated
for almost all arginine-utilizing mycoplasmas. The current reports about mycoplasma
aminopeptidase activity are reviewed. 
Choules and Gray (1971) discovered the aminopeptidase activity associated with Leu, Ser,
and Tyr from A. laidlawii was the cause of protein degradation during A. laidlawii cell membrane
preparation. This study first proposed the importance of aminopeptidases in mycoplasmas. 
Since then, different aminopeptidase activities have been investigated in various
mycoplasma strains. Neill and Ball (1980) investigated the aminopeptidase activities in A.
laidlawii, M. bovirhinis, M. bovis, and M. dispar, all of which cause calf pneumonia. Their results
showed that the ability of these four mycoplasmas to degrade the same substrates decreased in
order A. laidlawii > M. bovirhinis > M. bovis and M. dispar. Interestingly, their pathogenicity
increased in this order. Their results suggest that more aminopeptidase activity might result in
less pathogenicity. Among the 19 substrates tested, A. laidlawii showed a relative high activity
associated with Ala, Val, Asp, Leu, Phe, Arg, Tyr, and Trp. Mycoplasma bovirhinis showed a
relative high activity for Ala, Leu, Lys, Arg, and His-substrate. Mycoplasma dispar and M. bovis

















    
 





Ball et al. (1982) compared the aminopeptidase activity of 11 arginine-utilizing
mycoplasmas with 22 species of mycoplasmas not utilizing arginine on 20 different aminoacyl β-
naphthylamide substrates. Their results demonstrated that arginine-utilizing mycoplasmas can be
classified into two groups: group A with a high arginine aminopeptidase activity and group B
with a low arginine aminopeptidase activity. Their results suggest arginine aminopeptidase
activity was relatively higher in arginine-utilizing mycoplasmas than in mycoplasmas not
utilizing arginine. These results caused them to test arginine aminopeptidase activity in 23 more
species of arginine-utilizing mycoplasmas (Ball et al. 1985). They separated them into three
groups according to the enzyme activity. The first group showed high enzyme activity for all
strains, including M. gallinarum, M. iners, M. moatsii, M. opalescens, and two unidentified
canine isolates. The second group, including M. alvi, M. buccale, M. capricolum, M. 
columbinasale, M. columbinum, M. equirhinis, M. iowae, M. lipophilum, M. meleagridis, M. 
orale, M. primatum, M. putrefaciens, M. sualvi, and M. subdolum, showed low activity. In the
third group, the arginine aminopeptidase activity varied greatly for different strains of the same
species of mycoplasmas. This group included M. argininim, M. gateae, M. maculosum, and M.
spumans. 
Shibata and Watanabe (1989) incubated bradykinin with different mycoplasma cells, M. 
pneumoniae, M. genitalium, M. fermentans, M. hominis, M. salivarium, M. orale, U. urealyticum
and A. laidlawii, at 37 °C for 1 hour and then injected the mixture into rabbits. The results
indicated mycoplasmas were able to inactivate the vascular permeability-increasing activity of
bradykinin. They also suggested that arginine aminopeptidase and carboxypeptidase were
responsible for this activity.
Mycoplasma salivarium and M. orale, important pathogens in periodontal disease, show



















activity than did M. orale (Watanabe et al. 1985; Watanabe et al. 1984). The Leu aminopeptidase
was purified and characterized (Shibata and Watanabe 1987; Shibata et al. 1995). This enzyme is 
a membrane-bound enzyme composed of 50 kDa and 46 kDa domains. It is a metallo-
aminopeptidase showing both Leu and Arg aminopeptidase activity. Mn2+ and Zn2+ enhanced the
enzyme activity to 9 and 2 fold, respectively. An aminopeptidase My gene of M. salivarium was 
cloned and sequenced. The My gene encoded a 58 kDa protein and conserved the active sites of
bovine leucine aminopeptidase (Burley et al. 1990; Shibata et al. 1995). This protein has an
apparent hydrophobic region that suggests it is membrane-associated. However, leader peptide
was identified using SignalP (Nielsen et al. 1996; http://www.cbs.dtu.dk/services/SignalP-2.0/).
The reason might be that SignalP looks for bacterial signal peptidases that have features different
from the signal peptides from mycoplasmas (Edman et al. 1999). 
Including the putative aminopeptidase genes from the complete genomes of M. 
genitalium, M. pneumoniae, M. pulmonis, U. urealyticum, there are more than 37 various
aminopeptidase and peptidases protein sequences in GenBank. There are 7, 9, 10, and 7
aminopeptidases in M. genitalium, M. pneumoniae, M. pulmonis, and U. urealyticum, 
respectively (Table 3.2). The specificity of these aminopeptidases varies. However, none of these
genes have been characterized. To date, the My gene from M. salivarium is the only gene





   
  
    
 
    
  
 
    
 











Mycoplasmas gallinarum as a model to study host adaptation 
General features of M. gallinarum
M. gallinarum belongs to class Mollicutes, order I Mycoplasmatales, family I 
Mycoplasmataceae, Genus I Mycoplasma (Razin et al. 1998). It has a genome size of 727 kb and
26.5-28 Mol%G+C (Askaa et al. 1973; Maniloff et al. 1992). 
The antigenic and biochemical features of M. gallinarum are relatively homolgous.
However, different strains of this species have been reported that demonstrate some DNA 
polymorphisms. Seven field strains of M. gallinarum were compared with the type strain PG 16
for genotypic heterogeneity using restriction endonuclease analysis of genomic DNA with EcoRI, 
HindIII, BamHI, PstI, and XhoI (Dov! et al. 1991). Based on the result of BamHI digestion, they
found three different genotypes among the field strains from PG16. This might reflect the
molecular basis for the wide distribution of M. gallinarum through different hosts, although all
seven field strains involved in this research were isolated from different chicken tissues. 
Previous experiments showed an antigenic difference between the type strain M.
gallinarum (PG16) and M. gallisepticum (S6). The immuno-diffusion and immuno-
electrophoretic patterns between PG16 and the anti-sera of S6 showed two precipitin lines, while
six precipitin lines exist for S6. The antisera of PG16 had two precipitin lines for S6, whereas
there were five lines for PG16. The similarities were suggested to be group specific, and the
differences were suggested to be species specific (Ahuja and Chandiramani 1976).
Mycoplasma gallinarum is a non-fermentative and arginine-utilizing mycoplasma
(Aluotto et al. 1970). Its growth requires 13 amino acids, including Ala, Arg, Asp, Cys, Glu, Gly,
His, Ilu, Leu, Met, Phe, Thr, and Tyr (Lund and Shorb 1966). As with other non-fermentative
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mycoplasmas, arginine can be utilized by M. gallinarum as an energy source via the arginine
dihydrolase pathway. Mycoplasma gallinarum also shows a strong arginine aminopeptidase
activity and relatively low leucine aminopeptidase activity (Ball et al. 1982). The activity of
aminopeptidase may play a role in supplying the required nutrients. However, arginine is not the
single energy source for M. gallinarum. Taylor et al. (1994) found this species can oxidize
organic acid as alternative energy sources. These two processes can coexist without a prohibitory
effect on each other. 
There are very few reports concerning the molecular genetics of M. gallinarum. Currently, 
only the 16s rRNA gene has been sequenced (Genbank access number: L24105). It was reported
that cross reaction with EF-TU protein of M. synoviae occurs, suggesting the presence of this
protein in M. gallinarum (Ben!ina et al. 1999). 
Pathogenesis of M. gallinarum
Mycoplasma gallinarum has been isolated from various hosts, including poultry, pig,
cattle, and sheep (Singh and Uppal 1987; Taylor-Robinson and Dinter 1968; Poveda, et al. 1990).
This mycoplasma is also one of the mycoplasmas most frequently isolated from poultry (Shah-
Majid and Nihayah 1987; Kleven, Eidson, and Fletcher 1978). Generally, M. gallinarum does not
cause any signs or lesions among infected hosts (Power and Jordan 1976; Varley and Jordan 
1978a&b). The infection of hens with M. gallinarum was shown to have no effect on hatchability
(Shah-Majid 1994).  
This species of mycoplasma has been demonstrated to be much less pathogenic than
other mycoplasmas of poultry, including M. gallisepticum, M. synoviae, M. iowae, and M.
meleagridis (Kleven 1998; Power and Jordan 1976; Varlety and Jordan 1978a&b). Transmission












   
 









pathogenesis of M. gallinarum and M. gallisepticum (Abu-Zahr and Butler 1976). They showed
that M. gallisepticum directly attached to the epithelial cells. It colonized the cells first and then
the lamina propria. In contrast, M. gallinarum did not develop a close association with the
epithelium cells and mycoplamsa cells appeared first in the lamina propria. 
M. gallinarum inhibited the replication of goose parvovirus strain "B" in cell culture.
However, A. axanthum does not have this effect. Continuous supplementation of arginine into the
M. gallinarum and virus culture can remove the inhibitory effects (Kisary and Stipkovits 1975). 
Inoculation of chickens with M. gallinarum may cause airsaccutilis when combined with
infection by infectious bronchitis virus or vaccination for Newcastle disease or infectious
bronchitis (Kleven et al. 1978; Kleven 1998). Shah-Majid (1996) investigated the effects on the
tracheal epithelium by coinfection of M. gallinarum and Newcastle disease virus (F strain). They
found many non-ciliated tracheal epithelium cells during 1 to 3 days after the infection. These
cells regained the cilia by 1 week after the infection.  
The presence of M. gallinarum in different tissues was reported to depend on the host
species infected. In a series of laboratory experiments, M. gallinarum was only recovered from
the infra-orbital sinus and trachea of infected chicks (Varley and Jordan 1978a). However, M.
gallinarum can be recovered from different tissues of experimentally infected turkey poults,
including the infra-orbital sinus, trachea, left lung, left abdominal air sac, clavicular air sac, heart
blood, and muscle, caecal tonsil, bursa, spleen, liver, gonad, kidney, yolk, and right or left hocks.
None was recovered from pericaridium, foot pads, conjunctiva or brain (Varley and Jordan
1978b). 
The immunological responses of poultry were investigated in early research. Based on
the results of rapid serum agglutination tests and haemagglutination inhibition tests, in birds























Varley and Jordan 1978b). These results were confirmed further by Ben!ina and Bradbury
(1991a&1992) using immunofluorescein and immunoperoxidase techniques. Antibody responses
were investigated among chickens coinfected with M. gallinarum, M. gallisepticum, and M.
synoviae (Ben!ina et al. 1991b). They found that mycoplasma specific humoral IgG and IgM 
levels were very low or non-detectable, whereas IgG and IgM were detected with a high
frequency (over 50%) in the respiratory mucus and in the Harderian gland. IgA was relatively
undetectable for all samples. 
Mycopalsma gallinarum serving as a model for mycoplasmas host adaptation investigation 
The wide distribution of M. gallinarum among different species of hosts and its persistent
colonization demonstrates the presence of a unique host adaptation mechanism in this
mycoplasma. The low pathogenesis of M. gallinarum and the weak immunological host responses
suggest a unique mechanism to escape host immune responses. Thus, M. gallinarum serves as a
good model to investigate the host adaptation mechanisms between mycoplasmas and eukaryotes
cells. 
Hypothesis and objectives
The hypothesis tested in this study is that some membrane associated proteins of M. 
gallinarum play an important role in the host adaptation of this species. 
The objectives of this study were to: 1). identify and clone the aminopeptidase gene from
M. gallinarum; 2). generate the recombinant protein for this enzyme and polyclonal antisera
against this recombinant protein; 3). determine the subcellular location and the function of this
enzyme in host adaptation of M. gallinarum; 4). investigate the specific humoral response to





















DETECTION OF CYTADHESIN GENES IN MYCOPLASMA GALLINARUM
Abstract
P1-like and P30-like probes were designed from previously identified cytadhesins to
examine the presence of the P1 or P30 like genes in M. gallinarum genomic DNA by Southern-
blot hybridization analysis. The 28 bp P30-like probe and the 29 bp P1-like probe were not able
to bind with Eco RI digested M. gallinarum genomic DNA. However, during Southern
hybridization analysis, the 18 bp P30-like probe showed a 3-kb band in Eco RI digested M. 
gallinarum genomic DNA. The 3-kb DNA fragment was then purified and ligated into the
plasmid pBlueScript-KS(-) to construct a genomic plasmid library. The 18 bp P30-like probe was
utilized to screen this library, and three positive colonies were obtained. Sequence analysis of the
2,274 bp fragment demonstrated that the cloned sequence was composed of a partial
aminopeptidase gene candidate and a partial glutamyl-tRNA synthetase gene candidate. Sequence 
alignments showed this partial nucleotide sequence had a 54% nucleotide identity and 68% amino
acid identity to a leucine aminopeptidase gene from M. salivarium. Further analysis showed a
homology of 42% between the cloned nucleotide sequence and P30 gene from M. pneumoniae, 
which might be the reason why library screening using P30 gene resulted in an aminopeptidase-
like gene. Our results suggest that there is no P1-like and P30-like cytadhesins present in M. 
gallinarum, and that the adhesion of M. gallinarum to its hosts may involve other cytadhesins or




























The class Mollicutes constitutes a special subgroup of gram-positive bacteria with
minimal genomes and no cell wall. Within this class, mycoplasmas, members of the family
Mycoplasmataceae, have been most widely studied by scientists because of the mycoplasma
association with human and animal health. Mycoplasmas are spread widely among various hosts,
such as plants, animals, and arthropods (Maniloff et al. 1992). In general, mycoplasmas virulent
for humans and animals have evolved mechanisms of host adaptation to persist in the presence of
an immune response, and therefore induce chronic inflammatory-type infections of the respiratory
and urogenital tracts and, in some cases, induce arthritis-like lesions in joints (Baseman et al. 
1996; Citti and Rosengarten 1997).Therefore, mycoplasmas should have some strategies to avoid
clearance from the motile mucus and shield from innate and acquired immune responses.
Generally, mycoplasmas exist as “ideal parasites” (Razin et al. 1998). The physical association
with the host epithelial cells is required not only to avoid the surface-dependent motility but also
to acquire nutrients. 
Mycoplasma are able to attach to various host cells in vitro, such as erythrocytes, 
spermatozoa, fibroblasts, lung cells, skin cells, gill arches and rakers, and tracheal organ cultures
(Stadtlander and Kirchhoff 1995; DeBey and Ross 1994; Zielinski and Ross 1993; Washburn et al.
1993; Gabridge 1984; Watanabe et al. 1990; Cassell et al. 1981). Different cytadhesins,
membrane-associated proteins of mycoplasmas, have been identified to function in these
attachments to the glycoprotein or glycolipid receptors on the eukaryote epithelial cell surfaces
and are associated with the interaction between mycoplasma cells and their hosts. 
P1 cytadhesin is an important virulence factor in M. pneumonae, and it mediates the 
attachments of M. pneumonae to host cells (Krause 1996). The P30 cytadhesin was identified also
as another cytadhesin functioning in adhesion of M. pneumoniae to host cells (Dallo et al. 1990;























pneumaniae along with other accessory proteins. A loss of P1 or P30 may remove the capability
of M. pneumoniae cells to attach to epithelial cells and thus decrease the virulence of this
mycoplasma (Baseman et al. 1982; Krause and Baseman 1983; Krause 1996). P1-like cytadhesins
also have been identified in many other mycoplasma species, such as M. genitalium, M. 
gallisepticum, M. pirum, and M. synoviae (Dallo et al. 1989; Morsy et al 1993; Tham et al. 1994). 
In addition to M. pneumonae, P30-like cytadhesins were also identified in different mycoplasmas,
including M. agalactiae, M. gallisepticum, and M. genitalium (Fleury et al. 2001; Boguslavsky et
al. 2000; Hnatow et al. 1998; Reddy et al. 1995). 
Antigenic variation was reported to be an important strategy employed by mycoplasmas
to avoid elimination by host immune responses. Besides phenotype shifting by changing the
expression products, mycoplasmas can also turn on or off the expression of the adhesion-
associated genes by mutating nucleotides in the promoter region or by gene rearrangement 
(Theiss and Wise 1997; Razin et al. 1998).  
Unlike most other host-specific mycoplasmas, M. gallinarum has been identified in a
wide range of vertebrate hosts, including poultry, cattle, pigs, and sheep (Singh and Uppal 1987;
Taylor-Robinson et al. 1968; Taylor-Robinson and Dinter 1968; Wang et al. 1990). The
colonization of the respiratory tract of poultry by M. gallinarum alone does not result in
pathologic changes, although co-infection with respiratory viruses was reported to induce clinical
signs (Kleven et al. 1978; Shah-Majid 1996). Furthermore, M. gallinarum has not been found to
induce strong antibody responses (Ben!ina and Bradbury 1992). Therefore, M. gallinarum may
serve as a good model for basic studies in host adaptation. 
Currently there are no reports concerning the mechanism of M. gallinarum adhesion and
its association with the prevalence of this mycoplasma in various hosts. The goal of this project is
to identify M. gallinarum cytadhesins, such as P1-like and P30-like genes, which may be critical
















     




Materials and methods 
Mycoplasma strain and culture conditions 
The M. gallinarum used in these studies (kindly provided by S. H. Kleven, University of
Georgia, Athens, GA) was filter cloned three times and then used as an inoculum for a 400 ml
culture in Frey Broth incubated 24 hrs at 37 °C. Aliquots of the culture were stored at minus 80
°C for use throughout the study (Ellakany et al. 1997). 
Nucleic acid preparation 
Genomic DNA was isolated from overnight broth cultures of M. gallinarum using the 
QIAGEN genomic DNA isolation kit (QIAGEN, Inc., Valencia, CA). Plasmids were extracted
from 24 hrs cultures of E. coli using the QIAGEN miniprep plasmid extraction kit (QIAGEN, Inc., 
Valencia, CA). 
Hybridization probes preparation and Southern-blot hybridization 
To identify whether P1 or P30 genes are present in M. gallinarum, Southern-blot 
hybridization analysis was conducted with M. gallinarum genomic DNA and P1 or P30 probes 
designed from mycoplasma P1 or P30-like homologs. 
The P1 degenerate oligonucleotide 5’-GCNGTNGGNKSNGTNTTY-3’ was synthesized
complementary to the conserved regions identified in amino acid sequence alignments from the
P1 gene from M. pneumoniae (Su et al. 1987), MgPa gene from M. genitalium (Inamine et al.
1989), mgc1 from M. gallisepticum (Keeler et al. 1996), and P1-like gene from M. pirum (Tham
et al. 1994). The P30 degenerate oligonucleotide 5’-CTNGGNCTNGSNATHGGN-3’ was 
synthesized according to conserved regions identified in amino acid sequence alignments of the
 











   





   
- 50 -
P30 gene from M. pneumoniae (Dallo et al. 1990), P32 gene from M. genitalium (Reddy et al.
1995), and Mgc2 from M. gallisepticum (Hnatow et al. 1998). In these two probes, K=G+T,
S=G+C, H=A+T+C, Y=C+T, and N = all four nucleotides used in the synthesis. The P30 probe
was increased to 28 bp to increase the specificity, 5’-WTNGGNWTNGGNATHGGNWT 
NCCNATHG-3’, where W=A+T, N=A+T+C+G, H=A+T+C. These probes were synthesized by
Genosys, Woodlands, TX. 
The oligonucleotide probes were fluorescein-labeled using the enhanced
chemiluminescence (ECL) 3’-oligolabelling systems according to the manufacturer’s protocol
(Amersham, Arlington Heights, IL). The probes were fluorescein-labeled and made by incubating
at 37 °C for 90 mins a mixture of 100 pMol oligonucleotide, 10 µl fluoresecin-11-dUPT, 16 µl 
cacodylate buffer, and 16 µl terminal deoxynucleotidyl transferase. 
For Southern-blot hybridization, 5 µg EcoRI digested M. gallinarum genomic DNA was
loaded into 0.8% agrose gel and blotted onto nylon membranes (Amersham, Arlington Heights,
IL) by capillary transfer after eletrophoresis at 30 volts for 17 hrs. The nylon membranes were
baked at 80 °C for 2 hrs. The membranes were first prehybridized at 42 °C for 4 hrs, and then 10
ng labeled probe was added to the hybridization solution (Amersham, Arlington Heights, IL) and
hybridized for 16 hrs at 42 °C. Blots were then washed twice with a low stringency buffer
(5×SSC, 0.1% SDS) for 5 mins at room temperature. Finally, the blots were washed twice with a
high stringency buffer (1×SSC, 0.1%SDS) for 15 mins at 42 °C. Afterwards, the blots were
treated with chemiluminescence substrate. The chemiluminescent detection was performed with







   
  
 






   
 
    
   
- 51 -
Genomic plasmid library construction and screening 
Restriction fragments in the 3 kb size range were gel-isolated from EcoRI digested M. 
gallinarum genomic DNA and ligated into pBlueScript PBS-KS (-) plasmid vector (Stratagene,
Co., La Jolla, CA). For the ligation reaction, a mixture of 60 ng isolated DNA and 20 ng E.coli
predigested pBlueScript PBS-KS(-) vector was incubated at room temperature for 5 mins with 
Fast-link ligase ( Epicenter, Madison, WI ). After heat-inactivation of the ligase, the ligation
reaction products were then transformed into E. coli strain XL1-Blue (Stratagene, Co., La Jolla,
CA) and spread at a density of 100 antibiotic-resistant colonies per plates. Colony lifts were
prepared according to the protocol adapted from Sambrook et al. (1989). Briefly, duplicate nylon
membranes were placed on the plates for 1 min and then moved to 10%SDS to lyse the cells. The 
lifts were denatured and neutralized for 5 mins each and then incubated on 2×SSC buffer for 
another 5 mins. After drying on filter paper, the lifts were baked at 80 °C for 2 hrs. The colony
lifts were then hybridized with the P1 and P30 oligonucleotide probes by the methodology
described for genomic Southern blot hybridization. 
Nucleotide sequencing and sequence analysis
The inserts from library clones were sequenced by dye terminator cycle sequencing using
the Big-Dye terminator reaction (Applied Biosystems, Foster City, CA) and pBlueScript PBS-
KS(-) phagemid promoter primers or internal primers T7.1.854 (Stratagene, Co., La Jolla, CA).
Sequencing reaction products were analyzed on an ABI Prism 310 Genetic Analyzer (Perkin-
Elmer Corp., San Fernando, CA). Nucleotide sequence data were analyzed with MacDNASIS Pro 
V3.1 software (Hitachi Software Engineering America, Ltd., San Francisco, CA) and with the
GenBank database (National Center for Biotechnology Information). Alignments of predicted




















Hybridization results are shown in Figure 2.1. The results were negative for the
hybridization of M. gallinarum genomic DNA with the P1-like probe. There was a significant
hybridization signal at 3 kb with the 18bp P30-like probe. However, there was no hybridization
signal with 28bp P30-like probe. Interestingly, the results for two P30-like probes were different
for M. gallisepticum genomic DNA.  
Genomic library screening, nucleotide sequencing, and sequence analysis 
By screening the genomic plasmid library, three positive clones were identified and
characterized by nucleotide sequencing. Database searches with the nucleotide sequence data
obtained from one colony showed a homology with the leucine aminopeptidase gene from M. 
salivarium. Additional sequence of the insert was obtained with internal primers (Table 2.1). This 
sequence contained a partial aminopeptidase-like gene and a partial glutamyl-tRNA synthetase-
like gene (Figure 2.2). The partial nucleotide sequence from this aminopeptidase-like gene
showed a homology of 54% identity with the nucleotide sequence of the leucine aminopeptidase
gene from M. salivarium. The amino acid sequence derived from the aminopeptidase nucleotide
sequence had a 68% identity with the protein sequence of leucine aminopeptidase from M.



























A large number of lipoproteins, despite their small genome sizes, are encoded in
mycoplasma genomes (Chambaud et al. 2001). These lipoproteins have been reported as the
primary targets of the immune responses (Chambaud et al. 1999; Kaufmann et al. 1999). A
special formation of these lipoproteins, attachment organelles of mycoplasmas, would generate a
close, physical association with the eukaryotic epithelial cells (Krause 1996). Various adhesion
associated proteins have been characterized in these organelles in a number of mycoplasmas,
including P30-like and P1-like cytadhesins (Dallo et al. 1989; Morsy et al. 1993; Tham et al.
1994; Fleury et al. 2001; Boguslavsky et al. 2000; Hnatow et al. 1998; Reddy et al. 1995).
Additional studies characterizing the adhesion of mycoplasmas showed that different gene
families were employed by mycoplasmas as a strategy to face challenges from host immune 
responses, such as the pMGA gene family in M. gallisepticum, vaa gene family in M. hominis, 
vlp gene family in M. hyorhinis, and vsp gene family in M. bovis (Markham et al. 1993; Zhang
and Wise 1996; Rosengarten and Wise 1991; Beier et al. 1998). It is very intriguing that, for some
gene families, only a single gene copy was shown to be expressed in the associated mycoplasma
strain (Bhugra et al. 1995; Glew et al. 1995; Milosevic et al. 2000). There have also been more
adhesion associated genes identified that were not homologous with other cytahesins, such as P97
in M. hypopneumoniae (Zhang et al. 1995). 
Our results showed a positive signal in Southern-blot results with the P30-like 18 bp
probe and no signal with the P30-like 28 bp probe. However, sequencing results demonstrated
that the insert recognized with the P30-like probe was an aminopeptidase-like gene. The
conserved region of the P30 protein sequence, 5’-LGLGIG-3’, which was used to design the P30-
like probe, was not identified in the amino acid sequence predicted from the cloned
aminopeptidase gene. The cloned aminopeptidase gene fragment only had a 42% nucleotide


























did not give a positive result for Southern hybridization analysis, suggesting that the P30-like 
gene might not be present in M. gallinarum. The hybridization results of P1 suggested that a P1-
like gene is not encoded in M. gallinarum. Thus, M. gallinarum cytadhesins may have diverged
from the P1 and P30-like genes, or alternatively, other membrane components may be involved in 
interaction with host cells. 
The glycoglycerolipids of A. laidlawii PG8 demonstrated a capability to bind to human 
lymphoid cells (Toujima et al. 2000). Similarily, Mycoplasma gallinarum may also have some
other unique membrane components other than cytadhesin associated components involved in
adhesion. More experiments are required to explore the membrane adhesion of M. gallinarum. 
In prokaryotes, aminopeptidases have been associated with the digestion of intracellular
and extracellular peptides, which may be significant in the nutritional supply to prokaryotes (Tan
et al. 1993; Goldberg and Dice 1974). These functions of aminopeptidases may be especially
important to the persistence of parasites, such as mycoplasmas, which are not able to
biosynthesize amino acids and the precursors for other macromolecules. In eukaryotes, 
aminopeptidases were associated with cell adhesion and signal transduction (Riemann et al. 1999).
Mycoplasma gallinarum is a commensal in poultry, cattle, sheep, and pigs (Singh and
Uppal 1987; Taylor-Robinson et al. 1968; Taylor-Robinson and Dinter. 1968; Wang et al. 1990).
This species of mycoplasma is non-fermentative and requires most of the amino acids for their
growth.Interestingly, a higher aminopeptidase activity was reported in bovine mycoplasmas with
a lower pathogenesis (Neill and Ball 1980). It was shown that M. gallinarum had both leucine and
arginine aminopeptidases (Ball et al. 1982). Currently, these genes and their functions have not 
been characterized. It is unclear if these aminopeptidases are associated with the non-host specific
features and the low pathogenesis of M. gallinarum. 
The sequences identified in this study showed a higher homology with the leucine
aminopeptidase from M. salivarium. Cloning of the complete open reading frame of this gene and
 
 










functional characterization will be helpful in unveiling the details about the roles of this gene in
host adaptation of M. gallinarum. It may also provide some basis for the function of
aminopeptidases in mycoplasma host adaptation. 























Figure 2.1 The Southern-blot hybridization results using cytadhesin probes. Lanes 1, 4 and 7 were
loaded with 2 µg lambda DNA digested with Hind III; Lanes 2, 5 and 8 were loaded with 5 µg M.
gallisepticum F strain genomic DNA digested with Eco RI; Lanes 3, 6 and 9 were loaded with 5
µg M. gallinarum genomic DNA digested with EcoRI. Lanes 1, 2, and 3 were hybridized with
P1-like Probe; Lanes 4, 5, and 6 were hybridized with P30-like 18 bp probe; Lanes 7, 8, 9 were
hybridized with P30-like 28 bp probe. 
Figure 2.2 Gene organization of the cloned 2,274 bp sequence from M. gallinarum. BLAST 
showed two ORFs: one is aminopeptidase gene and the other one is glutamyl-tRNA synthetase.







MGN_APN_like TTTGTTGGAAAAGGAATTACTTTTGATACAGGTGGAATTAATACAAAAGGCTATCATATG 60 
MPN_P30 -------ATGAAGTTACCACCTCGAAGAAAGCTTAAACTGTTTTTATTAGCC--TGAATG 51 
***  *  ** *  * * ** *  **  *  *  *  **  ***  
MGN_APN_like TCAGGAATGAAATATGATATGTCAGGTTCTGCCATTGTGGCTTATGCTGTAAAAACCTTA 120 
MPN_P30 CTAGTGCTGTTCAGCGCTTTAATAGTGCTTGCAACCTTAATTTTGGTACAGCACAACAAT 111 
** ** * * * ** *** * * ** * * * * 
MGN_APN_like GCCGAATTAAAAGCAAATGTTAATGT-TGCTGCAATTATGATGATAACTGATAATCGTCA 179 
MPN_P30 ACCGAACTGACAGAAGTTAAGAGTGAATTGAGTCCCCTTAACGTTGTTTTACA--CGCAG 169 
***** * * ** *  *  * **  *  *  * * * *  * * *  **  
MGN_APN_like AGACGGAGATGCTTCATTGCCCGAAAATGTTTATGAATCTATGT-CAGGTTTGAGTGTTG 238 
MPN_P30 AAGAGGATACAGTACAAATTCAGGGCAAGCCGATTACTGAGCAAGCATGGTTTATTCCTA 229 
*  ***  *  * **  * *  * *  ** * *  ** * ** * *  *  
MGN_APN_like AAGTAACTGATACCGATGCTGAAGGACGTTTAGTTTTAGCAGATGGATTATATTATGGAG 298 
MPN_P30 CAGTTGCTGTTTGCTTTGGTTTTAGTGCCCTAGCCATCATCT-TGGGCCTTGCTATAGGA 288 
*** *** * * ** * * *** * *** * *** * 
MGN_APN_like CTACTAAATTAAAAGC------AACTACATTATTTGATGTTGCAACTTTAACAGGATCAG 352 
MPN_P30 CTGCCAATTGTGAAGCGCAAGGAAAAACGCTTATTGGAGGAAAAGGAACGCCAAGAACAG 348 
** * ** * **** ** ** * *** * * ** ** *** 
MGN_APN_like TTTT---AACAGCACTAGGACATACTTATTCTGGAATTTGATCAACAAATGAAGGAAAAT 409 
MPN_P30 TTAGCGGAACAGCTACAACGCATTTCTGCCCAACAAGAAGAGCAACAAGCGTTAGAACAA 408 
** ****** * ***  *  *  **  **  ****** * *** * 
MGN_APN_like GAGGACTTTTCGAAAAAGCAGGACAAATTAGTCATGAGAAAATT----TGAAGAATGCCA 465 
MPN_P30 CAAGCAGCTGCTGAAGCCCATGCTGAAGCGGAAGTTGAACCAGCACCACAACCAGTACCA 468 
* *  * * **  **  *  **  *  *  * *  * * * ***  
MGN_APN_like TTACATGATGATTTTCA---TCAATTTAATTTGGCTTCTGAAGTTGCTGATTTAAATAAT 522 
MPN_P30 GTACCACCTCAACCCCAAGTCCAAATTAACTTCGGTCCCCGTACTGGTTTCCCACCTCAA 528 
*** * * ** *** **** ** * * *  **  *  *  * *  
MGN_APN_like TATAATAATAGTGAAAAATCAGATTCTA-----ATACTGCTGCAATGTTCTTAAAACAAT 577 
MPN_P30 CCCGGTA-TGGCGCCTCGTCCAGGTATGCCGCCACACCCCGGTATGGCTCCAAGACCTGG 587 
** * * *  **  * *  * **  * * *  * **  * * *  
MGN_APN_like TTACTAAC---AATGTAG-ATTATATTCATTGTGATGTTGCCGGAAC-CGCTGATGTCGG 632 
MPN_P30 TTTCCCACCTCAACCCGGTATGGCGCCTCGTCCAGGTATGCCGCCACACCCCGGTATGGC 647 
** * ** ** * ** * ***** ** * * * * * *  
MGN_APN_like TGGAAAACCTCAAGGTGTTTTAATTGATACATTAGTTGAATTTGCTTTATTAAATGAAAA 692 
MPN_P30 TCCAAGACCT---GGTTTCCCACCTCAACCCGGTATGGCGCCTCGTCCAGGCATGCCGCC 704 
* ** **** *** * * * * * * * * * * * 
MGN_APN_like ATAG-------------------------------------------------------- 696 
MPN_P30 ACACCCCGGTATGGCTCCAAGACCTGGTTTCCCACCTCAACCCGGTATGGCGCCTCGTCC 764 
* *  
Figure 2.3 Alignment of P30 gene from M. pneumoniae and APN fragment from M. gallinarum. 
Alignment of P30 gene from M. pneumoniae with APN fragment from M. gallinarum showed a 















   
 
  







CLONING, SEQUENCING, AND CHARACTERIZATION OF AN AMINOPEPTIDASE  
GENE FROM MYCOPLAMSA GALLINARUM
Abstract
Unlike most other host-specific mycoplasmas, Mycoplasma gallinarum is a commensal
with a host range including most poultry as well as some mammals. This property of M.
gallinarum may reflect unique mechanisms for its colonization and persistence in hosts. The
aminopeptidases have been suggested to play a potential role in the host colonization by
supplying nutrition from peptide degradation and amino acid scavenging. Whereas M. gallinarum
shows leucine and arginine aminopeptidase activity, the genes encoding the enzymes had not
been cloned and characterized. We identified an aminopeptidase gene by oligonucleotide
hybridization to a genomic library of M. gallinarum in lambda ZAPII bacteriophage. Nucleotide
sequence analysis of overlapping phage clones identified a 1,362 bp open reading frame (ORF)
encoding a putative leucine aminopeptidase gene. Database searches indicate that this ORF has 
68% nucleotide identity and 51% amino acid identity with the M. salivarium leucine
aminopeptidase gene. The active sites of the leucine aminopeptidases in other eukaryotes and
prokaryotes were conserved in the cloned aminopeptidase gene. Northern-blot hybridization
analysis showed that this ORF is expressed on a 1.5 kb transcript. Southern-blot hybridization
analysis demonstrated this gene was present as a single copy in M. gallinarum. Characterization
of the leucine aminopeptidase demonstrated that leucine aminopeptidase is a metallo-
aminopeptidase (EC 3.4.11.1) and is located in cytoplasm with a weak interaction with the cell
membrane. These features suggest a potential role of this leucine aminopeptidase in the


























Mycoplasma gallinarum has been identified as a commensal in a wide range of vertebrate
hosts, including poultry, cattle, pigs, and sheep (Shah-Majid 1996; Singh and Uppal 1987;
Taylor-Robinson et al. 1968; Taylor-Robinson and Dinter 1968; Wang et al. 1990). M. 
gallinarum was reported as one of the most frequently isolated mycoplasmas from poultry (Shah-
Majid and Nihayah 1987; Kleven et al. 1978). Generally, colonization of the respiratory tract of
poultry by M. gallinarum does not result in pathologic changes and does not show clinical signs.
In vitro studies by Taylor-Robinson and Cherry (1972) suggest that M. gallinarum does not cause
reduction of tracheal epithelial cell ciliary activity in tracheal organ culture. However, M. 
gallinarum was reported to induce a temporary airsacculitis when chickens were infected by
aerosol or air-sac inoculation in combination with a field strain of infectious bronchitis virus (IBV)
or with vaccination for IB and Newcastle disease (Kleven et al. 1978). During an In vitro mixed
infection with Newcastle disease virus, M. gallinarum may temporarily destroy the cilia on the
epithelial surface of the tracheal organ culture, whereas the microvilli were not affected by this
infection (Shah-Majid 1996). Cilia were repaired after about one week. 
Mycoplasma gallinarum does not induce a strong antibody response, and the humoral 
IgG and IgM levels agaist the organism in infected individuals were reported to be almost
undetected (Varley and Jordan 1978a; Varley and Jordan 1978b; Bencina et al. 1991a; Bencina et
al. 1991b; Bencina et al. 1992). The capability to persist in various hosts and to escape the host
immune responses suggested that some unique host adaptation mechanisms might be present in
this mycoplasma. 
As a comparison, M. galliepticum is a pathogenic mycoplasma that causes chronic
respiratory diseases in chickens (Yoder 1991). M. gallinarum was reported to prevent the
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r e d u cti o n i n t h e vi a bilit y of M. g allis e pti c u m  ( T a yl or- R o bi ns o n a n d C h err y 1 9 7 2). If t h e e pit h eli al
c ell  e xf oli ati o n  o bs er v e d  i n  r es pir at or y  i nf e cti o ns wit h  M.  g allis e pti c u m  r es ults  fr o m  l o c al
i nfl a m m at or y-t y p e r es p o ns es, it is p ossi bl e t h at t h e pr es e n c e of M. g alli n ar u m  m a y a br o g at e t h e 
p at h ol o gi c al  c o ns e q u e n c es i n d u c e d b y M.  g alli s e pti c u m  b y s u p pr essi n g l o c al i n n at e r es p o ns es.
T h e r es ults fr o m tr a ns missi o n a n d s c a n ni n g el e ctr o n mi cr os c o p y s h o w e d t h e diff er e n c e b et w e e n 
t h e p at h o g e ni c m e c h a nis ms of M. g alli n ar u m  a n d M. g alli s e pti c u m ( A b u- Z a hr a n d B utl er 1 9 7 6).
T h e y  s h o w e d  t h e  p at h o g e n esis  of  M.  g allis e pti c u m c a m e  dir e ctl y  fr o m  its  att a c h m e nt  t o t h e
e pit h eli al  c ells.  It  c ol o ni z e d  t h e  c ells  first  a n d  t h e n  t h e  l a mi n a  pr o pri a.  I n  c o ntr ast,  t h e  
p at h o g e n esis of M. g alli n ar u m  m a y b e r el at e d t o f a ct ors ot h er t h a n t h e a d h esi o n. T h e y f o u n d M. 
g alli n ar u m  di d n ot d e v el o p a cl os e ass o ci ati o n wit h t h e e pit h eli al c ell s b e c a us e m y c o pl as m a c ells
a p p e ar e d first i n t h e l a mi n a pr o pri a, w hi c h ar e diff er e nt fr o m m ost ot h er m y c o pl as m as ( Kr a us e 
1 9 9 6; R a zi n et al. 1 9 9 8). 
T h e  a mi n o p e pti d as e  a n d  c ar b o x y p e pti d as e  a cti vit y  of  s e v er al  h u m a n  m y c o pl as m as,  
i n cl u di n g  s o m e  p at h o g e ns,  h as  b e e n  d e m o nstr at e d  t o  i n a cti v at e  t h e  i nfl a m m at or y  m e di at or  
br a d y ki ni n  ( S hi b at a  a n d  W at a n a b e  1 9 8 9).  I n  ot h er  pr o k ar y ot es,  pr ot e as es  h a v e  b e e n  s h o w n  t o  
d o w n r e g ul at e i m m u n e r es p o ns es b y t h e d e gr a d ati o n of p h a g o c yt e L P S r e c e pt or C D 1 4 a n d T N F α 
( C al ki ns  et  al.  1 9 9 8;  S u g a w ar a  et  al.  2 0 0 0).  M or e o v er,  ot h er  st u di es  h a v e  d e m o nstr at e d t h at
b a ct eri al  pr ot e as es  p oss ess  t h e  a bilit y  t o  s u p pr ess  i m p ort a nt  n e utr o p hil  f u n cti o ns,  s u c h  as  t h e  
o xi d ati v e b urst, i n r es p o ns e t o sti m ul ati o n wit h p h or b ol est ers ( K a d o w a ki et al. 1 9 9 4; N a k a y a m a 
et al. 1 9 9 5; Y o n e d a et al. 1 9 9 0). 
P e pti d e d e gr a d ati o n a n d a mi n o a ci d s c a v e n gi n g b y a mi n o p e pti d as es ar e r e p ort e d t o b e 
i m p ort a nt i n t h e n utriti o n al s u p pl y i n pr o k ar y ot es ( T a n et al. 1 9 9 3; M or al es et al. 2 0 0 1). B e c a us e
m y c o pl as m as  h a v e  b e e n  s h o w n  t o  l a c k  t h e  m aj or  g e n es  t o  s y nt h esi z e  m ost  m a cr o m ol e c ul es  




















may play a more important role in the survival of mycoplasmas in their hosts (Maniloff et al. 
1992; Razin et al. 1998). However, the activity of aminopeptidases from mycoplasmas may be
deleterious to the epithelial cells because they produce ammonia and hydrogen peroxide in the 
process of oxidizing the released amino acids (Cole et al. 1968; Abu-Zahr and Butler 1976).  
Previous studies have indicated that M. gallinarum possesses leucine and arginine
aminopeptidase activity (Ball et al. 1985). The functions of these aminopeptidases in the host
adaptation of M. gallinarum are unknown. From our pervious work, a partial aminopeptidase
gene candidate was identified from M. gallinarum (Chapter II). Herein we clone, sequence, and
characterize the complete open reading frame of this aminopeptidase gene candidate. 
Our results showed that the cloned aminopeptidase enzyme was a leucine aminopeptidase
(EC 3.4.11.1), and that this enzyme was located in the cytoplasm having a weak interaction with
the cell membrane, or on the inner side of the membrane portion of M. gallinarum cells. These 
results suggested the cloned leucine aminopeptidase would at least play an important role in the
nutrition supply for M. gallinarum. 
Materials and methods 
Mycoplasma strain and culture conditions 
The M. gallinarum used in these studies (kindly provided by S. H. Kleven, University of
Georgia) was filter cloned three times and then used as an inoculum for a 400 ml culture in Frey
Broth incubated overnight at 37 °C. Aliquots of the culture were stored at −80 °C for use





















Aminopeptidase activity assay and subcellular location of aminopeptidase 
The method for membrane protein purification was adapted from the methods described
previously (Neill and Ball 1980; Shibata and Watanabe 1987). Briefly, M. gallinarum cells were 
harvested by centrifuging a 1 liter 24 hrs culture at 40,000×g for 30 min and then washing twice
with 0.15 M NaCl. The final pellets were diluted with 5 ml 0.15 M saline solution or 0.1 M BBS
with 0.15 M saline (pH 8.0). The suspended pellets were sonicated 10 times on ice at the
maiximum setting for 15 sec with 30 sec intervals (Microson Ultrasonic Cell Distruptor, Model
XL2000). The broken cells were then centrifuged at 1000×g for 10 mins, and the supernatants
were collected as the source of total proteins of M. gallinarum. Protein concentration was 
determined using the Pierce bicinchoninic acid assay kit (Pierce Chemical Co., Rockford, IL).  
Leucine aminopeptidase activity was assayed with the Sigma LAP diagnostic kit
according to the manual’s procedure (Procedure NO. 251, Sigma Diagnostics, St. Louis, MO).
The arginine aminopeptidase activity assay procedure was the same as the leucine
aminopeptidase assay except the LAP substrate was replaced with L-arginine-β-naphthylamide 
substrate (Sigma Chemical Co., St. Louis, MO). The substrate degrading products were
quantified by absorbance at 600 nm and activity per mg of protein calculated. 
To test the effects of metal ions on leucine and arginine aminopeptidase activity, the
enzyme-substrate solution was adjusted with a final concentration of 1mM Zn2+, Mn2+, K+, or
Mg2+ before the aminopeptidase activity assay. To test the inhibitory effect of tetrasodium
ethylenediaminetetraacetate (EDTA) on the aminopeptidase activities, the total cell membrane 
was incubated with the final concentration of 1 mM EDTA at 37 °C for 15 mins before

























The above prepared sonicated cells were centrifuged at 114,000×g at 4 °C for 2 hrs to
separate cell membrane proteins from cytoplasmic proteins (Pollack 1995&1998). The
supernatants were filtered through 0.2 µm pore filters to yield the cytoplasmic protein fraction.
The cell pellets were suspended with an equal amount of the supernatants of 0.1 M BBS with
0.15 M NaCl saline and then centrifuged at 2,000×g at 4 °C for 3 mins to collect the supernatants
as membrane protein fraction. Protein concentrations were determined (Pierce Chemical Co.,
Rockford, IL) and the aminopetpidase activity was assayed for both fractions. 
Nucleic acid preparation 
Genomic DNA was isolated from overnight broth cultures of M. gallinarum using the 
QIAGEN genomic DNA isolation kit (QIAGEN, Inc., Valencia, CA). Plasmids were extracted
from 24 hrs cultures of component cells using the QIAGEN miniprep plasmid extraction kit
(QIAGEN, Inc., Valencia, CA). 
Total RNA was prepared from overnight cultures of M. gallinarum and M. gallisepticum
using Trizol (GibcoBRL, Invitrogen Co., Carlsbad, CA). To remove genomic DNA, total RNA
was treated with RNAase free DNAase I (2 units/µg RNA) at 37 °C for 1 hr, and then the
DNAase I enzyme was removed by incubation with a protein-binding resin (Ambion, Inc. Austin,
TX ).
Recombinant genomic library construction and library screening 
A recombinant bacteriophage lambda library was prepared as described by Minion et al.
(1995). Briefly, 200 µg genomic DNA were partially digested with 52 unit Tsp 509 I in a final 
volume of 1 ml at 65 °C for 1 hr (New England Biolabs, Inc., Beverly, MA), purified by
















     











DNA was size-fractionated by centrifugation at 11,300 × g for 16 hrs on sucrose gradients (Luthe
1983). The fragment sizes of the 64 fractions collected from the gradient were determined by gel 
electrophoresis. The gradient fractions containing DNA fragments in the 4-8 kb range were
combined and purified by phenol/chloroform (1:1) extraction and ethanol precipitation. The
purified DNA fragments (0.3 µg) were ligated into the EcoRI site of 1 µg λZAPII bacteriophage I
vector by Fast-link ligase at 13 °C for 16 hrs (Epicenter, Madison, WI). After denaturing the
ligase, a 3 µl ligation product was mixed with Gigapack Gold III packaging extracts (Stratagene, 
Co., La Jolla, CA), incubated at room temperature for 1 hr and 45 mins, and then mixed with 500
µl SM buffer. The packaged phage library was stored at 4 °C. 
For library plating, E.coli XL1-Blue cells were collected from 10 ml fresh XL1-Blue cell
culture (OD600nm 0.8) by centrifuging at 837 × g for 5 mins. The cell pellets were then
resuspended with 10 ml of 10mM MgSO4. The amount of 200 µl suspended XL1-Blue cells was
mixed with 30,000 plaque form unit (pfu) packaged phages and 10 ml top agrose, and the mixture
was poured onto 2XYT agar plates. The plates were incubated at 37 °C overnight. The
recombinant phage library was screened according to a protocol adapted from Sambrook et al.
(1989). Briefly, duplicate nylon membranes were put on the plates for 1 min, and then moved
onto the filter paper soaked with 10% SDS to lyse the cells. Afterwards, the lifts were put onto
the filter paper soaked with denaturation buffer for 2 mins and then transferred onto the filter
paper soaked with neutralization buffer for 5 mins. After drying on filter paper, the lifts were
baked at 80 °C for 2 hrs. 
The oligonucleotide T7.1.854 (Table 2.1) was fluorescein-labeled using the enhanced
chemiluminescence (ECL) 3’-oligolabelling system according to the manufacturer’s protocol
(Amersham, Arlington Heights, IL). The fluorescein-labeled probes were made by incubating at

























cacodylate buffer, and 16 µl terminal deoxynucleotidyl transferase. The labeled T7.1.854 probe
was used to screen the library for the aminopeptidase gene. 
Before the hybridization, the lifts were incubated with 2×SSC for 10 mins, and the cell
debris on the lifts was removed gently with Kimwipes (Kimberly-Clark Inc. Roswell, GA). Then
the blots were prehybridized at 42 °C for 4 hrs. The 10 ng labeled probe was added into the
hybridization solution and incubated for 16 hrs at 42 °C. Then the blots were washed twice with a
low stringency buffer (5×SSC, 0.1% SDS) for 5 mins at room temperature. Finally, the blots were
washed twice with a high stringency buffer (1×SSC, 0.1% SDS) for 15 mins at 42 °C. After 
hybridization, the blots were treated with chemiluminescence substrate. The chemiluminescent
detection was performed with ECL detection reagents and exposed to X-ray film for various time
periods. 
Nucleotide sequencing and sequence analysis
The inserts from library clones were sequenced by dye terminator cycle sequencing using
the Big-Dye terminator reaction (Applied Biosystems, Foster City, CA) and pBluescript
phagemid promoter primers (Stratagene, Co., La Jolla, CA) or internal primers (Genosys, The
Woodlands, TX) listed in Table 3.1. Sequencing reaction products were analyzed on an ABI
Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA). Nucleotide sequence data
were analyzed with MacDNASIS Pro V3.1 software (Hitachi Software Engineering America,
Ltd., San Francisco, CA) and with the GenBank database (National Center for Biotechnology
Information). Amino acid sequence prediction was based on mycoplasma codon usage with UGA
encoding tryptophan (Inamine et al. 1990). Alignments of predicted amino acid sequence were






    
 
 












PCR and RT-PCR 
Primers APN-F and APN-R (Table 3.1) were used to amplify the leucine aminopeptidase
open reading frame from M. gallinarum genomic DNA. In the PCR reaction, 20 pmol APN-F, 20 
pmol APN-R, and 50 ng M. gallinarum genomic DNA were used in a 50 µl volume. The PCR
reaction was conducted at 94 °C for 10 mins, 30 cycles of 94 °C for 30 secs, 55°C for 30 secs,
and 72 °C for 3 mins, and finally 72 °C for 5 mins. 
The cDNA was synthesized using 2 µg total RNA as template, 1 pmol random hexamer
primers and 200 units SuperScript II reverse transcriptase (Invitrogen Co., Carlsbad, CA) in a 
volume of 19 µl. The primers used in the amplification of cDNA were APN-F and APN-R as
described above. 
Identification of 3-terminus of mRNA 
Total RNA was polyadenylated with poly (A) polymerase (Ambion, Inc. Austin, TX )
prior to reverse transcription. Total cDNA was then synthesized from polyadenylated RNA
primed with an Oligo(dT)17 primer-adaptor 5’-ATAGACTCGAGTCGACATCGA-dT17-3’
(Frohman et al. 1988) and SuperScript II reverse transcriptase (Invitrogen Co., Carlsbad, CA).
The first round PCR was conducted as described above with a single primer, APN-F, for 30
cycles with the conditions described above (Rother 1992). The products of the first round PCR
were subjected to an additional 30 cycles of amplification with an internal gene specific primer
1220S (5’-TTTAGTTTTAGCAGATGGAT-3’) and the adaptor-primer 5’-ATAGACTCGAGTC


















   
  
     




Northern-blot hyrbidization and Southern-blot hybridization analysis
The PCR amplification products covering the entire aminopeptidase open reading frame
was labeled with biotin using BrightStarTM Psoralen-Biotin nonisotopic labeling kit (Ambion, Inc.
Austin, TX ). The labeled probe was used both in Northern-blot and Southern-blot hybridization
analysis. 
To confirm the transcription of the leucine aminopeptidase gene and determine the size of
this transcript, Northern blots were hybridized with the biotin-labeled APN PCR product
according to the manufacturer’s instructions (Ambion, Inc. Austin, TX). The amount of 5 µg 
glyoxal-treated total RNA was loaded onto 1% agarose (Ambion, Inc. Austin, TX), and the gel 
was electrophoresed at 135 volts for 115 mins. The RNA was blotted to the nylon membrane by
capillary transfer. Afterwards, the blots were baked at 80 °C for 2 hrs.  
During hybridization, the blots were prehybridized with the hybridization buffer (Ambion,
Inc. Austin, TX) at 42 °C for 3 hrs, and a final concentration of 0.1 pM of biotion labeled APN
probe was added into the hybridization solution to hybridize at 42 °C for 16 hrs. The blots were
then washed twice with a low stringency buffer (Ambion, Inc. Austin, TX) at room temperature
for 10 mins, and then washed twice with a high stringency buffer (Ambion, Inc. Austin, TX) at 55
°C for 15 mins. The blots were detected with BrightStarTM BioDetectTM non-isotopic detection kit
(Ambion, Inc., Austin, TX). M. gallisepticum lacks aminopeptidase activity (Ball et al. 1985) and
was used as a negative control. 
To quantify the copy number of the leucine aminopeptidase gene present in the genome, 
2 µg M. gallinarum genomic DNA was digested with Bsa AI, Cla I, Dde I, Ear I, Eco RI, Hind
III, Nco I, Pst I, and Xmn I overnight at 37 °C and evaluated by Southern blot. The reaction
products were separated by 0.8% agarose gel electrophoresis at 30 volts 17 hrs and then blotted to






















Northern Blotting hybridization analysis. Hind III digested M. gallisepticum genomic DNA was
used as a negative control. 
Three dimensional structure prediction 
Three dimensional (3D) modeling templates of the leucine aminopeptidase gene were
obtained with SWISS-MODEL (http://www.expasy.ch/swissmod/) Blast by searching the
ExNRL-3D database with the target sequence. A putative 3D structure of the aminopeptidase was
predicted with the Swiss-Model First Approach Model. The resulting structure was analyzed with
Swiss-Pdbviewer version 3.7 beta (Schwede et al. 2000). 
Phylogenetic relation and hydrophobicity analysis 
To investigate the phylogenetic relationships between the cloned aminopeptidase and
other peptidases from mycoplasmas, phylogenic trees were generated by Clustal W version 1.81
(http://www.ebi.ac.uk/clustalw/) based on the nucleotide sequence identities (Thompson et al.
1994; Higgins and Sharp 1988). The tree was drawn with TreeViewer. Protein sequences of 37
mycoplasmas peptidases and nine eukaryote leucine aminopeptidases were obtained from the
Genbank database (Table 3.2). To analyze the subcellular location, hydrophobic features of
leucine aminopeptidases in mycoplasmas were plotted by ProtScale (http://www.expasy.ch/cgi-
bin/protscale.pl) (Kyte and Doolittle 1982). 
Results 
APN activity assay
The total proteins from M. gallinarum showed both leucine and arginine aminopeptidase
activity. Arginine aminopeptidase activity was stronger than leucine aminopeptidase activity
 
 








   














(Table 3.3). These results are similar to previous reports (Ball et al. 1985). The addition of of K+, 
Mg2+, Mn2+, or Zn2+, did not significantly affect the arginine aminopeptidase activity. However,
leucine aminopeptidase activity was enhanced most effectively by Mn2+, which was followed by
Mg2+ and K+. Zn2+ could not serve as a cofactor for leucine aminopeptidase of M. gallinarum. 
EDTA almost completely inhibited both leucine and arginine aminopeptidase activity and
addition of Mn2+ restored the activities (Gonzales and Robert-Baudouy 1996). 
Subcellular location of aminopeptidase
The arginine and leucine aminopeptidase activities were detected in both membrane and
cytoplasmic fractions of M. gallinarum. The ratio of arginine aminopeptidase activity in the 
membrane fraction versus that in the cytoplasmic fraction was 1.77, and that ratio for leucine
aminopeptidase activity was about 1.22. These results suggested that these enzymes might be a
cytoplasmic having a weak interaction with the membrane (Scopes 1994). The enzyme activity
shown in the membrane fraction could result from the enzymes which are adhering to the
membrane.
Phage library screening and sequence analysis 
The unamplified library had a titer of 6×106 pfu/ml, with less than 1% non-recombinants
and an average insert size of about 5 kb. Six overlapping phage clones were identified and
characterized by restriction endonuclease digestion. Comparison of restriction patterns of the
phage clones suggests that a 3.8 kb region of the M. gallinarum chromosome had been cloned. 
The clones were then sequenced with the internal primers listed in Table 3.1. A 3,865-bp 
fragment was obtained that contained two potential open reading frames (ORF) (Figure 3.1).




















   
 
- 70 -
the M. salivarium aminopeptidase gene and that the 1.1 kb ORF2 sequence had 68% nucleotide
identity with glutamyl tRNA synthetase gene of M. pulmonis. Alignment of the predicted amino
acid sequence derived from ORF1 with the aminopeptidase protein of M. salivarium showed an
amino acid identity of 51% between the two sequences (Figure 3.2). 
The putative promoter region and Shine-Dalgarno sequence are shown in Figure 3.3.
There are four TGA codons in this gene (Figure 3.3), which encode tryptophans in mycoplasmas
while serving as stop codons in most eubacteria (Inamine et al. 1990; Yamao et al. 1985). A 30
bp inverted repeat at the 3’ terminus of this gene (Figure 3.3) has the potential to form a stem
loop structure for rho-independent termination of transcription. According to the methods of
SantaLucia (1998), the stem loop was formed as in Figure 3.4. 
The amino acid sequence showed the six active residues identified in other leucine
aminopeptidases from both eukaryotes and prokaryotes have been conserved in this
aminopeptidase gene candidate at position Lys 226, Asp 231, Asp 248, Asp 307, Glu 309, and
Arg 311 (Figure 3.2) (Burley et al. 1990; Kim and Lipscomb 1993; Strater and Lipscomb 1995a;
Strater and Lipscomb 1995b). The active sites were also labeled in the putative 3D structure of
the leucine aminopeptidase in Figure 3.5. 
Northern-blot hybridization analysis 
To confirm gene expression and the size of the transcripts, mRNA was hybridized with
the biotin-labeled primer that covered the whole M. gallinarum leucine aminopeptidase (ORF1).
The Northern-blot showed the leucine aminopeptidase of M. gallinarum was expressed as a 1.5










      










3’ termination site determination and characterization of APN ORF
The 3’ poly(A) tailing sequences showed the transcript terminated at poly(T) tails after
the 3’ of APN gene. The stem loop at the termination site of the leucine aminopeptidase gene
transcript was shown in Figure 3.4 using DNA structural determination methods described
previously (SantaLucia 1998). 
Southern blot hybridization analysis
To quantify the copy number of aminopeptidase genes encoded in M. gallinarum, its
genomic DNA was digested with Bsa AI, Dde I, Ear I, Eco RI, Hind III, and Xmn I, and
hybridized with APN biotin-labeled probe. The results are shown in Figure 3.7 A. Hind III 
digested M. gallisepticum genomic DNA was used as a negative control.
Hybridization to blots of Bsa AI and Ear I digests resulted in 2.9 kb and 6 kb bands, 
respectively. Dde I digest generated three DNA fragments at molecular weights of 2.5 kb, 1.1 kb, 
and 1.4kb. Eco RI resulted in two bands, 2.4 kb and 2.8 kb. Hind III showed two bands, 2.2 kb
and 1.9 kb. Xmn I showed four bands: a strong band at 1.8 kb and weak bands 2.5 kb, 0.9 kb, and 
0.6 kb. The DNA was digested with different units of Xmn I to determine if the banding patterns 
were consistent (Figure 3.7 C) 
Three dimensional structure prediction 
The published X-ray crystallography 3D structures of LAN, LAP, LAM, LCP, and BPN 
were used as templates (Burley et al. 1990; Kim and Lipscomb 1993; Strater and Lipscomb 1995a; 
Strater and Lipscomb 1995b). The amino acid sequence homology between M. gallinarum
leucine aminopeptidase and the templates are 38.3%. The sequence and secondary structure 
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3.5 is the predicted structure of the leucine aminopeptidase of M. gallinarum and showed four α-
helixes and a β-sheet formed the active sites of the enzyme. 
Phylogenetic relation and hydrophobicity analysis 
The phylogenic relationship between the aminopeptidase from M. gallinarum and other
peptidases (Figure 3.9 A) showed the leucine aminopeptidases are present as a different family
from the methionine aminopeptidase (pepM), proline aminopeptidase (pepP), proline
iminopeptidase (PIP), oligoendopeptidase F (pepF), signal peptidase II (singalPII), and o-
sialoglycoprotein endopeptidase (ISGendoP). Only the proline dipeptidase from M. pulmonis is
closer to the family of leucine aminopeptidases. The cloned aminopeptidase could be a member 
of the aminopeptidase family M17, which is a family of cytoplasmic proteins. They release an N-
terminal amino acid from Xaa-Xbb-, where Xaa- is preferably Leu and can also be Pro, and Xbb-
may be Pro. The aminopeptidase of M. gallinarum may have similar features with the leucine
aminopeptidases (EC 3.4.11.1). Among the seven annotated leucine aminopeptidases, the cloned
aminopeptidase (MGN_APN) and the leucine aminopeptidase from M. salivarium (MSA_LAP)
might diverge from a closer ancestor than other leucine aminopeptidases. The leucine
aminopeptidases from mycoplasmas represent a different family of leucine aminopeptidase from
other prokaryotes (Figure 3.9 B). However, the leucine aminopeptidases from M. pneumoniae, M.
genitalium, and U. urealyticum showed a closer relationship to the aminopeptidases of other
prokaryotes. The alignments of these seven leucine aminopeptidases were shown in Figure 3.10.
The reported six active aminopeptidases identified in other leucine aminopeptidases were
conserved in all the leucine aminopeptidases from mycoplasmas (Burley et al. 1990; Kim and
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Hydrophobicity analysis showed that the leucine aminopeptidase of M. gallinarum does 
not have a strong hydrophobic region suggestive of a transmembrane region (Figure 3.11).  
Discussion 
We have identified a leucine aminopeptidase of M. gallinarum. The probe that hybridized
with the aminopeptidase gene fragment in our plasmid library was designed from P30 cytadhesin
of M. genitalium and M. pneumonia. We obtained a short sequence from this plasmid library, 
which showed homology with the leucine aminopeptidase gene of M. salivarium. By screening a
M. gallinarum genomic library constructed in λZAP Express with oligonucleotides T7.1.854, we
obtained a full-length leucine aminopeptidase of M. gallinarum. This is the second gene in M.
gallinarum described after the 16s rRNA gene was published in 1993 (Boyle and Morrow 1993). 
Within the 1462 bp ORF1, there are four TGA codons. The presence of these codons
within the ORF demonstrated that UGA codons encode Trp in M. gallinarum, which a common 
characteristic of mycoplasma genes (Inamine et al. 1990; Yamao et al. 1985). This property is
unique to mycoplasmas and possibly results from AT pressure (Jukes et al. 1987). This feature
causes difficulty in expressing mycoplasma genes in eubacteria systems (Minion 1998). 
The sequence alignments showed that ORF1 encodes a leucine aminopeptidase. The 3’
Poly(A) tailing reaction confirmed the termination site of the transcript encoding this leucine
aminopeptidase gene. The potential step loop in the 3’ terminal indicates a rho-independent
termination character of this transcript (Calcutt et al. 1999; Taschke and Herrmann 1986; Bove
1993). The promoter sequences and ribosomal binding sites are similar to those described in
previous reports of mycoplasma genes (Bove 1993; Shibata et al. 1995). The presence of putative 
SD sequence suggests that M. gallinarum might use a leader translation initiation (Figure 1.1;
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active sites identified in other leucine aminopeptidases are conserved in M. gallinarum leucine 
aminopeptidase (Burley et al. 1990; Kim and Lipscomb 1993; Strater and Lipscomb 1995a;
Strater and Lipscomb 1995b). 
The Northern blotting results suggested that the leucine aminopeptidase gene of M. 
gallinarum is expressed as a moncistronic message of 1.5 kb. According to Southern blot
hybridization results, there is a single copy of leucine aminopeptiase in M. gallinarum. M.
gallinarum genomic DNA was digested with Bsa AI, Dde I, Ear I, Eco RI, Hind III, and Xmn I,
and hybridized with a biotin-labeled APN probe. In the restriction map of Figure 3.1, Bsa AI 
flanks the ORF1 and produces a fragment of 2,833 bp. There are three Dde I restriction sites at
356, 1708, and 2,863, thus the complete digestion will release two signals of 1,352 bp and 1,155
bp. The single Ear I site is present at position 3657. There is an Eco RI site at position 1126 so
that the digestion will divide this gene into two fragments. There are two Hind III sites at 1203 
and 3405, thus digestion will divide ORF1 at position 1203 into two fragments, one of which
would be 2,202 bp. There are three Xmn I sites at positions 184, 435, and 2871, respectively, each
of which flanks ORF1. The Southern-blot hybridization results we have obtained are consistent
with the restriction maps (Figure 3.7 A). However, Dde I digestion showed three bands at
molecular weight at about 2.5 kb, 1.1 kb, and 1.4kb, which might be the result of incomplete
digestion. The several bands that results from Xmn I digestion instead of an expected single band
are probably a result of the star activity of Xmn I (Promega, Madison, WI). Southern
hybridization analysis with different genomic DNA/enzyme ratios confirmed this possibility
(Figure 3.7 B). The lower the genomic DNA/enzyme ratio, the more completion of Xmn I 
digestion. Southern-blot with three enzymes flanking the aminopeptidase gene, Cla I, Nco I, and
Pst I, showed a single band, which also confirmed the single copy of aminopetidase gene present














Arginine aminopeptidases cleave the arginine amino acid from the N terminus of peptides.
Our results demonstrated that arginine aminopeptidase activity was not affected by the metallic 
ions, K+, Mg2+, Mn2+, or Zn2+. But it was inhibited by EDTA and this activity was resumed by
Mn2+, suggesting that arginine aminopeptidase is a metallo-aminopeptidase. Leucine 
aminopeptidases mainly cleave N terminal leucyl substrates, and they can cleave most other
peptides (Burley et al. 1990). Our results demonstrated the leucine aminopeptidase of M.
gallinarum is a metallo-aminopeptidase. EDTA can inhibit the activity of both leucine and 
arginine aminopeptidase activity. Mn2+ not only enhanced leucine aminopeptidase activity but 
also restored aminopeptidase activity inhibited by EDTA. Our results implied arginine and 
leucine aminopeptidase activities may result from different enzymes of M. gallinarum. 
The putative leucine aminopeptidase predicted by the cloned gene potentially belongs to 
the leucine aminopeptidase family (EC 3.4.11.1). According to the enzyme nomenclature from
the Nonmenclature Committee of the International union of Biochemistry and Molecular Biology
(NC-IUBMB), the enzymes in this family “release an N-terminal amino acid, Xaa-Xbb-. Xaa- is 
preferably be Leu, and can also be Pro although not Arg or Lys. Xbb- may be Pro 
(http://www.chem.qmul.ac.uk/ iubmb/enzyme/).” However, because this enzyme was not
activated by Zn2+ and even lost some activity because of Zn2+, it may be more similar to leucine 
aminopeptidase in E. coli than other typical leucine aminopeptidases, such as bovine leucine 
aminopeptidase. Leucine aminopeptidase (Genbank access No: P11648) was reported to be 
activated by Mn2+ but inhibited by Zn2+ and EDTA, and this enzyme was assumed to be involved 
in the processing and regular turnover of intracellular proteins as well as in catalyzing the 
removal of unsubstituted N-terminal amino acids from various peptides (Gonzales and Robert-
Baudouy 1996). In contrast, bovine leucine aminopeptidase (Genbank access No: P00727) can be















The phylogenetic relationship and hydrophobic plot comparison showed the leucine
aminopeptidase characterized in this study was related closely to the leucine aminopeptidase in M.
salivarium. Shibata et al. (1995) showed this enzyme is a membrane associated enzyme. However, 
more recently, they annotated it as a possible cytoplasmic protein (Genbank access No: P47707).
Based on our results, the leucine aminopeptidase of M. gallinarum is a cytoplasmic protein
having a weak interaction with the cell membrane. 
Because mycoplasmas lack many of the genes to synthesize most macromolecule
precursors, such as amino acids, lipids, and nucleic acid precursors, the survival of mycoplasmas 
depends on the nutrient environment (Maniloff et al. 1992; Razin et al. 1998). Thus, 
mycoplasmas require a “fastidious” environment (Maniloff et al. 1992). Mycoplasma gallinarum
is one of the most fastidious mycoplasmas and requires 13 amino acids for its growth, including
leucine, arginine, alanine, asparagines, cystine, glutamic acid, glycine, histidine, isoleucine, 
methionine, phenylalanine, threonine, and tyrosine. The leucine aminopeptidase might play an 
important role in peptide degradation and amino acid scavenging in M. gallinarum (Tan et al. 
1993; Morales et al. 2001). The possible association of M. gallinarum aminopeptidase with the 
cell membrane could result in the close proximity of this enzyme with membrane transport 
systems. Peptides transported across the membrane could be cleaved by the enzyme to provide a 
source for leucine as well as to render peptides susceptible to further degredation (Gonzales and 
Robert-Baudouy 1996). 
The lack of transmembrane regions in the hydrophobicity plot of the cloned 
aminopeptidase suggested that this enzyme is a cytoplasmic protein having a weak interaction 
with the cell membrane. Alternatively, the several weak hydrophobic regions predicted are 
possibly involved the interaction of this enzyme with other membrane proteins by noncovalent 












   
 
  






Through comparison of the aminopeptidase activities between A. laidlawii, M. bovirhinis,
M. bovis, and M. dispar, Neill and Ball (1980) found the pathogenicity of mycoplasmas 
decreased as the associated aminopeptidase activity increased. A. laidlawii is another non-host-
specific strain, which was reported in humans, birds, cattle, and even plants and insects (Tully
1993; Maniloff 1992; Stipkovitis and Kempf 1996; Yoder 1991). A. laidlawii had the strongest
aminopeptidase activity among these four investigated mycoplasmas. On the other hand, the
depletion and oxidation of amino acids by mycoplasmas may generate ammonia and hydrogen 
peroxide, which could induce cytopathology (Cole et al. 1968; Abu-Zahr and Butler 1976). The
role that the leucine aminopeptidase may play in host-pathogen interaction of mycoplasmas is 
unknown. M. gallinarum is also a non-host specific mycoplasma and is relatively nonpathogenic
and does not produce clinical signs in its hosts (Yoder 1991). Whether the leucine
aminopeptidase activity has a role in nonpathogenesis is unknown. 
Other studies demonstrated that mycoplasmal aminopeptidase and carboxypeptidase
activity can inactivate the inflammatory mediator bradykinin (Shibata and Watanabe 1989).
Similarily, peptidases from the other prokaryotes were reported to down regulate immune 
responses by degradation of the phagocyte LPS receptor CD14 and TNFα, and even to suppress
neutrophil functions, such as oxidative burst (Calkins et al. 1998; Sugawara et al. 2000;
Kadowaki et al. 1994; Nakayama et al. 1995; Yoneda et al. 1990). It is unknown whether the
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a. Shibata demonstrated MSA_LAP is a membrane protein (Shibata et al. 1995). However, they described it as a possible cytoplasmic protein when they submitted the sequence into Genbank (Locus: P47707).
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Table 3.3 Effects of metallic cofactors on aminopeptidase activity of M. gallinarum
APN Activity (OD600nm Unit/mg protein)a,b 
Metal name Leu substrate Arg substrate 
No metal ion 0.43 ± 0.03c,d 11.9 ± 0.03g,h 
K+ 0.94 ± 0.06c,e 12.17 ± 0.32g 
Mg2+ 1.95 ± 0.06c,e,f 12.29 ± 0.14g 
Mn2+ 2.38 ± 0.06c,e,f 12.31 ± 0.38g 
Zn2+ 0.39 ± 0.05d 11.61 ± 0.15h 
a. It is calculated by dividing the OD600nm value by the test protein concentration.
b. The values in table are the activity mean values from three experiments ± standard error. 
c. Significant difference for leucine aminopeptidase activity between the no metal ion
control group and the group treated with K+, Mg2+, or Mn2+. 
d. No significant difference for leucine aminopeptidase activity between Zn2+ treated group 
and the no metal control group. 
e. Significant difference for leucine aminopeptidase activity between the group treated with
K+ and the group treated with Mg2+ or Mn2+. 
f. Significant difference for leucine aminopeptidase activity between the group treated with
Mg2+ and the group treated with Mn2+. 
g. No significant difference for arginine aminopeptidase activity between the no metal ion
control group and the group treated with K+, Mg2+, or Mn2+. 
h. No significant difference for arginine aminopeptidase acitivity between Zn2+ treated


































Table 3.4 Effects of EDTA on aminopeptidase activity of M. gallinarum lysed cells 
APN Activity (OD600nm Unit/mg protein)a,b 
Inhibitor name Leu substrate Arg substrate 
No metal ion 0.40 ± 0.01c 7.23 ± 0.12e 
EDTA 0.00 ± 0.00c 0.00 ± 0.00e 
Mn2+ 1.26 ± 0.09c,d 6.90 ± 0.28e,f 
EDTA+ Mn2+ 0.65 ± 0.07c,d 7.05 ± 0.24e,f 
a. It is calculated by dividing the OD600nm value by the test protein concentration.
b. The values in table are the activity mean values from three experiments ± standard error. 
c. Significant difference for leucine aminopeptidase activity between EDTA treated group 
and the other three groups. 
d. Significant difference for leucine aminopeptidase activity between Mn2+ treated group
and EDTA+Mn2+ treated group. 
e. Significant difference for arginine aminopeptidase activity between EDTA treated group
and the other three groups. 
f. No significant difference for arginine aminopeptidase activity between EDTA treated
group and the other three groups. 
Table 3.5 Aminopeptidase activity of M. gallinarum lysed cells 
Arg APN activity Leu APN activity
(OD600nm Unit/mg protein)a,b (OD600nm Unit/mg protein)a,b 
Membrane fraction Cytoplasmic fraction Membrane fraction Cytoplasmic fraction 
2.53 1.36 3.65 0.96 
a. It is calculated by dividing the OD600nm value by the test protein concentration. 
b. The listed values are from the group with the maximum enzyme activity in cytoplasmic
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Figure 3.1 Restriction map of the cloned 3,865 bp sequence. Database searches indicate that the
1,362-base ORF1 sequence has 68% nucleotide identity with the M. salivarium leucine
aminopeptidase gene, whereas the 1.1 kb ORF2 sequence has 68% nucleotide identity with
glutamyl tRNA synthetase gene of M. pulmonis. Alignments of the predicted amino acid
sequence, which was derived from ORF1, with the aminopeptidase protein of M. salivarium
showed an amino acid identity of 51% between the two sequences. 
 







MSA_LAP MELIKEIETSRNSSVLLKAIFEGDDAPTLLVKKQSQITEYLKENVAYVYLGKKSEFGYKD 60 
MGN_APN MNKL-EFLTKRDNNFLLVAVDYNNLPFEWISKKNGAISENLSKNEAYITIKEIK--NYDE 57 
*: :.*: *.*:...** *: .: . : **:. *:* *.:* **: : : ..  .*.: 
MSA_LAP AYEFARDLAENCARSYQLDLTTFVTEK-LCIKGVVDAFTKGINFSAFQYYNLKTFTKRVN 119 
MGN_APN LVEFIKKNILNSQRAFQIDLNSFKNVLNINYEDILKAFISSIVFYQAKLFNKK--KEKSK 115 
** :. *. *::*:**.:* . : :.::.** ..* * : :* *: .:: : 
MSA_LAP ENSLSFYLENISQDVLNVFKKALILVDAQNFARNLGVTPPNELNSEQLAEIIRKDFKKYH 179 
MGN_APN KTNFSLLFN--SDEDKEVFNKFNLIAENRNKIRNLQIMPENYCNSVELANYIVEDFSNLK 173 
:..:*: ::. *:: :**:* ::.: :* *** : * *  **  :**: * :**.: : 
MSA_LAP NLKVKVLERKQIELLGMDLLLSVNKGSVYEPRVVIIEYKGNPSSQEKTVLVGKGITFDSG 239 
MGN_APN NLKVTVLDKNMIEKLKMGLILSVNKGSTHEPRVVIVEYNGNKKSKDKIVFVGKGITFDTG 233 
****.**::: ** * *.*:*******.:******:**:** .*::* *:********:* 
MSA_LAP GYSLKPPKFMLGMKYDMSGSAIVAAVMKAIAQLKPNKNVSAIMCITDNRINGDASLPDSV 299 
MGN_APN GINTKG-YHMSGMKYDMSGSAIVAYAVKTLAELKANVNVAAIMMITDNRQDGDASLPENV 292 
* . * . .*  ************* .:*::*:**.* **:*** ***** :******:.* 
MSA_LAP YTSMSGKTVEVNNTDAEGRLVLADRLYYGATKLNATRLIDTATLTGTMLTALGQTYSGIY 359 
MGN_APN YESMSGLSVEVTDTDAEGRLVLADGLYYGATKLKATTLFDVATLTGSVLTALGHTYSGIW 352 
* **** :***.:*********** ********:** *:*.*****::*****:*****: 
MSA_LAP ATSCKIWHQFEDAAKIAHEKVWRMPLHEDFNKTNKESLVADLNNYSNNEKSDCNTAAMFL 419 
MGN_APN STNEGKWGLFEKAGQISHEKIWRMPLHDDFHQFNLASEVADLNNYNNSEKSDSNTAAMFL 412 
:*. * **.*.:*:***:******:**:: * * *******.*.****.******* 
MSA_LAP KEFTNNVPYIHCDVAGTADKKGMGLGILVSTFVEFGKSQQR 
MGN_APN KQFTNNVDYIHCDVAGTADVGGKPQGVLIDTLVEFALLNEK 
*:***** *********** * *:*:.*:***. ::: 
Figure 3.2 Alignment of ORF1 with M. salivarium leucine aminopeptidase gene. The alignment
of amino acid sequence derived from M. gallinarum ORF1 with the leucine aminopeptidase gene
of M. salivarium (Shibata et al. 1995) showed a 51% identity. The active sites of leucine
aminopeptidases (Burley et al. 1990; Kim and Lipscomb 1993; Strater and Lipscomb 1995a;
Strater and Lipscomb 1995b) were predicted in this aminopeptidase candidate and are designated
as bold. In the consensus line, “*” designates identical amino acids, and “:” designates conserved
















-35 -10 +1 
841 ACTTTTTTCATTACAATCCTTTATATATTTGTCTTTATATTTTTATATAATTATAAAATTAAAAAAATGTCAAATAAGGAGATATATGAATAAATTGGAATTTTTGACAAAAAGAGACAA 
SD  M N K L E F L T K R D N  
961 CAATTTTTTATTAGTTGCAGTCGATTATAATAATTTACCATTTGAATGAATTTCTAAAAAAAATGGCGCAATAAGTGAAAATTTATCTAAAAATGAAGCATATATAACTATAAAAGAAAT 
N F L L V A V D Y N N L P F E W I S K K N G A I S E N L S K N E A Y I T I K E I 
1081 TAAAAATTATGATGAATTAGTAGAATTTATCAAGAAAAATATTTTGAATTCTCAAAGAGCTTTTCAAATTGATTTAAATTCTTTTAAAAACGTATTGAATATAAATTATGAAGATATTTT 
K N Y D E L V E F I K K N I L N S Q R A F Q I D L N S F K N V L N I N Y E D I L 
1201 AAAAGCTTTTATTTCTTCAATCGTTTTTTATCAAGCAAAATTGTTTAACAAGAAAAAAGAAAAAAGTAAAAAAACTAATTTTTCTTTATTATTTAATTCTGATGAAGATAAAGAAGTTTT 
K A F I S S I V F Y Q A K L F N K K K E K S K K T N F S L L F N S D E D K E V F 
1321 TAATAAATTTAATTTAATCGCAGAAAATAGAAACAAAATTAGAAACTTGCAAATAATGCCTGAAAATTACTGCAATTCAGTAGAGTTAGCTAATTATATTGTTGAAGATTTTTCTAATCT 
N K F N L I A E N R N K I R N L Q I M P E N Y C N S V E L A N Y I V E D F S N L 
1441 AAAAAATTTAAAAGTCACCGTTTTAGATAAAAATATGATAGAAAAATTAAAGATGGGTTTAATTTTGTCTGTAAATAAGGGTTCAACACACGAACCAAGAGTGGTTATTGTTGAATACAA 
K N L K V T V L D K N M I E K L K M G L I L S V N K G S T H E P R V V I V E Y N 
1561 TGGAAACAAGAAATCAAAAGATAAAATCGTCTTTGTTGGAAAAGGAATTACTTTTGATACAGGTGGAATTAATACAAAAGGCTATCATATGTCAGGAATGAAATATGATATGTCAGGTTC 
G N K K S K D K I V F V G K G I T F D T G G I N T K G Y H M S G M K Y D M S G S 
1681 TGCCATTGTGGCTTATGCTGTAAAAACCTTAGCCGAATTAAAAGCAAATGTTAATGTTGCTGCAATTATGATGATAACTGATAATCGTCAAGACGGAGATGCTTCATTGCCCGAAAATGT 
A I V A Y A V K T L A E L K A N V N V A A I M M I T D N R Q D G D A S L P E N V 
1801 TTATGAATCTATGTCAGGTTTGAGTGTTGAAGTAACTGATACCGATGCTGAAGGACGTTTAGTTTTAGCAGATGGATTATATTATGGAGCTACTAAATTAAAAGCAACTACATTATTTGA 
Y E S M S G L S V E V T D T D A E G R L V L A D G L Y Y G A T K L K A T T L F D 
1921 TGTTGCAACTTTAACAGGATCAGTTTTAACAGCACTAGGACATACTTATTCTGGAATTTGATCAACAAATGAAGGAAAATGAGGACTTTTCGAAAAAGCAGGACAAATTAGTCATGAGAA 
V A T L T G S V L T A L G H T Y S G I W S T N E G K W G L F E K A G Q I S H E K  
2041 AATTTGAAGAATGCCATTACATGATGATTTTCATCAATTTAATTTGGCTTCTGAAGTTGCTGATTTAAATAATTATAATAATAGTGAAAAATCAGATTCTAATACTGCTGCAATGTTCTT 
I W R M P L H D D F H Q F N L A S E V A D L N N Y N N S E K S D S N T A A M F L 
2161 AAAACAATTTACTAACAATGTAGATTATATTCATTGTGATGTTGCCGGAACCGCTGATGTCGGTGGAAAACCTCAAGGTGTTTTAATTGATACATTAGTTGAATTTGCTTTATTAAATGA 
K Q F T N N V D Y I H C D V A G T A D V G G K P Q G V L I D T L V E F A L L N E 
















Figure 3.3 Nucleotide and deduced amino acid sequences of the aminopeptidase gene cloned
from M. gallinarum. The marked SD denoted the putative Shine-Dalgarno sequence. The
potential stem loop at the end of the APN gene suggests a rho-independent termination signal of
transcription. The putative promoter regions are shown upstream of the APN gene. The four TGA 
used to encode Trp were denoted in bold letters in both nucleotide and amino acid sequences. The




Figure 3.4 The potential loop at 3’ terminusof the leucine aminopeptidase identified gene in M.














Figure 3.5 The predicted 3D structure of the leucine aminopeptidase identified in M. gallinarum. 
This structure covered the length of the protein from amino acid 110 to 433. The 3-D modeling
templates of the leucine aminopeptidase gene were obtained with SWISS-MODEL
(http://www.expasy.ch/swissmod/) Blast by searching the ExNRL-3D database with the sequence,
and the structure was predicted with the Swiss-Model First Approach Model and analyzed with 
Swiss-Pdbviewer version 3.7 beta (Schwede et al. 2000). The six active sites reported in other
leucine aminopeptidases (Burley et al. 1990; Kim and Lipscomb 1993; Strater and Lipscomb
1995a; Strater and Lipscomb 1995b) were conserved in this structure. They are labeled as Lys
117, Asp 122, Asp 139, Asp 198, Glu 200, and Arg 202, representing the amino acid Lys 226,









Figure 3.6 The results of Northern-blot hybridization analysis. Lane 1, RNA molecular marker;
lane 2. M. gallisepticum total RNA; lane 3-4, M. gallinarum total RNA. The blot was hybridized
with APN biotin-labeled probe which was amplified by PCR from M. gallinarum genomic DNA 
and covered ORF1. 
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A B C 
Figure 3.7 The results of Southern-blot hybridization analysis. The blot was hybridized with APN
biotin-labeled probe that was amplified by PCR from M. gallinarum genomic DNA and covered
ORF1. A. Lane 1, lambda DNA digested with Hind III; Lane 2, 2 µg M. gallisepticum F strain
genomic DNA digested with Hind III; Lane 3-8, 2 µg M. gallinarum genomic DNA digested with
10 units of Bsa AI, Dde I, Ear I, Eco RI, Hind III, and Xmn I; Lane 9, 1kb DNA ladder. B.
Southern-blot results from partial digested M. gallinarum genomic DNA with Xmn I. Lane 1,
lambda DNA digested with Hind III; lane 2, 2 µg M. gallisepticum F strain genomic DNA
digested with Hind III; lane 3-4, 2 µg M. gallinarum genomic DNA digested with 10 and 20 units
of BsaI, respectively; Lane 5-7, 2 µg M. gallinarum genomic DNA digested with 2, 5, and 10
units XmnI, respectively. C. Lane 1, 2 µg M. gallisepticum F strain genomic DNA digested with
Hind III; Lane 2-6, 2 µg M. gallinarum genomic DNA digested with 10 units of Cla I, Ear I, Nco
I, Pst I, and Xmn I; Lane 7, lambda DNA digested with Hind III.
 
 
   
 




MGN_APN 110 KKEKSKK TNFSLLFNSD 
LAP 101 QDLEIPSVEV DPCGDAQAAA EGAVLGLYEY D--DLKQKRK VVVSAKLHGS 
.* * ... 
MGN_APN 
LAP hh sssss s hhhhh hhhhhh sssss 
MGN_APN 117 EDKEVFNKFN LIAENRNKIR NLQIMPENYC NSVELANYIV EDFSNLKN-L 
LAP 149 EDQEAWQRGV LFASGQNLAR RLMETPANEM TPTKFAEIVE ENLKSASIKT 
** * . *.* .* * * * * . .*. . *.. . 
MGN_APN hhhhhhhh hhhhhhhhhh hhhh hhhhhhhhh hhhh 
LAP hhhhhhhh hhhhhhhhhh hhhh hhhhhhhhh hhhhhh ss 
MGN_APN 176 KVTVLDKNMI EKLKMGLILS VNKGSTHEPR VVIVEYNGNK K-SKDKIVFV 
LAP 199 DVFIRPKSWI EEQEMGSFLS VAKGSEEPPV FLEIHYKGSP NASEPPLVFV 
* . *. * * ** .** * *** * . . *.*. . * .*** 
MGN_APN sss hhhh hh hhhhh hhh s ssssssss ssss 
LAP sssss hhhh h hhhhhh hhh s ssssssss ssss 
MGN_APN 225 GKGITFDTGG INTKGYHM-S GMKYDMSGSA IVAYAVKTLA ELKANVNVAA 
LAP 249 GKGITFDSGG ISIKAAANMD LMRADMGGAA TICSAIVSAA KLDLPINIVG 
*******.** *. *. *. **.*.* . *. . * * .*. . 
MGN_APN sssss hhhhh hhhhhhhhhh hh sssss 
LCP sssss sss sss h hh hhhh hhhhhhhhhh hh sssss 
MGN_APN 274 IMMITDNRQD GDASLPENVY ESMSGLSVEV TDTDAEGRLV LADGLYYGAT 
LAP 299 LAPLCENMPS GKANKPGDVV RARNGKTIQV DNTDAEGRLI LADALCYAHT 
. . .* * *. * .* . .* ...* .*******. ***.* *. * 
MGN_APN sssss sss ss sssss hhhh hhhhhhhh 
LCP sssss sss ss sssss hhhh hhhhhhhhhh 
MGN_APN 324 KLKATTLFDV ATLTGSVLTA LGHTYSGIWS TNEGK-WGLF EKAGQISHEK 
LAP 349 -FNPKVIINA ATLTGAMDIA LGSGATGVFT NSSWLWNKLF EASIETG-DR 
... ... *****.. * ** .*. . . ** * . . . ..  
MGN_APN sssss s hhhhh ssss hh hhhhh s 
LAP sssss s hhhhh sssss s hhhhhhhh hhhhhh s 
MGN_APN 373 IWRMPLHDDF HQFNLASEVA DLNNYNNSEK SDSNTAAMFL KQFTNNVDYI 
LAP 397 VWRMPLFEHY TRQVIDCQLA DVNNIGKYRS AGACTAAAFL KEFVTHPKWA 
.***** . . . . ..* *.** . . . *** ** *.* . 
MGN_APN ssss hh hhhhh sss hhhhhhhhh h sss 
LAP ssss hh hhhhh sss hhhhhhhhh h ss 
MGN_APN 423 HCDVAGTADV G 
LAP 447 HLDIAGVMTN KDEVPYLRKG MAGRPTRTLI EFLFRFSQ 
* *.** 
MGN_APN ssss 
LAP ssss sss s ss hhhhh hhhhhhh 
Figure 3.8 Alignment of the leucine aminopeptidase of M. gallinarum and the template LAP
obtained from the ExNRL-3D database (Burley et al. 1990; Kim and Lipscomb 1993; Strater and
Lipscomb 1995a; Strater and Lipscomb 1995b). MGN_LAP represents the cloned
aminopeptidase gene from M. gallinarum. LAP is an abbreviation for bovine lens leucine
aminopeptidase. There is a 38.3% homology between MGN_LAP and LAP. * designates the
identical amino acids; conservative amino acid are designed by “.”. Dashes indicate gaps 















Figure 3.9 Phylogenetic relationships of leucine aminopeptiases. A. Phylogenetic relations for 37
peptidases from mycoplasmas. B. Phylogenetic relations for 7 leucine aminopeptidases from
mycoplasmas and 9 leucine aminopeptidases from other prokoyotes. The phylogenetic trees were
predicted with the Clustal W version 1.81 (http://www.ebi.ac.uk/clustalw/) (Thompson et al. 1994;









MSA_LAP --MELIKEIETSRNSSVLLKAIFEGDDAPTLLVKKQSQITEYLKENVAYVYLGKKSEFGY 58 
MPN_LAP ------MKLN--KLF--DSKTVVFKKSDKYGKSDCCKTKCVEG-QIEFG--VKIPTDFP- 46 
MGE_LAP ------MRIN--KPFSDDSNTVVFVSSKTYG----VKEEAAHNPNVEFG--VVLPTDFP- 45 
: : . : . 
MGN_APN --MNKL-EFLTKRDNNFLLVAVDYNNLPFEWISKKNGAISENLSKNEAYITIKEIK--NY 55 
MPU_LAP2 ---MLLEKQTRERNNEMLLKAVFDSEAKIEGLIKTKNVITEFVEKNEAYVFLGKKEDFSR 57 
MPU_LAP1 MKGKKVIKVSNEKEFPISLKLIFKQENMNDFLIQEDHQITEINSENTLYYFVKDKSKYDI 60 
UUR_LAP ------MTLNEKKEFVYELKAVEKNHN-LKGFEENTTEHVVFGGLYQKQQYLILTPDFDS 53 
MSA_LAP KDAYEFARDLAENCARSYQLDLTTFVTEK-LCIKGVVDAFTKGINFSAFQYYNLKTFTKR 117 
MGN_APN DELVEFIKKNILNSQRAFQIDLNSFKNVLNINYEDILKAFISSIVFYQAKLFNKK--KEK 113 
MPU_LAP2 EVWNSFLDSFIPSMKRSYQLDILSFETPS-YKLEDIIYDLYIKYDYIKADLFSHRKKESD 116 
MPU_LAP1 KFFKKAASKIVENQNRNLNIDISSFSHNS-IALESIVKIFVEKYEFKHANLFKEKDKDDK 119 
MPN_LAP -AFNRALVTFLKTQKNQLNVDLDSFVELYKAEN--LCYKTALKVVVASITFCETTPFTMK 103 
MGE_LAP -AFNRALVQFLKRKKTKLNINLDSLIELYKKNENSGCFHTAIKTVITSVTFCETTPFTMK 104 
UUR_LAP NELSRSLISFLEKSPKSVSVDLNSFLSLVPESR----HASLLNVVISALEYVEVTPFSLK 109 
.::: :: . 
MSA_LAP VNENSLSFYLENISQDVLNVFKKALILVDAQNFARNLGVTPPNELNSEQLAEIIRKDFKK 177 
MGN_APN SKKTNFSLLFN--SDEDKEVFNKFNLIAENRNKIRNLQIMPENYCNSVELANYIVEDFSN 171 
MPU_LAP2 ENKVSLTIWNN-ANRCFAEVYEKAKLISSLVNFARDLQTTPPNICNSEWMAKKVEEKAKS 175 
MPU_LAP1 QYSINLYVSDKQKILVLETLLEKTLILTNALNTVRKLQIYPPNICNSEWLADFVYEDLKK 179 
MPN_LAP TEPQKNVEVAVKCDSEHTSLIKEYEVVGNYVNMARQLQDTPSDQLYPEEFVKRFEKAATG 163 
MGE_LAP TKPEKNVEVAVQCAVEYHNLVKEYETVGEYVNLARELQDTPSDLLYSEVFVKHFEKAASK 164 
UUR_LAP SKIETKNIHNLVVDQKYHDLINKLHVIAQSQTITRTLQDTPANLMTPGDFEERIKELFKD 169 
.  : ::  : . . * *  * :  . : . . : .  
MSA_LAP YHNLKVKVLERKQIELLGMDLLLSVNKGSV---YEPRVVIIEYKGNPSSQEKTVLVGKGI 234 
MGN_APN LKNLKVTVLDKNMIEKLKMGLILSVNKGST---HEPRVVIVEYNGNKKSKDKIVFVGKGI 228 
MPU_LAP2 FENVEVKVLDKKAIEKHGMNLLLSVNKGSM---FEPRVVVLSYNGDSSSKERTSLIGKGI 232 
MPU_LAP1 IDSLKINIYNKSQIEDLGMNLFLSVNKGSA---YEPRLVSIEYNGDPSSEEKTVLVGKGI 236 
MPN_LAP LG-VKITVLKQADLIKKKMGLLLGVNKGSE---REARLLVISYNNNKKSSETLALVGKGI 219 
MGE_LAP LP-VKIKVLKQSDLIKKKMGLLLGVNQGSE---REARLLVISYQANKNSKEKLAFVGKGI 220 
UUR_LAP LPEVKVSVLYRKDLEAKGMNAHVGVGKAAVSDKAQPRLVVVEYNNNPETNEKYAFVGKGV 229 
:::.: : : *. :.*.:.: :.*:: :.*: : .:.: ::***: 
MSA_LAP TFDSGGYSLKPPKFMLGMKYDMSGSAIVAAVMKAIAQLKPNKNVSAIMCITDNRINGDAS 294 
MGN_APN TFDTGGINTKG-YHMSGMKYDMSGSAIVAYAVKTLAELKANVNVAAIMMITDNRQDGDAS 287 
MPU_LAP2 TFDSGGYSLKPAKSMVGMKYDMSGAAIVSAVVFALSALGVKRNVSAVLAITDNRVNGDAN 292 
MPU_LAP1 TFDSGGYNIKT-SHMGGMKFDMSGAAIAAYALKAMAQLRAKSNFAALMLITDNRLNSVAN 295 
MPN_LAP TYDSGGMNIKTGDYMRGMKYDMSGAAIVCSTVLALAKNKVKTNVVAVAALTENLPGPHAQ 279 
MGE_LAP TYDSGGMNIKTGDYMRGMKYDMSGAAIVCSTVLALAKNKVKTNVVAVAALTENLPGAKAQ 280 
UUR_LAP CFDSGGYNVKTGSHMRWMKFDMSGSAIVSMTVRALALNKEKVNVVAVCPLVLNLLAPEGQ 289 
:*:** . * * **:****:**.. .: ::: : *. *: :. * .. 
MSA_LAP LPDSVYTSMSGKTVEVNNTDAEGRLVLADRLYYGATKLNATRLIDTATLTGTMLTALGQT 354 
MGN_APN LPENVYESMSGLSVEVTDTDAEGRLVLADGLYYGATKLKATTLFDVATLTGSVLTALGHT 347 
MPU_LAP2 LPDSVWKSMNGKSVEINNTDAEGRLVMVDAMTYAIRELKSTDLIDVATLTGAIVVALGNT 352 
MPU_LAP1 IPDSVWKSMNGKTVEVTDTDAEGRLVLADGITFAIRKLNATRVITIATLTGTILYTLGTS 355 
MPN_LAP RPDDIQTAYNGKTVEIDNTDAEGRLVLADAISYAAKDLKATQIIDVATLTGLMSYILSTT 339 
MGE_LAP RPDDIKIAYNGKSVEIDNTDAEGRLVLADAITYAAKDLAATHIIDVATLTGLMSYILSTT 340 
UUR_LAP KPDDIVKSYNGKTIELDNTDAEGRLILADALTYAVRDLKASKLFDVATLTGAMIYALGDT 349 
*:.: : .* ::*: :*******::.* : :. .* :: :: ***** : *. : 
MSA_LAP YSGIYATSCKIWHQFEDAAKIAHEKVWRMPLHEDFNKTNKESLVADLNNYSNNEKSDCNT 414 
MGN_APN YSGIWSTNEGKWGLFEKAGQISHEKIWRMPLHDDFHQFNLASEVADLNNYNNSEKSDSNT 407 
MPU_LAP2 YTGVWSTNDSKWEKLEKASKVAGEKIWRMPIDAEFAKGIKKSSVADLRNVDYSGLGGSNS 412 
MPU_LAP1 YTGGWATNNKTWKELLSAAKKHDEPIWRLPLNEDYIESYKKSKVADLVNWSSASKPDSNS 415 
MPN_LAP YTGIFSTCDMAWDAFKKAACCAGEPVWRLPMHPDYLKPLES-KLADLQNSTSVKGAGSSR 398 
MGE_LAP YTGIFSTCDHQWESFKKAACSAGEPVWRLPMHPDYLKPLQLTKLADLQNSTSARGAGSSR 400 
UUR_LAP YSGVWATNNDIWNEVVVAADYAGELVWRLPFHNDFLKMLNS-NVADIANSVSDPRGGSSR 408 
*:* ::* * . *. * :**:*:. :: : :**: * ... 
MSA_LAP AAMFLKEFTNNVPYIHCDVAGTADKKGMGLGILVSTFVEFGKSQQRNCESCECDEQKCET 474 
MGN_APN AAMFLKQFTNNVDYIHCDVAGTADVGGKPQGVLIDTLVEFALLNEK-------------- 453 
MPN_LAP AACFLAEFREGVPLIHCDIASTASIQDLGQGVLVRTLYERAAQQAKE------------- 445 
MGE_LAP AACFLAEFREGVSLIHCDIASTASIENLGQGVLVRTLYERASQLANK------------- 447 
UUR_LAP AACFLKEFTEGVPYAHFDIAITADVGHKGTGVMLRTFYRIAQNQKFN------------- 455 
*  ** :* :  * *:*  **.  *::: *: .  .  
MPU_LAP2 AMMFLNEFNEGVDHIHIDIAGTANVGDSCTGVMVKTLVEYLK------------------ 454 
MPU_LAP1 AAMFLKEFTEEKDFVHLDIAGTAEIEGEPQGVLVKTLAQLALDI---------------- 459 
Figure 3.10 Alignments of leucine aminopeptidases in mycoplasmas. The six active sites of
leucine aminopeptidases identified in other leucine aminopeptidases were conserved in all leucine
aminopeptidases from mycoplasmas (Burley et al. 1990; Kim and Lipscomb 1993; Strater and








Figure 3.11 Hydrophobic plots for leucine aminopeptidase of M. gallinarum. It was drawn by
ProtScale (http://www.expasy.ch/cgi-bin/protscale.pl) (Kyte and Doolittle 1982). It suggested that 
























EXPRESSION AND CHARACTERIZATION OF THE AMINOPEPTIDASE GENE OF 
MYCOPLASMA GALLINARUM
Abstract
Unlike most other host-specific mycoplasmas, Mycoplasma gallinarum exists as a
commensal with a host range that includes most poultry and some mammals. This property of M.
gallinarum may reflect unique mechanisms for its colonization and persistence in various hosts.
Our previous studies cloned and characterized a leucine aminopeptidase (APN) from M. 
gallinarum, which was suggested to play a role in host colonization by supplying nutrition from
peptide degradation and amino acid scavenging. This study evaluated protein expression of this
leucine aminopeptidase gene. After mutation of the four TGAs encoded in the leucine
aminopeptidase gene from M. gallinarum, the gene was ligated into the pET32b(+) expression
vector and overexpressed in E. coli AD494(DE3)pLysS cells. The recombinant protein was
purified and employed as an antigen to immunize chickens to obtain polyclonal anti-APN serum,
which was utilized to identify the subcellular location by immuoblotting with Triton X-114
partitions. The results of these experiments confirmed our former conclusion that the leucine
aminopeptidase gene product is located in the cytoplasmic portion of M. gallinarum cells with a 
weak interaction with the M. gallinarum cell membranes. Three samples were shown positive to
M. gallinarum antigen using ELISA from 79 serum samples from chickens experimentally




















M. gallinarum recognized to the host immune responses and that leucine aminopeptidase was not 
able to provoke production of specific humoral antibody in natural infection. Our results suggest 
that the leucine aminopeptidase is not strongly immunogenic. 
Introduction 
Mycoplasmas are a class of unique gram-positive bacteria lacking a cell wall, and
represent a distinct subgroup of pathogens for humans and animals (Razin et al. 1998). Many
mycoplasmas have been found in the past two decades associated with human and animal
diseases (Maniloff et al. 1992). For instance, Mycoplasma genitalium is an important pathogen 
for human nongonococcal urethritis (Deguchi and Maeda 2002). Mycoplasma pneumoniae causes 
community-acquired respiratory infections in children and adults (Hammerschlag 2001).
Mycoplasma gallisepticum can cause chronic respiratory diseases in chickens. The co-infection of
infectious bronchitis virus, Newcastle disease virus, or other disease in chickens has been
reported to cause a major loss on many farms (Kleven 1998). 
Colonization by mycoplasmas initially stimulates innate immune responses, followed by
specific immune responses. Because the isolation of mycoplasmas is difficult and time-
consuming, serodiagnosis has been used as an important means for diagnosis of mycoplasmal 
infection (Maniloff et al. 1992; Levisohn and Kleven 2000). In chickens infected intratracheally 
with M. gallisepticum, the humoral responses were detected as early as one week post infection
by leukocyte migration inhibition (LMI) test or the hemagglutination-inhibition (HI) test
(Chhabra and Goel 1980). The surface lipoproteins of mycoplasmas have been reported to be
“preferential” targets of the host immune responses (Chambaud et al. 1999). Antigenic variation
of these lipoproteins may play an important role in escaping clearance by the host immune 









   
   
 
  









(Roitt 1997). After phagocytosis, mycoplasma cells will be degraded within the lysosome, and the
degraded components may be presented to T cells MHC II. The T cells activate B cells for the
production of specific antibody. 
Mycoplasma gallinarum has been identified as a commensal in a wide range of vertebrate
hosts, including poultry, cattle, pigs, and sheep (Shah-Majid 1996; Singh and Uppal 1987;
Taylor-Robinson et al. 1968; Taylor-Robinson and Dinter 1968; Wang et al. 1990). Mycoplasma
gallinarum was reported as one of the most frequently isolated mycoplasmas from poultry (Shah-
Majid and Nihayah 1987; Kleven et al. 1978). Studies have shown that the colonization of the
respiratory tract of poultry by M. gallinarum did not result in pathologic changes. In in vitro
studies, Taylor-Robinson and Cherry (1972) found that M. gallinarum did not cause reduction of
epithelial cell ciliary activity in tracheal organ culture. 
However, M. gallinarum was reported to induce temporary airsacculitis when it infected
chickens via aerosol or air-sac inoculation with the combination of a field strain of infectious
bronchitis virus (IBV) or vaccination with IB and Newcastle disease (Kleven et al. 1978). In vitro, 
with infection with a Newcastle disease virus, M. gallinarum temporarily destroyed cilia on the
epithelial surface of the tracheal organ culture, whereas microvilli were not affected by this
infection (Shah-Majid 1996). Cilia resumed normal function after about one week. 
Mycoplasma gallinarum does not induce a strong antibody response. In infected
individuals with M. gallinarum, specific humoral IgG and IgM levels were very low and almost
undetected (Varley and Jordan 1978a; Varley and Jordan 1978b; Bencina et al. 1991a; Bencina et
al. 1991b; Bencina et al. 1992). The capability to persist in various hosts and to escape host
immune responses suggested that some unique host adaptation mechanisms might be present in
this mycoplasma. 
 
   
  









    
 







In our previous studies, we cloned and characterized a leucine aminopeptidase from M.
gallinarum. Our results showed that this enzyme is located in the cytoplasmic portion of M.
gallinarum cells and may play a role in the nutrition supply of M. gallinarum for host adaptation
(Chapter III). In this project, we generated recombinant leucine aminopeptidase by
overexpression of this aminopeptidase gene in E. coli, and antisera were produced in chickens
against this protein. Western botting analysis with the mycoplasma proteins obtained by Triton X-
114 partitioning demonstrated that this leucine aminopeptidase was not present in the internal
membrane of M. gallinarum. We also identified three M. gallinarum positive serum samples after
ELISA surveying of a group of serum samples from chickens experimentally infected with M. 
gallinarum. We found by Western blot analysis the chicken serum samples did not have specific
antibodies for the leucine aminopeptidase of M. gallinarum. 
Materials and Methods 
PCR amplification of aminopeptidase gene 
Primer APNFpET and APNRpET1 (Table 4.1) were used to PCR amply the leucine
aminopeptidase gene open reading frame from M. gallinarum genomic DNA. APNFpET and 
APNRpET1 have Bam HI and Xho I restriction sites, respectively, to facilitate cloning of the PCR
product. In the PCR reaction, 20 pmol of both primers, and 50 ng M. gallinarum genomic DNA 
and 1 unit of DeepVent DNA polymerase (New England Biolabs, Inc., Beverly, MA) were used
in a 50 µl volume. The PCR reaction was conducted at 94 °C for 10 mins, 30 cycles of 94 °C for 






















Construction of the expression plasmid and site-directed mutagenesis 
The M. gallinarum leucine aminopeptidase PCR products were blunt-end ligated into
pT7Blue blunt ligation vector (Novagen, Madison, WI) to constructe pT7Blue-APN plasmid
(Figure 4.1). The site-directed mutagenesis was conducted according to the manufactures
protocol using the multi-directed mutagenesis kit (Stratagene, Co., La Jolla, CA). The first round
mutagenesis was conducted with primers 1b and 3 (Table 4.1) to mutate codons TGA to TGG at
position 1009 and 2002 (Figure 3.3) to create plasmid pT7Blue-APN-FirstRoundMutation. These
changes would create restriction endonuclease sites Bsm FI and Bst XI (Figure 4.1). These
restriction endonucleases were used to screen plasmids containing the desired mutations. The
mutations of plasmid pT7Blue-APN-FirstRoundMutation were then confirmed by nucleotide
sequencing. The second round of site-directed mutagenesis of plasmid pT7Blue-APN-
FirstRoundMutation was the conducted with primers 2a and 4 (Table 4.1) to mutate codons TGA
to TGG at position 1971 and 2047 (Figure 3.3) create plasmid pT7Blue-APN-CompleteMutation.
After screening by restriction enzyme digestion with HincII (New England Biolabs, Inc., Beverly,
MA), the mutations pT7Blue-APN-CompleteMutation were confirmed by nucleotide sequencing.
The APN gene with the expected mutations were released from plasmid pT7Blue-APN-
CompleteMutation by digestion with Bam HI and Xho I. The APN gene was gel purified and
ligated into the Bam HI and Xho I sites of pET32b(+) vector, creating plasmid pET32b(+)-APN
(Figure 4.1). Nucleotide sequencing was used to confirm that the correct open reading frame 




    
 
 

















Induction of APN overexpression in E.coli
The plasmid pET32b(+)-APN were transformed into E. coli strains AD494(DE3)pLysS,
BL21(DE3) or JM109, and plated on the appropriate selective media. Colonies were inoculated
into 2 ml LB with appropriate antibiotics and incubated with agitation at 37 °C for 16 hrs. The
2ml culture was poured into 50 ml LB with appropriate antibiotics and incubated with shaking at
37 °C for about 3 hrs until the OD600nm of the culture was 0.6. For induction, the concentration of
IPTG was adjusted to a final concentration of 3 mM and incubation continued at 37 °C for 3 hrs,
or 28 °C for 6 hrs, or 15 °C for 17 hrs. 
Purification of recombinant proteins
The subcellular location of recombinant protein in E. coli was determined according to
the pET system manual (Novagen, Madison, WI). Eschericha coli cells were collected by
centrifugation of 50 ml culture at 10,000×g at 4 °C for 10 mins. The cell pellets were resuspended
in 5 ml of 20 mM Tris-HCl pH7.4 with a final concentration of 100 mg/ml lysozyme. After
incubation at room temperature for 10 mins, the suspension was sonicated 10 times on ice at the
maximum setting for 15 secs with 30 secs intervals (Microson Ultrasonic Cell Distruptor, Model
XL2000). The broken samples were then centrifuged at 14,000×g at 4°C for 10 mins, and the
supernants collected as soluble fraction. The pellets were then washed twice by resuspending the
cells in 5 ml 20 mM Tris-HCl pH7.4 followed by a centrifugation at 10,000×g at 4°C for 5 mins.
Finally, the pellets were suspended in 5 ml 20mM Tris-HCl pH7.4 to represent the insoluble
cytoplasmic fraction. Both the soluble and insoluble fractions were evaluated for the recombinant
protein by SDS-PAGE gel electrophoresis. 
After identifying the presence of expression products in the inclusion bodies, the 






















A 200 ml cell culture was centrifuged at 10,000×g at 4°C for 10 mins, and 1 g cell pellets were
resuspended in 5 ml BugBuster reagent with Benzonase (25 units/ml). The mixture was incubated
at room temperature for 10 mins and then centrifuged at 16,000×g for 20 mins at 4°C. The cell
pellets were resuspended further with 5 ml BugBuster reagent with lysozyme (200 µg/ml) and 
incubated at room temperature for 5 mins. After centrifuging at 16,000×g for 15 mins at 4 °C, the
cell pellets were resuspended with 30 ml of 1:10 diluted BugBuster reagent. The cell pellets were
collected again with centrifugation at 16,000×g for 15 mins at 4 °C. This washing step was
repeated twice. Finally, the pellets were resuspended the pellet in 5 ml 1×binding buffer
containing 6M urea. The collected inclusion body was further purified by His-Bind kit (Novagen,
Madison, WI). The final products were eluted with 6 ml 1×elute buffer containing 6M Urea. 
The 6 ml of inclusion bodies were injected into Certain Slide-A-Lyzer Dialysis Cassettes,
whose membranes are 0.45 mil thick with a 10,000 MWCO (Pierce Chemical Co., Rockford, IL),
and soaked into 400 ml of 0.1 M BBS with 0.15 NaCl and 4M Urea at 4 °C for 24 hrs. Then the
dialysis cassette was transferred into 400 ml of 0.1 M BBS with 0.15 NaCl and 2M Urea and
dialyzed at 4 °C for 12 hrs. Finally, the dialysis cassette was transferred into 400 ml of 0.1 M 
BBS with 0.15 NaCl at 4 °C for 12 hrs. The refolded proteins were then concentrated with
Centricon-50 centrifugal filter (Millipore Co., Beford, MA). 
Digestion of recombinant proteins 
To release the APN protein from the APN-trxA fusion protein, 10 µg recombinant APN-
trxA protein was incubated with 0.1, 0.2, 0.5 or 1 unit enterokinase (Novagen, Madison, WI) at 
22 °C for 16 hrs or 4 °C for 48 hrs, respectively. The digests were checked for APN protein
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Production of chicken anti-APN polyclonal antiserum 
Two 4-week old mycoplasma free lenghorn hens were immunized intramuscularly with
75 µg recombinant APN-trxA protein with Freund’s complete adjvant (1:1). These chickens were
then admistrated a second intramuscular immunization with 280 µg recombinant APN-trxA
protein after 2 weeks. Sera were collected one week after the second immunization. The serum
samples were utilized to determine the subcellular location of the leucine aminopeptidase of M. 
gallinarum by Western-blot with Triton-X114 phase partitions of M. gallinarum proteins. 
Phase partition of mycoplasma proteins in Triton X-114 
The phase partition protocol was adapted from those presented by Bendjennat et al. (1997)
and Riethman et al. (1987). Mycoplasma gallinarum cells were harvested by centrifugation of 1
liter of a 24 hrs culture at 40,000×g for 30 mins. The pellets were washed twice with 0.15 M 
NaCl and then resuspended with 4 ml 0.15 M BBS containing 0.15 M NaCl. Triton X-114 was
added to the suspension to a final concentration of 1% and the solution was incubated at 4 °C for 
3.5 hrs. The solution was centrifuged at 13,000×g at 4 °C for 1 min to remove the unsolublized
cells. The supernatants were collected and incubated at 37 °C for 10 mins to partition the
hydrophobic and hydrophilic phases, and then centrifuged at 2,000×g for 5 mins. The aqueous
phase was the hydrophilic fraction. The pellet was partitioned an additional time by adding the 
equal amount of water and then vortexed briefly. The final lower phase was the hydrophobic
phase of M. gallinarum cells. 
ELISA assay 
An ELISA assay was developed to identify the presence of antibody in 79 serum samples























preparation was conducted according to methods described by Razin and Tully (1983). Briefly,
mid-log phase mycoplasma cells were harvested by centrifugation at 34,000×g at 4°C for 30 mins
and then washed twice with a 0.2 M Tris buffer. Following incubation in glycerol, cells were
lysed and washed in 0.05 M NaCl/PBS. Each 96-well plate was coated with 2.5 µg antigen per
well, fixed with 0.25% glutaraldehyde, and blocked with 3% BSA/PBS before ELISA testing.
The chicken sera were applied to the appropriate wells and incubated at 37 °C for 3 hrs. Plates
were then washed with TBS-0.05% Tween 20 and incubated 1.5 hrs with alkaline phosphatase
conjugated rabbit anti-chicken IgG (Sigma Chemical Co., St. Louis, MO). Plates were then
washed and developed with the chromogenic alkaline phosphatase substrate p-nitrophenyl
phosphate (Sigma Chemical Co., St. Louis, MO), and the color reactions quantitated at 405 nm. 
SDS-PAGE 
Protein samples were prepared by mixing the sample with sample buffer (1:1) containing
5% 2-mercaptoethanol (APPENDIX A). The preparation was incubated at 95 °C for 5 mins
before loading on the gel. Two µg protein was loaded per well in the 10% SDS-PAGE gel, and
electrophoresis conducted at 100 volts for 1.5 hrs. Following electrophoresis, the protein gel was
stained in coomassie blue stain solution (Bio-Rad Laboratories, Hercules, CA) for 45 mins and
then destained twice in distain solution for 45 mins (APPENDIX A). 
Western-blot hybridization analysis 
The Western-blot hybridization protocols were adapted from Harlow and Lane (1988).
Proteins were separated under the same conditions as described above for the SDS-PAGE method. 
Immediately following by electrophoresis, the gel was soaked in 4 °C pre-cooled transfer buffer

















Laboratories, Hercules, CA) at 100 volts for 1 hr. The membrane was rinsed briefly in TBS and
then blocked in TBS with 20% horse serum and 5% bovine serum albumin maintained at 4 °C for 
16 hrs. The membrane was then washed five times, 5 mins each time, in TBS-0.05%Tween 20.
After incubation with chicken serum samples or control serum at room temperature for 1 hr, the
membrane was washed five times, 5 mins each time, in TBS-0.05%Tween 20. The NIH Donkey 
anti-M. gallinarum polyclonal antiserum was used as a positive control antisera and the SPF
chicken serum (Sigma Chemical Co., St. Louis, MO) as a negative control antisera. Then the
membrane was incubated with corresponding rabbit anti-chicken IgG alkaline phosphatase
conjugate or rabbit anti-donkey IgG alkaline phosphatase conjugate (Sigma Chemical Co., St.
Louis, MO) at room temperature for 30 mins. The membrane was rinsed with TBS-0.05%Tween
20 for 5 times, 5 mins each time. Finally, the membrane was developed with Sigma Fast 5’-
bromo-4-chloro-3-indolyl phosphate/intro blue tetrazolium (Sigma Chemical Co., St. Louis, MO) 
solution for 15 mins and dried between layers of filter paper. The membrane was stored at room
temperature shielded from light. 
Quantification of protein and nucleic acid 
Protein concentration was determined using the Pierce bicinchoninic acid protein assay
kit (Pierce Chemical Co., Rockford, IL). Bovine serum albumin was used as a standard. The
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Results 
Mutagenesis of aminopeptidase gene of M. gallinarum
To express the leucine aminopeptidase gene in E. coli, the TGA codons encoding
tryptophan had to be mutated to TGG for recognition as the codon tryptophan in E. coli. After 
ligation of APN gene into pT7Blue, the encoded four TGAs were mutated into TGGs. Table 4.2
shows the changes of restriction sites after mutation. Primer 1b generated a Bst XI site and Primer
3 generated a single Bsm FI. Primer 2a generated another Hinc II site. Primer 4 did not generate
any new restriction sites and deleted an MboII restriction site. However, Mbo II could not be used
to screen the mutants because several other Mbo II sites in the APN gene and the pT7Blue vector
make differentiation difficult. Figure 4.2 shows the restriction site changes before and after site-
directed mutagenesis. The nucleotide sequencing of the APN gene confirmed that the expected
mutations had been generated. 
Overexpression of aminopeptidase gene of M. gallinarum in E. coli
The expression of the APN-trxA fusion protein resulted in formation of inclusion bodies
at 15°C, 28 °C, or 37°C for AD494(DE3)pLysS, BL21DE3, and JM109 (Kindly provided by Dr.
Ma, Mississippi State University). Figure 4.3 shows APN-trxA fusion protein and trxA
expression with induction with IPTG at 37 °C for 3 hrs. The APN-trxA is expressed as a 67 kDa
fusion protein, and the trxA expression is expressed as a 23 kDa protein. Figure 4.4 shows the
purified APN-trxA protein and its digestion products with enterokinase. The results showed that
two fragments of 51 kDa and 16 kDa were generated from APN-trxA after digestion by
enterokinase. The first fragment is associated with the leucine aminopeptidase of M. gallinarum, 
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of trxA protein is due to the fragment within the multiple cloning sites which was digested and
released before ligation. 
Subcellular location of leucine aminopeptidase of M. gallinarum
To determine the subcellular location of leucine aminopeptidase of M. gallinarum, 
polyclonal chicken anti-APN-trxA sera were diluted to 1:1000 for Western-blot with phase 
partitions of M. gallinarum proteins. Figure 4.5 B is the result for Western-blot with pre-immune 
chicken sera 319, and Figure 4.5C shows the Western-blot for chicken sera 319 after 
immunization with APN-trxA recombinant protein. The results showed that the endogenous 
leucine aminopeptidase was present in the hydrophilic partition of Triton X-114. This supports 
the previous finding that the leucine aminopeptidase is a cytoplasmic protein probably having a 
weak interaction with the cell membrane (Chapter III).
ELISA screening of sera from chickens infected with M. gallinarum
Three samples were identified as positive for M. gallinarum infection from 79 sera from
birds with M. gallinarum infection (Table 4.3). After comparison with the negative control of
0.22 and the positive control of 1.55, the three serum samples ranged from 0.67 to 1.05. Figure 
4.6 shows the Western-blot results with M. gallinarum total protein. The results show that very
few proteins were immunogenic. A 50 kDa protein showed the strongest reactivity with the 
samples from infected chickens. The results were confirmed by Western-blot with the NIH 
donkey anti-M. gallinarum positive control serum and SPF chicken serum as negative control

















    
 
   
      
-105-
Detection of chicken humoral immune responses to leucine aminopeptidase of M. 
gallinarum
To investigate the humoral immue responses to leucine aminopeptidase of M. gallinarum, 
Western blotting was used to analyze the chicken serum 59 for the presence of anti-APN antibody. 
Results demonstrated that the antibody in the chicken serum 59 against APN of M. gallinarum
was not detectable. However, the NIH donkey anti-M. gallinarum polyclonal sera did recognize
the expressed APN-trxA recombinant protein, and the result for normal chicken serum illustrated
the background (Figure 4.7). 
Discussion 
We cloned and characterized a leucine aminopeptidase gene of M. gallinarum. Our
results suggest that this gene might have a role in the nutrition of M. gallinarum. Leucine
aminopeptidase activity was found both in the ultrasonic separated membrane and cytoplasmic
fractions of M. gallinarum cells (Chapter III). In this chapter, we expressed the product of the
gene and produced antibodies to characterize the gene product location. 
The gene expression in the model bacterium, E. coli, has been utilized widely as a
common and efficient means for “purification, location and functional analysis of proteins”
(Sambrook et al. 1989). However, the expression of mycoplasma genes is more challenging than
expression of genes from other prokaryotes (Minion 1998). First of all, UGA is used to encode
tryptophan in the genus Mycoplasma, but serves as a stop codon in other prokaryotes (Inamine et
al. 1990; Maniloff et al. 1992). Moreover, UGA is found to be a more frequent used tryptophan
codon (Minion 1998). Escherichia coli cells were reported to have less than 3% UGA suppressor 
activity such that these UGAs will result in the expression of truncated products (Lewin 1997).
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The second challenge is from the low Mol%G+C, 23-40%, in mycoplasma genomes (Razin et al.
1998). In E. coli, the AT rich regions are considered as the RNA polymerase binding regions,
which may lead to unexpected transcription initiation within the target mycoplasma gene;
therefore it is very difficult to control the expression of mycoplasma genes in E. coli (Knudtson
and Minion 1994; Notarnicola et al. 1990; Jarvill-Taylor et al. 1999). 
There are two ways of getting around the UGA tryptophan codon: the use of suppressor 
mutants of E. coli or mutagenesis of the mycoplasma gene. The trpT176 allele has been used as
UGA suppressor and can transport tryptophan into the UGA codon. But this function is UGA
context-dependent and might not be efficient for some codons. Moreover, the efficiency will be
much lower if there are multiple UGAs. In addition to trpT176, Smiley and Minion (1993) used
another suppressor (prfB3 or rrsB (SuUGA-delta C1054)), which influenced termination events to
allow the read-through of multiple UGAs. ISM612, a constructed E. coli strain with trpT176 and 
prfB3, was reported in the M. pneumoniae genomic library screening (Minion et al. 1995). In
addition to E. coli, Bacillus subtilis with prfB was reported also to enhance the readthrough of
UGA as trptophan (Kannan and Baseman 2000). 
We tried this procedure with no success. The leucine aminopeptidase gene of M.
gallinarum was inserted into a fusion expression vector pTYB2 (APN-pTYB2) (New England 
Biolabs, Inc., Beverly, MA). APN-pTYB2 was then transformed into ISM943 (kindly provided
by Dr. Minion, F. C., Iowa State University). ISM943 is a similar E. coli strain to ISM612 except
it encodes T7 DNA polymerase, which allows using a T7 promoter plasmid for expression.
However, the expression failed probably because the second UGA was too close to the third UGA
























Therefore we mutated the four TGA codons to TGGs and cloned it into the pET32b(+)
expression vector. To release the effects of His-Tag on the target protein, a stop codon was
introduced at the end of the APN gene and before the His-Tag of C-terminus of trixA. We got
high levels of expression in AD494(DE3)pLysS, BL21(DE3) or JM109 cells but the recombinant
APN-trxA was found in inclusion bodies.  
The purification of inclusion bodies resulted in a very high concentration of recombinant
APN-trxA protein. After attempts to solubilize the inclusion bodies and refold the protein by
dialysis, the recombinant protein did not show leucine aminopeptidase activity. This suggests that
the APN-trxA fusion protein derived from inclusion bodies did not completely refold to its native
functional structure. However, digestion of protein APN-trxA with enterokinase released a 51
kDa protein, which compares well with the products predicted from the APN open reading frame,
and a 16 kDa protein, which is associated with trxA. Increasing the concentration of enterokinase
resulted a more complete digestion of APN-trxA. We also found much of the proteins were
degraded during enterokinase digestion, making it difficult to purify quantities of the recombinant
protein. 
Previous studies showed that the recombinant protein in inclusion bodies preserved their 
antigenicity and immunogenicity (D’Souza et al. 1994). To obtain a reagent for detection of the
endogenous expressed APN, we generated the chicken anti-APN-trxA polyclonal antisera. The
antisera obtained exhibited a very strong reaction with the APN-trxA recombinant protein and
recognized with the aminopeptidase of M. gallinarum. 
Jensch and Fricke (1997) compared seven isolation methods for their ability to release
cytoplasmic proteins from the periplasm. Those methods included osmotic shock (Nossal and
Heppel 1966), chloroform treatment (Ames et al. 1984), MgCl2 treatment (Cheng et al. 1970),
polymyxin treatment (Kimura et al. 1992), EDTA/lysozyme spheroblasting (Joannou and Brown
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1992), MgCl2 /lysozyme spheroblasting, and phase partition methods. Jensch and Fricke (1997)
applied these methods on alanyl aminopeptidase, a periplasmic enzyme, and leucyl
aminopeptidase, a cytosolic protein that is located close to the cytoplasmic membrane in cells of
Pseudomonas aeruginosa. They concluded the Triton X-114 phase partition was the most
efficient method to prevent the contamination of the periplasm with cytosolic protein.  
The results of Western-blot experiments suggested that the leucine aminopeptidase was
present in both cytoplasmic and membrane ultrasonic fractions but only in the hydrophilic
partition by Triton X-114 partition treatment. These results are consistent with previous enzyme
activity assays of the ultrasonic fractions of M. gallinarum cells, which demonstrated the
presence of leucine aminopeptidase activity in both membrane and cytosolic fractions (Chapter
III). Our results indicated that the leucine aminopeptidase of M. gallinarum is a cytoplasmic
protein with a weak interaction with cell membrane. The peptide degradation and amino acid
scavenging by aminopeptidases are reported to be important in the nutrition of prokaryotes (Tan
et al. 1993; Morales et al. 2001). Because mycoplasmas lack the major genes to synthesize most 
macromolecular precursors, such as amino acids, lipids, and nucleic acid precursors, the
aminopeptidase activity may play a more important role in the survival of mycoplasmas in their
hosts (Maniloff et al. 1992; Razin et al. 1998). Thus the cloned leucine aminopeptidase might 
have a nutritional role in host adaptation of M. gallinarum. Our results suggest that ultrasonic
treatment was less effective than Triton X-114 phase partition in releasing the cytosolic protein 
and removing the contamination of cytosolic protein from the cytoplasmic membrane.
Mycoplasma gallinarum generally has a low pathogenic potential (Shah-Majid and 
Nihayah 1987; Kleven et al. 1978). The infection of chickens with this species of mycoplasma
does not stimulate a strong host immune response and the antibody level was reported to be
undetectable (Varley and Jordan 1978a; Varley and Jordan 1978b; Ben!ina et al. 1991a; Ben!ina
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et al. 1 9 9 1 b; B e n č i n a et al. 1 9 9 2). T his s u g g ests t h at M. g alli n ar u m  a v oi ds r e c o g niti o n b y t h e h ost
i m m u n e s yst e m. A b u- Z hr a n d B utl er ( 1 9 7 6) s h o w e d t h at M. g alli n ar u m  di d n ot d e v el o p a cl os e
ass o ci ati o n  wit h  t h e  e pit h eli u m  c ells  b e c a us e  m y c o pl as m a  c ells  a p p e ar e d  first  i n  t h e  l a mi n a
pr o pri a, w hi c h is diff er e nt fr o m m ost ot h er m y c o pl as m as ( Kr a us e 1 9 9 6; R a zi n et al. 1 9 9 8). O ur 
W est er n- bl ot r es ults wit h c hi c k e n s er u m s a m pl es d e m o nstr at e d t h e pr es e n c e of li mit e d s p e cifi c 
h u m or al a nti b o di es a g ai nst M. g alli n ar u m  pr ot ei ns b ut n ot a g ai nst t h e l e u ci n e a mi n o p e pti d as e of
M.  g alli n ar u m. Si mil aril y p ol y cl o n al a nti b o d y pr o d u c e d i n d o n k e y s h o w e d o nl y w e a k s p e cifi cit y
t o t h e A P N a n d t his s u g g est e d t h at A P N of M. g alli n ar u m  is n ot v er y i m m u n o g e ni c or e x pr ess e d
at v er y l o w l e v els. T h e us e of o ur A P N s p e cifi c p ol y cl o n al a nti b o d y s u g g est e d t h e l at er mi g ht b e 
t h e c as e b e c a us e o nl y w e a k b a n ds w er e d et e ct e d i n M. g alli n ar u m  l ys at es.  
T h e  a mi n o p e pti d as e  a n d  c ar b o x y p e pti d as e  a cti vit y  of  s e v er al  h u m a n  m y c o pl as m as,  
i n cl u di n g  s o m e  p at h o g e ns,  h as  b e e n  d e m o nstr at e d  t o  i n a cti v at e  t h e  i nfl a m m at or y  m e di at or  
br a d y ki ni n  ( S hi b at a  a n d  W at a n a b e  1 9 8 9).  I n  ot h er  pr o k ar y ot es,  pr ot e as es  h a v e  b e e n  s h o w n  t o  
d o w n r e g ul at e i m m u n e r es p o ns es b y t h e d e gr a d ati o n of p h a g o c yt e L P S r e c e pt or C D 1 4 a n d T N F α 
( C al ki ns  et  al.  1 9 9 8;  S u g a w ar a  et  al.  2 0 0 0).  M or e o v er,  ot h er  st u di es  h a v e  d e m o nstr at e d t h at
b a ct eri al  pr ot e as es  p oss ess  t h e  a bilit y  t o  s u p pr ess  i m p ort a nt  n e utr o p hil  f u n cti o ns,  s u c h  as  t h e  
o xi d ati v e b urst, i n r es p o ns e t o sti m ul ati o n wit h p h or b ol est ers ( K a d o w a ki et al. 1 9 9 4; N a k a y a m a 
et  al.  1 9 9 5;  Y o n e d a  et  al.  1 9 9 0).  T h e  r ol e  of l e u ci n e  a mi n o p e pti d as e  of M.  g alli n ar u m  i n its  































Table 4.1 Primers used for site-directed mutagenesis and PCR reaction 
Name Oligonucleotides
Primer 1b 5’-CGATTATAATAATTTACCATTTGAATGGATTTCTAAAAAAAATGGC-3’ 
Primer 2a 5’-CTTATTCTGGAATTTGGTCAACAAATGAAGG-3’ 
Primer 3 5’-CAACAAATGAAGGAAAATGGGGACTTTTCGAAAAAGCAGG-3’ 
Primer 4 5’-GTCATGAGAAAATTTGGAGAATGCCATTACATG-3’ 
APNFpET 5’-GATATCGGATCCGATGAATAAATTGGAATTTTG-3’ 
APNRpET1 5’-GCCGCACTCGAGCTATTTTTCATTTAATAAAGC-3’ 
* Note: The bold letter is denoted for site-directed mutated site. They were designed to mutate A
to G.
Table 4.2 Restriction sites changes from site-directed mutagenesis 










Primer 4 MboII None 
*Note: The restriction enzymes labeled as bold were used to screen the mutations.
Table 4.3 ELISA results for chicken serum samples 
Serum samples Titer*
NIH Donkey anti-M. gallinarum sera 1.55










































Figure 4.1 Site-directed mutagenesis and construction of expression plasmid. A. APN gene were
replicated and inserted into pT7Blue plasmid to construct plasmid pT7Blue-APN; B. the first
round site-directed mutagenesis with primer 1b and primer3 (plasmid pT7Blue-APN-
FirstRoundMutation), and then the second round site-directed mutagenesis with primer 2 and
primer 4 (plasmid pT7Blue-APN-CompleteMutation); C. The mutated APN gene was digested
with BamH I and Xho I; D. The PCR products of mutated APN was inserted into pET32b(+)
expression vector (plasmid pET32b(+)-APN). 
 




































































Figure 4.2 Mutants screening with restriction enzymes. Lane 1: 1 kb DNA marker; Lane2:
pT7Blue-APN digested with BsmFI; Lane3: pT7Blue-APN-FirstRoundMutation digested with
BsmFI; Lane4: pT7Blue-APN digested with BstXI; Lane5: pT7Blue-APN-FirstRoundMutation
digested with BstXI; Lane 6: pT7Blue-APN-FirstRoundMutation digested with HincII; Lane 7:
pT7Blue-APN-CompleteMutation digested with HincII.
 







































































Figure 4.3 Overexpression of pET32b(+)-APN and control plasmid pET32b(+) in
AD494(DE3)pLysS E. coli cells. The expression was induced with 3 mM IPTG and incubated at
37 °C for 3 hr. Lane 1: Protein molecular weight marker; Lane 2: AD494(DE3)pLysS cell control;
Lane3: soluble fraction from pET32b(+) expression in AD494(DE3)pLysS; Lane 4: insoluble
fraction from pET32b(+) expression in AD494(DE3)pLysS; Lane 5: soluble fraction from
pET32b(+)-APN expression in AD494(DE3)pLysS; Lane 6: insoluble fraction from pET32b(+)-










































































Figure 4.4 Digestion of APN-trxA fusion protein with enterokinase. The purified recombinant 
APN-trxA was digested with enterokinase at 22°C for 24 hrs. Lane 1: Bench marker; Lane 2:
purified recombinant protein incubated with cleavage buffer; Lan3-6: 10 µg APN-trxA digested 
with 0.1, 0.2, 0.5 or 1 unit of enterokinase. 
-115-
A 










 1 2 3 4 5 6 7  8 9 10 1 2 3 4 5 6 7  8 9 10 
118 kDa 
















                                                        



































































































Figure 4.5 Subcellular location of leucine aminopeptidase of M. gallinarum. A. SDS-PAGE of
the loaded protein samples; B. Western-blot results with chicken serum before challenging with
APN-trxA recombinant protein; C. Western-blotting results with chicken anti-APN-trxA 
polyclonal serum. Lane 1: Protein molecular weight marker; Lane 2: AD494(DE3)pLysS cells
with trxA recombinant proteins; Lane 3: AD494(DE3)pLysS cells with APN-trxA recombinant
proteins; Lane 4: purified inclusion body (APN-trxA recombinant protein); Lane 5: M.
gallinarum total protein; Lane 6: M. gallinarum Triton X-114 phase hydrophobic partition; Lane
7: M. gallinarum Triton X-114 phase hydrophilic partition; Lane 8: M. gallinarum ultrosonic
membrane fraction; Lane 9: M. gallinarum ultrasonic cytosolic fraction; Lane 10:
AD494(DE3)pLysS cell control. 
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A B C 
Figure 4.6 Western-blot hybridization results with chicken serum samples with M. gallinarum 
infection. A. SDS-PAGE for loaded protein samples; B. Results with SPF chicken negative 
control serum; C. Results with NIH Donkey anti-M. gallinarum polyclonal positive control serum; 
D. Results with chicken serum sample 59; E. Results with chicken serum sample 139; F. Results 
with chicken serum sample 292. Lane 1: protein molecular weight marker; Lane2. M. 




                                 
                                                   
                          
 
 
                                                     
 






























































































































































Figure 4.7 Western-blot hybridization results with chicken serum. A. SDS-PAGE for loaded 
protein samples; B. Results with SPF chicken negative control serum; C. Results with NIH
Donkey anti-M. gallinarum positive control serum; D. Results with chicken serum sample 59.
Lane 1: Protein molecular weight marker; Lane2: AD494(DE3)pLysS insoluble proteins; Lane 3:
AD494(DE3)pLysS soluble proteins; Lane 4: soluble protein of AD494(DE3)pLysS with APN-
pET32b(+) after induction with 3 mM IPTG at 37 °C for 3 hr; Lane 5: insoluble protein of
AD494(DE3)pLysS with APN-pET32b(+) after induction with 3 mM IPTG at 37 °C for 3 hr ; 
Lane 6: purified APN-trxA inclusion body; Lane 7: purified APN-trxA digested with
enterokinase; Lane 8: M. gallinarum total protein; Lane 9: M. gallinarum membrane protein 
























Summary of results 
A leucine aminopeptidase gene from M. gallinarum was cloned, sequenced, and
characterized. The leucine aminopeptidase gene reported in this paper is the first protein coding
gene cloned and characterized in M. gallinarum. This represents the second leucine
aminopeptidase gene characterized in mycoplasmas after leucine aminopeptidase gene from M.
salivarium (Shibata et al. 1995). 
The cloned leucine aminopeptidase gene has a closer phylogenetic relationship to the
leucine aminopeptidase of M. salivarium than do other mycoplasma aminopeptidase genes. The
cloned leucine aminopeptidase gene conserved the enzyme active sites reported previously
(Burley et al. 1990; Kim and Lipscomb 1993; Strater and Lipscomb 1995a; Strater and Lipscomb
1995b). An enzyme activity assay confirmed the presence of leucine aminopeptidase activity in M.
gallinarum. The enzyme activity was enhanced effectively with Mn2+ and inhibited by EDTA.
This suggests that the enzyme is a metallo-aminopeptidase. Subcellular location of leucine 
aminopeptidase with ultrasonic treatment indicated this enzyme is a cytosolic protein with a weak
interaction with cell membrane of M. gallinarum cells. Thus this enzyme belongs to the family of 
leucine aminopeptidase (EC 3.4.11.1). The cloned leucine aminopeptidase gene has a 1,562 bp
open reading frame, which is transcribed as a moncistronic message. 
To further analyze the functions of the leucine aminopeptidase of M. gallinarum, the
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encoded four TGA codons were successfully mutated into TGG to facilitate the overexpression of
the cloned gene in E. coli. A very high level of expression was obtained after induction with
IPTG, and the recombinant proteins were purified for production of antisera and investigation of
host humoral immune responses against this protein in natural infection. Western-blot results
showed that M. gallinarum stimulated the chicken to generate very limited specific antibodies
against some M. gallinarum proteins but not against the leucine aminopeptidase of M. gallinarum. 
The recombinant protein was used to immunize in chickens to generate polyclonal sera,
which recognized a 51 kDa protein in M. gallinarum. Using the anti-sera, Triton X-114 phase
partition confirmed the subcellular location of leucine aminopeptidase of M. gallinarum. 
Mycoplasma gallinarum is a non-host specific mycoplasma and its growth requires most of the
standard amino acids. This suggests that the activity of leucine aminopeptidase may play a role in
the nutritional supply during host adaptation of M. gallinarum. 
Future work 
Future work needs to evaluate the substrate specificity of the cloned aminopeptidase of M.
gallinarum. An appropriate protein refolding method should be explored. More work is also 
needed to evaluate the role of leucine aminopeptidase in vivo and in vitro in host adaptation of M.
gallinarum. If the aminopeptidase has a role in nutrition, it should be possible to produce an
aminopeptidase activity negative mutant that can grow in amino acid supplying media. Based on
our data, we can use a transposon to generate a leucine aminopeptidase activity negative M. 
gallinarum strain. We can compare the effects of this enzyme on the survival of M. gallinarum
during amino acid starvation. In addition, understanding the regulation of gene expression of
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Culturing media 
LB Medium (Luria-Bertani Medium) (pH7.0) 2XYT Medium (pH 7.0) 
Bacto-tryptone                   10 g Bacto-tryptone                   16 g
Bacto-yeast extract      5 g Bacto-yeast extract                      10 g
NaCl                10 g NaCl 5 g
H2O              1 litter H2O              1 litter 
For plates add 12 g agar For plates add 12 g agar 
Mycoplasma media (pH 7.7)
Part A 
     Frey Brot               22.5 g
Dextrose     3 g
H2O          500 ml
After autoclaving Part A, mixed with Part B
Part B 
     Porcine serum                120 ml
     Penicillin                     0.64 g
 Q.S. to 500 ml with  sterile H2O 
Southern-blot and Northern-blot hybridization buffer 
Denature Buffer Neutralization Buffer
NaOH 20 g Tris HCl                        60.55 g
NaCl                 87.5 g NaCl              175.5 g
Q.S. to 1 liter with H2O Ajust pH to 7.4 with HCl  






                           
                        
                  
                                   
 
 
                           
                        
                              





                           
                    
                                  
 
                           
                    





              
         
                             
                      
                
 
                         
                                   
                           




                         
                                   
                              
                                
 
 
                                          
                                   




SDS-PAGE and Western-blot hybridization buffer 
Running Buffer
Tris Base   
Glycine        
SDS 
Q.S. to 1 liter with H2O 
1.5M Tris (pH 8.8) 
Tris Base   
Tris HCl           
Q.S. to 100 ml with H2O 
Sample Prep Buffer
H2O 






KCl   
Na2HPO4 
KH2PO4 
Q. S. to 1 liter with H2O 
               3.03 g
               14.4 g
                1.0 g
            15.39 g
              3.69 g
              4.8 ml
              1.2 ml
              1.0 ml
               2.0 ml
               0.5 ml
               8.0 g
                0.2 g
              1.44 g
              0.24 g
Transfer Buffer
Tris Base                  3.03 g
Glycine                        14.4 g
Methanol                200 ml
Q. S. to 1 liter with H2O 
1.0 M Tris (pH 6.8) 
Tris Base                 0.8 g
Tris HCl                        14.6 g
Q.S. to 100 ml with H2O 
 TBS (25 mM) 
NaCl               8.0 g
KCl                  0.2 g
Tris Base                  3.3 g
Tris HCl                        0.48 g
Q. S. to 1 liter with H2O 
 Distain solution
Ethenol       2.5% 
Galactic acid     7.5% 
dH2O 90% 
